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Attaching and effacing (A/E) pathogens contribute to a significant burden of diarrheal 
disease, which accounts for 10% of childhood deaths under age 5 worldwide.  These Gram-negative 
bacterial pathogens have evolved sophisticated and complex mechanism to regulate the host immune 
responses and manipulate their microenvironment. Through combined approaches including in vivo 
Citrobacter rodentium mouse infection models and in vitro protein assays, we have uncovered a novel 
mechanism by which A/E pathogens regulate the nuclear factor kappa B (NF-κB) signaling pathway 
in the host cell. Briefly, A/E pathogens encode a type III secretion system that is used to deliver 
virulence proteins (effectors) into the host cell. Among these, the zinc metalloprotease, NleC, targets 
p65 within the host cell as a substrate for cleavage. While only cleaving a small percentage of the total 
p65 molecules within the cell, NleC mediates a robust effect on inflammatory signaling. This 
amplification is achieved by the interaction between the small N-terminal fragment of p65, produced 
by NleC cleavage, with RPS3, the NF-κB promoter specifier. RPS3 is a non-Rel subunit protein 
present within the NF-κB complex that targets the transcriptional activation of a select sub-set of 
NF-κB target genes. Thus, we have revealed a novel mechanism by which A/E pathogens regulate 
gene expression within the host that may serve as a model for the many other pathogen-encoded 
proteases that selectively target p65 as a substrate. We have also identified a novel virulence factor in 
C. rodentium that abrogates the pathogen’s ability to generate an inflammatory response following 
infection. Disruption of a DNA recombinase prevents the intimate attachment of C. rodentium to 
colon epithelial cells in the IL-22-/- mouse which is exquisitely permissive to infection, however 
further work is need to determine the mechanism by which this occurs. The work presented in this 
thesis serves as an example of the importance of examining how the host-pathogen interactions 
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1 Introduction 
1.1 Attaching and effacing pathogens 
Diarrheal disease is responsible for approximately 10% of the deaths in children under 5 
worldwide, with the majority of that burden being shouldered by the developing world (Croxen et al., 
2013; Kotloff et al., 2013; Liu et al., 2012). Rotavirus, Cryptosporidium, and pathogenic bacterial 
infections are the leading causes of diarrheal disease with the Gram-negative Escherichia coli (E. coli) 
pathogens accounting for a large burden of those cases (Croxen et al., 2013). One type of pathogenic 
E. coli strains are classified as attaching and effacing (A/E) pathogens due to the characteristic lesion 
formed on the epithelial brush border upon infection and are transmitted through the fecal-oral 
route. The characteristic A/E lesion occurs by the delivery of the bacterial receptor Tir into the host 
cell, via a type three-secretion system (T3SS) (McDaniel et al., 1995), causing the rearrangement of 
actin and many other host cellular proteins to form pedestals (Goosney et al., 2000). It is through 
these formations the bacteria are able to anchor themselves onto the epithelial cell and cause disease, 
however the specific mechanisms by which these pathogens cause disease remains an area of active 
investigation.  
1.1.1 EPEC/EHEC 
There are six currently recognized pathogenic profiles of E. coli that range in their expression 
of virulence factors, infection sites, and disease profile. Of these, enteropathogenic E. coli (EPEC) 
and enterohemorrhagic E. coli (EHEC) are among the best studied. EPEC is a leading cause of 
diarrhea in infants, 0-11 months in age, in low-income countries (Croxen et al., 2013; Kotloff et al., 
2013). Estimates of mortality following dehydration range as high as 1 million infants a year (Mead et 
al., 1999). EPEC was first isolated following a series of diarrheal outbreaks among infants in the 
1940s and 1950s (Robins-Browne, 1987). Since then, the disease outbreaks associated with EPEC 
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have shifted from primarily in the developed world into the developing world, with sporadic 
food/water borne outbreaks still occurring within the developed world (Croxen et al., 2013).  
EHEC, however, is more prevalent in developed countries and differentiates itself mainly 
through the expression of Shiga toxin 1 or 2 (stx1 or stx2). The most commonly isolated serogroup 
of EHEC, O157:H7, is associated with contaminated food and water borne exposure. EHEC causes 
a more severe form of diarrhea that, in some, is accompanied by hemorrhagic colitis resulting in 
hospitalizations in 42% of cases and sometimes death (Croxen et al., 2013; Levine, 1987). In 
approximately 15% of childhood infections, EHEC causes hemolytic uremic syndrome, leading to 
acute renal failure (Law et al., 2013; Tarr et al., 2005). The severity of disease caused by EHEC is 
attributed to toxin production and release. While the regulatory mechanisms of Stx gene expression 
are yet unclear, hydrogen peroxide exposure from neutrophils in the gut and antibiotic treatment are 
known to facilitate the release of stx toxins into the gut (Johannes and Romer, 2010). The toxin 
blocks protein synthesis by selectively targeting the 3’ end of 28S rRNA, which results in deficient 
host cellular processes and inflammatory signaling.  
EPEC and EHEC have a limited range of hosts for infection making studying these infections 
in vivo extremely challenging. The restricted host range has necessitated the use of related bacterial 
strains for the development of animal models, which has given rise to the C. rodentium – murine 
infection model. 
1.1.2 C. rodentium 
The rodent-restricted pathogen, non-motile, Citrobacter rodentium (C. rodentium), was isolated 
following a series of disease outbreaks in mouse colonies and was originally classified as a murine 
pathogenic E. coli (Petty et al., 2010). However, it was determined that C. rodentium caused this 
transmissible colonic hyperplasia resulting in colonic thickening that could spread to co-housed mice 
(Mundy et al., 2005). Following its isolation, C. rodentium was used to examine host pathogen 
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interaction within the gut, providing a robust animal model for the study of A/E pathogens. Prior to 
the use of the C. rodentium-mouse infection model, studies on A/E pathogens were limited to in vitro 
experimental systems where characterizing the immune response to infection was restricted to innate 
signaling pathways.   
In orally inoculated mice, the non-invasive C. rodentium colonizes the cecum within a few 
hours and within a few days spreads to the distal colon (Wiles et al., 2004). This is followed by the 
infiltration of inflammatory cells, mostly neutrophils. Bacterial numbers reach their peak around 14 
days post infection, and complete clearance is achieved by 28 days post infection (Wiles et al., 2004). 
The immune response to C. rodentium infection elicits a robust CD4 T cell response and antibody 
response that provides sterilizing immunity to subsequent infections (Collins et al., 2014). Despite C. 
rodentium being a natural mouse pathogen there are variations in the susceptibility of each strain to 
morbidity and mortality, with C57Bl/6 mice experiencing limited mortality while C3H/HeJ mice 
experiencing high mortality (Mundy et al., 2005). Infection in mice recapitulates many of the same 
clinical manifestations of EPEC and EHEC infection in humans and therefore C. rodentium became 
widely used as a model to study the innate and adaptive immune response to A/E infection (Collins 
et al., 2014; Koroleva et al., 2015; Lebeis et al., 2008; Mundy et al., 2005). This is particularly 
important since neither EPEC nor EHEC can naturally infect mice, making understanding these 
pathogens challenging. EPEC, EHEC, and C. rodentium share 67% of their genes (Petty et al., 2010), 
among which are the LEE pathogenicity island, the T3SS, and many of the effectors used to 
modulate their microenvironment (Collins et al., 2014). The interactions of these effectors with many 
host proteins has led to the further characterization of host responses toward A/E pathogens, 
providing additional insight into the complex responses following infection with EPEC or EHEC. 
However, novel effector proteins continue to be identified and characterized for their roles in 
mediating pathogenesis. As the list of effectors and their functions grow, so does the appreciation of 
the interaction with host signaling cascades, which remains a fertile area of study. 
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Aside from acting as a model for studying infection, the inflammatory response following C. 
rodentium colonization has been used to model Crohn’s disease and ulcerative colitis. The involvement 
of bacterial immune stimulation and the differences in microbiota between healthy controls and IBD 
patients suggest that bacteria play an important role in driving IBD (Wu and Wu, 2012). The role of 
the microbiota has been widely studied for its interaction with the immune sensors in the gut. The 
interplay between the innate immune system and the microbiota commonly induce immune 
tolerance, where the immune system will not react to commensal organisms but still activate in 
response to colonization by foreign pathogens (Wu and Wu, 2012).  Studies using germ free mice 
have demonstrated that the presence of the microbiota can modulate the responses of immune cells 
and lead to skewed immune responses (Bergstrom et al., 2012; Buffie and Pamer, 2013; Collins et al., 
2014; Lievin-Le Moal and Servin, 2006; Wu and Wu, 2012). It appears that antigens from the 
microbiota prime the innate and adaptive responses by stimulating specific responses, leading to 
constitutive low level mucus production, antimicrobial peptides and appropriate T cell responses, 
which work to keep the microbiota in check (reviewed in (Lievin-Le Moal and Servin, 2006; Wu and 
Wu, 2012)). These immune stimulatory effects and the nutrient-competitive environment of the gut 
also provide another level of protection against pathogen invasion. In fact, when the microbiota of 
mouse strains traditionally resistant to infection by C. rodentium are transferred to traditionally 
susceptible mice, the recipient mice achieve resistance as well (Ghosh et al., 2011; Willing et al., 
2011).  However, the microbiota is sensitive to disruption by overt inflammatory responses, antibiotic 
use, and invasion by pathogens. The inflammatory response to infection alters the microbial 
composition in the gut and may lead to a more permissive environment for the invading pathogen 
(Lupp et al., 2007). This dysbiosis alters the diversity of the microbiota and reduces the population of 
commensals while allowing C. rodentium to multiple to overwhelming numbers (Lupp et al., 2007).  
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1.1.2.1 Genetic organization and similarity to EPEC/EHEC 
EPEC, EHEC, and C. rodentium share 3000 genes out of 5000 encoded by C. rodentium, 
accounting for the similarities in their infection phenotypes and virulence mechanisms, while 
maintaining approximately 1,500 unique genes (Petty et al., 2010). The C. rodentium genome is 
composed of one bacterial chromosome and four plasmids. The 5.3 Mb genome encodes roughly 
5000 predicted coding sequences distributed over 17 genomic islands (Petty et al., 2010). Aside from 
the LEE encoded T3SS, C. rodentium also encodes a type IV pilus and 2 putative T6SSs some of 
which are shared with either EPEC or EHEC. C. rodentium also encodes 29 effector proteins that are 
delivered into host cells via the T3SS, 22 of which are also found in EPEC and other A/E pathogens 
(Petty et al., 2010).  
Bacteria are capable of acquiring genetic material either from their surrounding environment, 
phage infection, or through horizontal gene transfer. This leads to the generation of highly variant 
strains of bacteria that while related induce different pathology via different mechanisms. It was 
determined that the C. rodentium genome shows a high degree of insertional sequences and 
pseudogenes that suggests that its genome is highly dynamic (Petty et al., 2011). These sequences are 
also associated with almost half of the shared genes between EHEC and EPEC that are not part of 
the core E. coli genes. The sequence identity and evidence of more recently acquired genes led to the 
conclusion that EHEC, EPEC, and C. rodentium demonstrate convergent evolution. This genetic flux 
is hypothesized to account for the adaptability of C. rodentium, and other A/E pathogens, to their 
surrounding environment, chiefly the harsh conditions of the gastro-intestinal tract. Petty and 
colleagues determined that following stressors from the host, prophages within the genome might be 
activated to induce a different transcriptional profile (Petty et al., 2011). The exact mechanisms, 
protein mediators, and regulation of these recombination events remain unclear and further work is 
needed to elucidate these events during infection. 
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1.1.3 Virulence factors 
The LEE pathogenicity island is structured into 5 operons that control 41 genes encoding 
gene regulators, the genes needed for the structural proteins of the T3SS, the genes needed for 
bacterial attachment, and the core set of secreted protein effectors (Deng et al., 2001; Goosney et al., 
2000). The T3SS encoded by LEE is composed of the structural proteins, EspA, EspB, EspD that 
function to create the translocon used to translocate bacterial effector proteins from the bacterial 
cytoplasm into the host cell cytoplasm. Among those effectors, the translocated intimin receptor (tir) 
is the best studied and induces the formation of pedestals and mediates the strong attachment of 
these bacteria to host epithelial cells by binding to its receptor intimin on the bacteria (Croxen et al., 
2013; Goosney et al., 2000; Mundy et al., 2005). The remaining LEE encoded effectors are primarily 
involved in assisting in the tight binding of bacteria to the host cell, however some have roles within 
the host as well. It is through the expression of the LEE virulence genes that C. rodentium is able to 
maintain its close colonization of the epithelial cells during the early stage of infection, bypassing the 
mucus layer and therefore establishing itself away from the competition of the microbiota (Kamada 
et al., 2012). However, as the infection peaks around 12-14 days post infection, LEE expression is 
down-regulated and C. rodentium colonization shifts toward to the lumen where they are eventually 
outcompeted by the microbiota (Kamada et al., 2012).  
The regulation of the LEE pathogenicity island is well studied, owing to its importance for 
A/E lesion formation. The Ler protein promotes the transcriptional activation of the LEE operons, 
as well as GrlA, another positive regulator, as well as GrlR, the negative regulator of LEE (Deng et 
al., 2004; Yang et al., 2010). Encoded by the LEE1 operon, Ler expression is controlled by other 
common transcriptional activators that are stimulated by environmental factors. Ler acts to stimulate 
the expression of GrlA, which further stimulates the transcription of the remaining LEE encoded 
genes. GrlR expression is also induced and it negatively regulates LEE by blocking the transcription 
of the LEE1 operon, limiting the expression of Ler and GrlA (Deng et al., 2004; Yang et al., 2010). 
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1.1.3.1 T3SS effectors 
Aside from the LEE encoded effectors, EPEC, EHEC, and C. rodentium encode a variety of 
non-LEE effectors that have been collected through mobile genetic elements. Of the 29 effectors 
currently recognized in C. rodentium, 22 are shared with EPEC and EHEC (Petty et al., 2010). The 
flanking DNA sequences surrounding these genes suggest that these were mostly acquired through 
horizontal gene transfer. The effectors are proteins of diverse functions such as proteases, kinases, 
adhesions, ligases, etc. (Wong et al., 2011). The functions of these effectors allow for the virulence 
associated with each of these pathogens, accounting for the shared and unique mechanisms each of 
these pathogens employ. The fact that C. rodentium encodes so many of the same virulence factors as 
EPEC and EHEC has greatly advanced the study of these pathogens and the understanding of their 
pathogenesis. Of these 29 effectors, 7 are the LEE effectors related to A/E lesion formation, and the 
remaining have functions relating to manipulating the host signalling pathways (Petty et al., 2010; 
Wong et al., 2011). Effectors have been implicated in altering actin polymerization, NF-κB signaling, 
tight junction maintenance, cell survival and apoptosis, ion transport, and other cell outcomes. Often 
many effectors will target multiple levels of a particular pathway. For example, NleB, NleC, NleH, 
and NleE have all been shown to alter various stages of the NF-κB pathway (Baruch et al., 2011; 
Shames and Finlay, 2012; Wong et al., 2011). Among the variety of effectors, the non-LEE encoded 
effectors (Nle) NleH and NleC are of particular interest to this thesis due to their interaction with 
NF-κB signaling and RPS3 (see section 1.2.2.2).  
1.1.3.1.1 Kinases NleH1 and NleH2 
EPEC and EHEC encode two NleH effectors, NleH1 and NleH2, of which only NleH1 has 
a homolog in C. rodentium. These two effectors share high sequence homology to each other, 84% 
similar, as well as to the Shigella OspG effector, known to alter the NF-κB pathway (Tobe et al., 
2006). These proteins have a conserved kinase active site and are PDZ-domain containing proteins 
(Wong et al., 2011). NleH1 and NleH2 were shown to block apoptosis in infected cells by interacting 
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with Bax-inhibitor 1 and preventing the action of caspase-3 (Hemrajani et al., 2010). Unlike the 
OspG effector, which inhibits the NF-κB pathway by preventing the ubiquitination and degradation 
of IκB, NleH1 and NleH2 were found to bind to RPS3, a specifier of NF-κB activity (Gao et al., 
2009; Wan et al., 2007). It was determined that NleH1 blocks the phosphorylation of RPS3 at serine 
209 by IKK that is required for its nuclear function in stimulating the expression of a subset of NF-
κB genes (Wan et al., 2011). The kinase function of NleH1 is required for its function, however it 
does not direct phosphorylate RPS3 or IKK. Furthermore, NleH1 blocked the activation of an 
RPS3-dependent reporter plasmid, whereas NleH2 induced the expression of the reporter (Gao et al., 
2009). Using NleH1 to selectively manipulate NF-κB gene expression results in an incomplete 
inflammatory response to infection, and in fact an NleH mutant strain was demonstrated to be 
hyper-virulent (Gao et al., 2009). As discussed in Chapter 2 and 3 of this thesis, the selective 
inhibition of the RPS3 branch of NF-κB signaling is a novel mechanism by which A/E pathogens 
can acutely regulate their microenvironment.  
1.1.3.1.2 NleC 
NleC is a zinc metalloprotease that has been extensively studied in the last few years. In a 
series of screening experiments, NleC was identified as down-regulating the expression of IL-8, a key 
proinflammatory chemokine that recruits neutrophils. As a protease, it was determined that NleC 
cleaves p65 in order to reduce the activity of the NF-κB pathway within the infected cell (Li et al., 
2014; Muhlen et al., 2011; Pearson et al., 2011; Turco and Sousa, 2014; Yen et al., 2010). More 
detailed mutagenesis experiments determined that the N-terminus of NleC was needed for the 
interaction with p65 and that NleC contained an HEXXH motif conserved amongst 
metalloproteases (Muhlen et al., 2011). Chelating zinc ions, such as with EDTA, is sufficient to block 
the cleavage of p65, as is mutagenesis of the conserved metalloprotease motif (Baruch et al., 2011; Li 
et al., 2014; Muhlen et al., 2011; Yen et al., 2010). Aside from p65, NleC has also been demonstrated 
to cleave p300 (Shames et al., 2011), p50 (Muhlen et al., 2011; Pearson et al., 2011; Turco and Sousa, 
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2014), and IκB (Muhlen et al., 2011). However, the majority of these studies are using over 
expression systems that utilize ectopically expressed proteins at non-relevant concentrations, which 
may provide false positive results. Given the sequence homology between p50 and p65 at the Rel 
homology domain, further examination of the mechanisms by which NleC targets its substrates is 
required to determine specificity. Moreover, there are discrepancies in the field regarding the cleavage 
site on p65, with proline 10 and alanine 11 (P10/A11) (Yen et al., 2010), and cysteine 38 and 
glutamic acid 39 (C38/E39) (Li et al., 2014; Muhlen et al., 2011; Turco and Sousa, 2014) both 
proposed by different studies. The complete cleavage of p65 within the cell will affect the cell’s ability 
to respond to pathogen infection by blocking activation of inflammatory genes, block anti-apoptotic 
signaling to protect the cell from death, and alter other cellular pathways. However, NleC only 
mediates cleavage of a small percentage of p65, leaving a large amount of full-length p65 present 
within the cell available for activating gene transcription. It is therefore striking that despite only 
cleaving a small portion of the total p65 present within the cell, there is such a large effect on the 
transcription of IL-8 as has been measured by multiple studies (Li et al., 2014; Muhlen et al., 2011; 
Pearson et al., 2011; Turco and Sousa, 2014; Yen et al., 2010). The specific cleavage site and amount 
of cleavage is of particular interest as the sequence and fate of the cleavage product may have 
important downstream implications as discussed more thoroughly in Chapters 2 and 3.  
1.1.3.2 Phase variation 
Aside from directly manipulating host proteins in an effort to subvert host responses to 
infection, bacteria also use phase variation to alter the expression of antigens on their cellular surface 
to evade recognition by antibodies (Goldberg et al., 2014). This process of inducible phenotypic 
heterogeneity involves the reversible rearrangement of genetic elements to turn on and off the 
expression of select genes (van der Woude and Baumler, 2004). Phase variation is either carried out 
via the homologous recombination machinery or through recombinases that recognize specific 
flanking sequences. Studied since the early 1920s, the antigenic variations seen in Salmonella 
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infections have been attributed to hin gene that encodes the Hin-catalyzed site-specific DNA 
invertase, a serine DNA recombinase that functions as part of an operon (reviewed (Johnson, 2015)). 
Briefly, the Hin system involves a specific enhancer, two imperfect palindromic sequences, and a 
promoter. The Hin brings together the enhancer regions along with the two palindromic sequences 
and mediates the inversion of the intervening DNA sequence. Transcription of the flagellin genes 
depends on the orientation of the promoter sequence, where in the “on” orientation the FljB flagellin 
is expressed along with the repressor for FljC flagellin. In the “off” orientation, neither the FljB nor 
the FljC repressor is transcribed, allowing for the transcription and translation of the FljC gene, 
respectively (reviewed (Johnson, 2015). This antigenic variation strategy allows immune escape, 
rendering the antibody response generated toward the original antigen obsolete, giving Salmonella a 
temporary advantage over its host.  In E. coli the fim operon functions a similar way to regulate the 
expression of fimbriae, a major target for the immune response and a virulence factor that mediates 
the early stages of bacterial attachment to epithelial cells. It remains to be seen what other virulence 
factors may be controlled in such a manner. 
1.2  Innate responses 
As the first line of defense against infection, the innate immune response to the gut 
microbiota and infection begin to shape the inflammatory response and the outcome of disease. The 
functions of the innate immune response contribute to the clearance of C. rodentium infection and 
structure the subsequent adaptive immune response (Collins 2014, Liu 2012). Gut epithelial cells, 
macrophages, dendritic cells, and the innate lymphocytes lining the intestinal mucosa form a barrier 
that physically separates the microbiota and invading bacteria from the immune system (Peterson 
2014). Aside from the physical barrier, these cells also interact with bacteria by producing various 
anti-microbial peptides, mucin, cytokines and chemokines in response to microbial stimulation.  
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1.2.1 Maintenance of the mucus barrier 
The mucus layer within the colon exists to minimize the direct contact of the colonic 
epithelial cells with the microbiota to prevent inducing an overwhelming immune response (Peterson 
and Artis, 2014). In order to maintain this physical barrier, specialized epithelial cells produce and 
secrete mucin proteins into the luminal space where they form a complex network. There are two 
layers of mucus covering the entire length of the human colon, which are the loosely attached outer 
layer and the intimately attached inner layer (Johansson et al., 2011). Studies examining the 
localization of Muc2, the most abundant mucin protein, demonstrate the difference in density of the 
outer and inner layers as well as the exclusion of bacteria from the inner layer (Johansson et al., 
2011). The outer mucus layer, however, is heavily colonized by the microbiota as it provides both a 
scaffolding and a nutrient source (Bergstrom et al., 2010; Johansson et al., 2011; Lievin-Le Moal and 
Servin, 2006; Mizoguchi, 2012). The mucin proteins are heavily glycosylated and form long polymers 
that along with other proteins, such as trefoil factor 3 (TFF3), secreted into the lumen form a cross-
linked and complex network (Johansson et al., 2011). This dense network is relaxed by proteolytic 
cleavage events as it moves toward to the lumen and more mucin is secreted by goblet cells 
(Johansson et al., 2011).  
Goblet cells produce mucins and anti-microbial peptides in response to IL-22-STAT3 
signaling (Lievin-Le Moal and Servin, 2006; Mizoguchi, 2012; Sugimoto et al., 2008). TFF3 and 
resistin-like molecule- (RELM) are among the anti-microbial peptides that further stimulate 
epithelial cells and goblet cells in a positive feedback loop, enhancing the barrier integrity by 
providing repair signals (Peterson and Artis, 2014).  However since goblet cells rely on these signals 
in order to produce mucus, alterations to the microenvironment can have robust effects on the 
mucus layer. Antibiotic treatment (Wlodarska et al., 2011), infection (Linden et al., 2008), and 
depletion of IL-22 (Sugimoto et al., 2008), can all affect the production of mucin. Most animal 
models of spontaneous colitis (such as Muc2-/-, IL10-/-, or TLR5-/- mice) also have altered mucus 
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layers (Johansson et al., 2014) emphasizing the importance of this physical and chemical barrier in 
separating the mucosa from the microbiota. The lack of the mucus layer leads to constant stimulation 
and ulcerative lesions along the mucosa resulting in barrier permeability and inflammatory responses. 
The effect of infection and injury on mucus production and the immune mediated regulatory 
mechanisms inducing mucin production requires more detailed study. 
1.2.2 Innate signaling pathways 
Various cellular immune receptors, either on the cellular surface or within the cytoplasm, act 
to initiate signaling cascades that activate diverse aspects of the immune response. These receptors 
are classified as pattern recognition receptors (PRRs) and they recognize pathogen-associated 
molecular patterns (PAMPs). PRRs recognize a varied but restricted number of microbial structures 
that are conserved across many pathogens. Among the PRRs are the Toll-like receptors (TLRs) 
which sense viral, bacterial, and parasite PAMPs (Janssens and Beyaert, 2003; Mogensen, 2009; 
Uematsu and Akira, 2006); the Nod-like receptors (NLRs) that sense primarily bacterial PAMPs but 
also chemical danger signals (Chen et al., 2009; Franchi et al., 2009; Sirard et al., 2007; Wen et al., 
2013); and the RIG-I-like receptors (RLRs) that sense nucleic acids, primarily viral RNA (Dixit and 
Kagan, 2013; Schlee et al., 2009) (reviewed in (Tam and Jacques, 2014)). PRRs stand as the first step 
in a signaling cascade that involves many scaffold and adaptor proteins that work to transmit and 
amplify signals from the site of detection (cell surface or endosome) to nucleus to induce a cellular 
response. Each pathway differs in their use of adaptor molecules and the steps needed to activate a 
response, yet these pathways all eventually activate a set of transcription factors to cause 
transcriptional activation of a set of target genes. Effector functions such as inducing the expression 
of anti-microbial peptides, reactive oxygen species, and chemokine production to recruit 
inflammatory cells to the site of infection are all induced following activation of innate signaling 
pathways (Bergstrom et al., 2012; Kawai and Akira, 2010).  In the intestinal epithelium, these PRR 
function to maintain a constant low level of stimulation, from the microbiota, providing important 
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signals for maintaining homeostasis; in the absence of the microbiota, dysregulation occurs (Rakoff-
Nahoum et al., 2004). Homeostatic activation results in the intestinal epithelial and resident immune 
cells striking a constant balance between basal and inflammatory signalling. In an attempt to strike 
this balance, PRRs responsiveness is segregated along the polarized epithelial cell layer, with apical 
(luminal) stimulation resulting in very little activation or tolergenic responses, whereas basolateral 
stimulation results in the inflammatory activation (Blander and Sander, 2012; Gewirtz et al., 2001; 
Lee et al., 2006; Rhee et al., 2005).  
1.2.2.1 TLRs, NODs, and sensing bacterial infection 
The TLRs are transmembrane protein receptors that recognize pathogens at either the 
cellular surface (TLR1, TLR2, TLR4, TLR5, TLR6) or from within endosomes (TLR3, TLR7, TLR8, 
TLR9) (Barton and Kagan, 2009). TLR1, TLR2, TLR4, TLR5, and TLR6 detect bacterial products 
such as lipoproteins and flagellin (Tam and Jacques, 2014). The other TLRs primarily sense nucleic 
acids that originate from bacteria, viruses, or parasites (Albiger et al., 2007; Bafica et al., 2006; Barber, 
2011; Barton, 2007; Tam and Jacques, 2014). Following extracellular (or endosomal) receptor 
engagement, the TLRs dimerize leading to the auto-phosphorylation of their cytosolic 
Toll/Interleukin 1 receptor (TIR) domains. The following events are dependent on the specific TLR 
involved and the stimuli. The TLR’s TIR domains will interact with the TIR domains of either of two 
adaptor molecules, myeloid differentiation primary response gene 88 (MyD88) or TIR-domain-
containing adapter-inducing interferon-β (TRIF). For the purposes of this thesis we will focus on 
TLR2 and TLR4, whose involvement has been reported in response to C. rodentium infection (Gibson 
et al., 2008). TLR2 forms heterodimers with TLR1 and TLR6 giving it a broader range of bacterial 
lipid detection and ultimately activates NF-κB. In contrast, TLR4 forms homodimers and specifically 
detects Gram-negative bacterial lipopolysaccharide (LPS) leading to the downstream activation of 
NF-κB and IRFs (Kagan et al., 2008). Both TLR2 and TLR4 signal through the MyD88 adaptor 
protein (Kawai et al., 1999; Takeuchi et al., 2000), which interacts with several interleukin-1 receptor-
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associated kinase (IRAKs) proteins, then TNF-receptor-associated factor 6 (TRAF6) and a series of 
other kinases and ubiquitin conjugating enzymes that result in the activation of the MAPK (leading 
to p38 and JNK activation) and NF-κB pathways (Chen, 2005). TLR4 can also signal independent of 
MyD88, using the TRIF adaptor, leading to the downstream activation of IRF3 and IRF7 (Hirotani 
et al., 2005; Yamamoto et al., 2003). The activation of these transcription factors leads to 
inflammatory immune responses engineered to aid in clearing infections, albeit these immune 
responses can also induce some pathology (Bhullar et al., 2015).  
 The role of TLR4 in activating immune responses during systemic infection has 
demonstrated its importance in limiting disease spread (Campos et al., 2004; Mann et al., 2004; 
Miyake, 2004; O'Brien et al., 1982; Schilling et al., 2003; Vazquez-Torres et al., 2004). However, 
during C. rodentium infection in the gut, TLR4 was revealed to have an immunopathogenic effect. 
Immunopathology is being recognized more and more for causing a lot of the damage to the host 
previously associated with infections (Karupiah and Chaudhri, 2007; Yang et al., 2013). Namely, 
TLR4 expressing mice experienced more severe disease as measured by tissue pathology and 
infiltrating immune cells. Moreover, the spread of C. rodentium through the colon was slowed in 
TLR4-/- mice, taking longer to reach high numbers in the distal colon (Khan et al., 2006). Despite the 
delay in colonization, TLR4-/- mice were still able to clear the infection at a similar rate as wild-type 
mice, likely due to other compensatory signaling pathways. TLR4 signaling was found to be 
important for the transcriptional activation of two chemokines, MIP-2 and MCP-1. This results in 
the recruitment of macrophages and neutrophils in response to infection (Khan et al., 2006). This 
unexpected effect of TLR4 deficiency may have more to do with the low level of TLR4 expression in 
colonic epithelial cells, which are the primary site of C. rodentium infection. In contrast, the high levels 
of TLR4 expression in macrophages may yield the greater effects of TLR4 in systemic disease 
(Schilling et al., 2003; Vazquez-Torres et al., 2004). Similarly, in TLR4-/- mice, less severe 
inflammation occurs in the dextran sodium sulfate (DSS) model of intestinal inflammation. This 
effect was attributed to decreased chemokine expression, despite an overall increase in morbidity in 
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DSS-treated TLR4-/- mice (Fukata et al., 2005; Rakoff-Nahoum et al., 2004). The differences in 
responses in these inflammatory models may stem from the mechanisms by which these models 
induce tissue injury.  
Conversely, the role of TLR2 in regulating C. rodentium infection in the mouse intestinal tract 
was explored utilizing the TLR2-/- mouse TLR2 was hypothesized to be necessary for inducing the 
activation of the immune response from the lipoproteins produced by the bacteria (Gibson et al., 
2008). Interestingly, during infection TLR2-/- mice induced a similar profile of inflammatory 
cytokines and chemokines to wild-type mice with C. rodentium infection (Higgins et al., 1999; 
Simmons et al., 2002), indicating that TLR2 signaling does not play a role in clearing the pathogen 
(Gibson et al., 2008). However, TLR2-/- mice were deficient in their expression of IL-6 post-infection 
and maintaining the proper localization of tight junction proteins, both during infection and under 
basal conditions, which is known to be affected during C. rodentium infection (Cario et al., 2004, 2007; 
Conlin et al., 2009; Gibson et al., 2008). The devastating effect of TLR2 deficiency after C. 
rodentium infection uncovered the importance of maintaining the integrity of the epithelial barrier 
and the role of IL-6 for protecting against widespread epithelial apoptosis. These aspects of gut 
mucosal immunity were later confirmed by other studies (Conlin et al., 2009; Dann et al., 2008; 
Guttman and Finlay, 2009). Therefore, it was determined that TLR2 plays a vital support role in 
minimizing the damage to the C. rodentium infected epithelial cell layer by preventing apoptosis and 
supporting barrier integrity.  
The conflicting effects of TLR4 and TLR2 in response to C. rodentium infection are indicative 
of how important it is to maintain a balanced response to infection. Robust activation of TLR4 leads 
to the production chemokines that recruit immune cells to the site of infection, however, this costs 
the host by also inducing tissue damage. The activation of TLR2 protects the host from 
overwhelming damage by inducing the expression of IL-6 that exacts anti-apoptotic effects on the 
epithelial cells. In this way the inflammatory TLR4 response and the protective TLR2 response 
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balance each other. Aside from invading pathogens, the colonic epithelial cells and resident 
macrophages are constantly exposed to and stimulated by the microbiota and these low level, 
balanced interactions are critical for maintaining homeostasis in the gut. The microbiota stimulate the 
proliferation of intestinal epithelial cells as well as their production of anti-microbial peptides 
(Khoury et al., 1969; Nenci et al., 2007; Rakoff-Nahoum et al., 2004; Reikvam et al., 2011; Wu and 
Wu, 2012). 
Unlike the TLRs which exhibit more restricted expression and activity within the gut 
epithelia, the nucleotide-binding oligomerization domain (NOD) and leucine-rich repeat-containing 
proteins (NLRs) are thought to play the primary role of immune activation in the gut. The NLRs are 
cytoplasmic sensors of infection, detecting nucleic acids from invading pathogens from all classes as 
well as other PAMPs. While there are many NLRs and not all are fully characterized, in terms of 
bacterial immune responses, Nod1 and Nod2 recognize peptidoglycan molecules present within the 
host cytoplasm (Kanneganti et al., 2007). Nod1 primarily recognizes Gram-negative bacteria (and a 
few Gram-positive species), whereas Nod2 recognizes both Gram-negative and Gram-positive 
bacteria (Girardin et al., 2003a; Girardin et al., 2003b; Girardin et al., 2003c). Nod1, thought to act as 
sensor of the microbiota present within the gut and expressed in both hematopoietic cells and 
intestinal epithelial cells (Kim et al., 2004), recognizes the release of peptidoglycan that occurs during 
rapid bacterial proliferation (Goodell and Schwarz, 1985; Rosenthal et al., 1987; Vance et al., 2009). 
Peptidoglycan is taken up by cells via endocytosis (Lee et al., 2009), phagocytosis of the infecting 
bacteria (Greenberg and Grinstein, 2002; Stuart and Ezekowitz, 2005; Underhill and Ozinsky, 2002), 
host peptide transporters (Daniel and Kottra, 2004; Lee et al., 2009; Vavricka et al., 2004). This is 
further supported by a study demonstrating that Nod1-/- mice have an exponential expansion of their 
gut microbiota numbers (Bouskra et al., 2008). 
 Much like the TLRs, the specific arrangement of adaptor proteins and the specific 
stimulating signal will determine the response induced by activating the Nod1 and Nod2 pathways. 
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Both Nod1 and Nod2 interact with the RIP2 kinase, via their caspase activation and recruitment 
domains (CARD), leading to the downstream activation of NF-κB and MAPK and the 
transcriptional activation of inflammatory cytokines (Hasegawa et al., 2006; Kobayashi et al., 2002; 
Park et al., 2007a). The inflammasome, composed of NLRC4/ASC/caspase-1, is activated via 
flagellin molecules delivered into the cell via the T3SS. Upon activation, it cleaves IL-1 and IL-18 
from the pro-form to the active form (Franchi et al., 2006; Hersh et al., 1999; Miao et al., 2006; Miao 
et al., 2008). The various combinations of NOD domain and CARD domain containing proteins that 
form the NLR signaling pathway provide specificity in the response induced by activation of these 
proteins.  
The role of NLRs has been studied in the context of C. rodentium infection as a means to 
understand the inflammatory responses that could also lead to inflammatory bowel disease (IBD) 
since nucleotide polymorphisms have been associated with increased risk of IBD (Cho, 2008). 
Studies utilizing Nod1-/- and Nod2-/- double knockout mice demonstrated deficient early Th17 
responses, leading to the conclusions that the NLRs are important for the induction of the innate 
Th17 response following infection (Geddes et al., 2011). Moreover, they observed less inflammation 
and pathology at the early time points following infection in the Nod1-/- and Nod2-/- mice which was 
followed by a enhanced inflammatory response at the later time points. This suggests that early iTh17 
cells are important for controlling the infection at the later stages (Geddes et al., 2011). Similarly, in 
Nod2-/- mice, there is an increase in the bacterial load at early time points resulting in prolonged 
infection and a high degree of inflammation at later time points during the course of the infection, 
compared to wild-type mice (Kim et al., 2011). These effects were attributed to deficient trafficking 
of inflammatory monocytes into the colon that the authors speculated limited direct killing of the 
bacteria and impaired a monocyte-directed Th1 response needed to drive antibody production and 
clearance (Bry and Brenner, 2004; Bry et al., 2006; Kim et al., 2011).  
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1.2.2.2 The NF-κB pathway 
 The NF-κB signaling pathway is a major regulator of the cellular response to stimuli of all 
kinds (Hayden and Ghosh, 2012; Li and Verma, 2002; Rahman and McFadden, 2011; Sun and 
Andersson, 2002; Vallabhapurapu and Karin, 2009; Wan and Lenardo, 2009, 2010). Many of the 
previously discussed extracellular receptors initiate signaling cascades that converge on NF-κB 
signalling for inducing the activation of many genes. There are two main activation pathways that 
result in the activation of NF-κB- responsive genes; the classical pathway and the alternative 
pathway.  
 The classical pathway begins with the activation of the trimeric IκB kinase (IKK) complex, 
containing the IKKα, IKKβ, and IKK (also called NEMO; NF-κB essential modulator) subunits. 
The activated IKK complex in turn phosphorylates IκBα (inhibitor of NF-κB) and induces its 
degradation by the ubiquitin-proteasome pathway (Chen, 2005). This releases the NF-κB dimer, 
uncovering its nuclear localization signals (NLS) allowing for its translocation into the nucleus. The 
NF-κB dimer is typically a hetero- or homodimer composed of two members of the Rel domain 
family subunits: p65 (RelA), RelB, c-Rel, p50, and p52. The Rel-homology domain mediates protein-
protein interactions and DNA binding. Of these, only p65, c-Rel, and RelB contain transcription 
activation domains (TAD) that initiate transcription (Hayden and Ghosh, 2012). More recently, a 
non-Rel containing subunit was discovered to form part of some NF-κB complexes. Ribosomal 
protein S3 (RPS3) is found associated with the NF-κB complex inhibited by IκBα (Wan et al., 2007; 
Wan et al., 2011). When the NF-κB complex is released for nuclear translocation, RPS3 is also 
phosphorylated and translocates into the nucleus where it enhances the binding affinity of p65/p50 
heterodimers at specific NF-κB sites (Wan et al., 2007). Since then, other co-activating proteins have 
been found to interact with the NF-κB subunits to mediate the expression of a particular sub-set of 
genes over others (Fu et al., 2013; Zhang et al., 2014). These studies have begun to shed light on the 
elusive regulatory mechanisms regarding promoter selectivity and specificity that have lingered in the 
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NF-κB field for many years. Many of the classical pathway’s target genes are involved in 
inflammatory signaling, immune activation, proliferation, and apoptosis. This makes the classical 
pathway a prime target of many invading pathogens in order to evade the immune response 
(discussed in thorough detail in Chapters 2 and  3). 
The alternative (non-canonical) activation pathway of NF-κB involves the stabilization and 
activation of the NF-κB-inducible kinase (NIK) (reviewed in (Sun, 2011)). When NIK is stabilized 
(Liao et al., 2004), it activates IKK and induces the processing of p100 into p52 (Senftleben et al., 
2001; Xiao et al., 2001; Yilmaz et al., 2003) allowing for the RelB/p52 heterodimer to enter the 
nucleus (Rahman and McFadden, 2011; Vallabhapurapu and Karin, 2009) and activate target gene 
transcription.   
1.2.2.2.1 Promoter Specificity 
The question of how NF-κB complexes generate specific and discrete responses following 
different stimuli has loomed in the field, until recently. Interactions with other transcription factors 
and post-translational modifications have demonstrated effects on the transcriptional activation of 
NF-κB (reviewed in (Oeckinghaus et al., 2011)). In 2007, it was discovered that a non-Rel protein, 
RPS3, selectively regulates the transcriptional activation of a subset of NF-κB genes. RPS3 was 
termed a “specifier” and since then more work has been done to uncover the exact function and 
mechanism of RPS3 dependent selectivity, as well as other “specifier” proteins. 
RPS3 is a KH domain containing protein that can bind RNA and DNA (Siomi et al., 1993). 
In drosophila, RPS3 was shown to be able to cleave DNA at damaged residues and it was therefore 
thought to have a role in DNA repair (Wilson et al., 1993). Indeed, this was confirmed when RPS3 
was shown to remove 8-oxo-G lesion following oxidative stress (Deutsch et al., 1997; Yacoub et al., 
1996). Aside from its function in the ribosome, RPS3 was found within the p65/p50 cytoplasmic 
complex as well as within the nucleus. Containing a nuclear localization sequence, RPS3 was 
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demonstrated to shuttle back and forth following phosphorylation similar to p65 and to interact with 
importin  (Wan et al., 2011). Phosphorylation-induced nuclear translocation abilities were also 
demonstrated for RPS3 following DNA damage (Yadavilli et al., 2007). The interaction of RPS3 and 
the p65/p50 heterodimer in the nucleus was found to stabilize p65/p50 binding at the promoters of 
specific NF-κB genes in T cells (Wan et al., 2007). This was confirmed when knock down of RPS3 
expression resulted in the decreased activation of select genes, while not affecting the nuclear 
translocation of p65 or the transcription of other NF-κB genes (Wan et al., 2007). Importantly, 
knock down of RPS3 by siRNA targets the ribosome free pool of RPS3, presumably the population 
of RPS3 molecules capable of interacting with NF-κB, without affecting the ribosomal pool of RPS3. 
Subsequent work demonstrated that aside from certain inflammatory genes such as IL-2 and IL8 
(Wan et al., 2007), the transcription of a subset of anti-apoptotic genes are also RPS3 dependent and 
prevented islet cell death (Mokhtari et al., 2009), such as Bcl-Xl, cIAP2, TRAF, and A20 (Mokhtari et 
al., 2009; Sen et al., 2012). This study also determined that the p65- cysteine 38 residue has a 
sulfhydration modification that strengthens the interaction with RPS3 (Sen et al., 2012). 
A/E pathogen infection has been shown to abrogate the interaction between p65 and RPS3 
via the NleH1 and NleH2 effector proteins discussed previously. While both effectors can bind to 
RPS3, only NleH1 was shown to inhibit the nuclear translocation of RPS3 (Gao et al., 2009). This 
inhibition occurs by blocking the phosphorylation of RPS3 by IKK (Gao et al., 2009; Wan et al., 
2011). This resulted in the selective inhibition of inflammatory responses, but not global suppression 
of NF-κB genes. Similarly, previous work from our lab has shown that overexpression of an N-
terminal fragment of p65 (containing the C38 residue) is capable of successfully sequestering RPS3 
away from full length p65 and therefore block downstream p65-RPS3 dependent gene transcription 
(Wier et al., 2012). Furthermore, during apoptosis caspase-3 cleaves p65 generating an N-terminal 
fragment containing amino acids 1-97. This fragment is also capable of blocking the RPS3-p65 
interaction by preventing the nuclear translocation of RPS3. In this model, an N-terminal fragment 
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of p65 containing the C38 residue needed for binding RPS3 is sufficient to sequester RPS3 in the 
cytoplasm preventing its nuclear function (Wier et al., 2012). While more work is needed to fully 
outline all of the p65-RPS3 dependent genes, it is clear that this axis of NF-κB signaling plays a very 
important role in multiple infection settings. This topic is revisited in chapter 2.  
Sam68 is another KH domain containing protein that has a wide range of functions from 
splicing, RNA stabilization, adipogenesis, regulating fertility, and carcinogenesis (Bielli et al., 2011; 
Huot et al., 2012; Iijima et al., 2011; Lukong and Richard, 2003; Paronetto et al., 2009). Sam68 is a 
signal transduction activator of RNA (STAR) member and as an RNA binding protein its function 
modulates many cellular pathways (Lukong and Richard, 2003; Sette et al., 2010). Previous work by 
our group has defined a role for Sam68 in regulating the transcription of a subset of NF-κB genes in 
T cells, different from those regulated by RPS3 (Fu et al., 2013). The mechanism of Sam68 regulating 
NF-κB gene transcription differs from RPS3, because Sam68 is a predominantly nuclear protein. It 
was therefore demonstrated that Sam68 is activated in the nucleus by phosphorylation by IKKα, 
which translocates to the nucleus following T cell receptor engagement. Following phosphorylation 
Sam68 was found to mediate and strengthen p65/p50 DNA binding to the promoter for CD25, the 
α chain of the IL-2R (Fu et al., 2013).  Like in the RPS3 studies, this was confirmed by showing a 
lack of CD25 transcriptional activation following siRNA knock down of Sam68.  
 Kruppel-like factors (KLFs) are another branch of transcription factors that have roles in 
stimulating responses involved in cell development and homeostasis. Among these, KLF-6 was 
shown to regulate the transcriptional activity of NF-κB following TNF-α and IL-1β stimulation 
(Zhang et al., 2014). They showed that KLF-6 interacts with p65 within the nucleus and is present at 
the promoters of NF-κB downstream genes with p65. Based on the known consensus site for each 
of these proteins, it is likely that p65 and KLF-6 are targeting the same DNA sequences, as their 
 22 
consensus sequences are reverse complements of each other (Zhang et al., 2014). This represents 
another novel mechanism by which NF-κB promoter selectivity is achieved.  
1.2.3 Innate immune cells and infection 
Resident innate immune cells in the gut typically maintain a regulatory, anti-inflammatory 
phenotype to prevent the over stimulation of the tissue to the normal microbiota. Macrophages 
present in the lamina propria, just under the epithelial cell layer in the gut, constitutively express IL-
10 (Denning et al., 2007). Moreover, in response to pathogen infection these cells induce less of a 
proinflammatory Th1 response than their bone marrow counterparts (Monteleone et al., 2008). 
Similarly, gut resident dendritic cells induce more of a Th17 like response following stimulation 
rather than a Th1 response (Monteleone et al., 2008; Schulz et al., 2009). The microbiota have been 
shown to be critical for the development of appropriate responses to infection. Following C. 
rodentium infection however, the stimulation of TLRs and NLRs as discussed above, induce the 
production of inflammatory mediators such as IL-6, IL-12, TNF, and IL-23 as well as IL-1β and IL-
18 (Clarke and Weiser, 2011). Stromal cells within the gut, also expressing PRRs are induced to 
produce chemokines, such as CCL2 and CXCL1, that result in the recruitment of neutrophils to the 
site of infection to directly kill and control the spread of infection (Borregaard, 2010; Kim et al., 
2011; Park et al., 2007b; Spehlmann et al., 2009). These inflammatory innate cells induce the robust T 
cell responses that are both Th1 and Th17 in nature.  
Innate lymphoid cells (ILCs) compose a more recently described cell type that has shown to 
be critical in the maintenance of mucosal homeostasis and found to be present at multiple barrier 
sites (Kim et al., 2013; Monticelli et al., 2012; Tait Wojno and Artis, 2012). These cells mount 
responses to pathogens and injury while lacking the antigen-specific receptors of traditional CD4+ T 
helper (Th) cells (Spits and Cupedo, 2012). Similar to the classical Th cells, ILCs have varying 
functional phenotypes induced by the cytokine milieu that have been categorized as group 1 (akin to 
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the Th1 proinflammatory cells), group2 (Th2-like in response and development), and group 3 (Th17-
like with proinflammatory and protective properties) (Peterson and Artis, 2014; Spits et al., 2013; Tait 
Wojno and Artis, 2012).  
Within the gut, the group 3 ILCs have been demonstrated to play an important role in 
maintaining barrier integrity and control of the microbiota, while group 2 ILCs are responsible for 
important roles during helminth infection, unsurprisingly due to their Th2-like phenotype (Peterson 
and Artis, 2014; Tait Wojno and Artis, 2012). Given the documented role of group 3 ILCs, 
particularly the RORγt+ ILCs, in intestinal barrier maintenance and inflammatory responses within 
the gut, their role in response to A/E pathogen infection has begun to be characterized.  These cells 
are a constant source of IL-22, in response to IL-23, within the gut and in that way reinforce the 
barrier by stimulating the epithelial cell expression of anti-microbial peptides and goblet cell mucus 
production (Sanos et al., 2009; Satoh-Takayama et al., 2009; Sonnenberg et al., 2011). DSS-induced 
injury and inflammation induces the expansion of RORγt+ ILCs and their production of IL-22 in an 
attempt to limit local inflammation and prevent commensal systemic dissemination (Sawa et al., 2011; 
Sonnenberg et al., 2012). Likewise, several studies have indicated that during C. rodentium infection 
group 3 ILCs, in an IL-23 dependent manner, are major producers of IL-22 independent of a 
functional lymphocyte compartment (Cella et al., 2009; Satoh-Takayama et al., 2009; Sonnenberg et 
al., 2011; Zheng et al., 2008). The rapid lethality experienced by IL-22-/- mice underscore the 
importance of this cytokine, and therefore these cells, for protecting against intestinal inflammation. 
However, the dual nature of IL-22 has also led to studies examining the capacity of group 3 ILCs to 
exacerbate IBD in both mouse models and human patients. The pathogenic capacity of ILCs appears 
to be context dependent in murine models (Ahern et al., 2008; Monteleone et al., 2012), though 
further work is needed to confirm these phenotypes. 
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Apart from IL-22, cells resembling ILCs and producing IL-17 have been isolated from 
human patient samples (Geremia et al., 2011). Moreover, the discovery of an innate Th17 like cell 
type that was responding to C. rodentium infection via NLR receptors and was critical for driving the 
neutrophil response demonstrates that ILCs are variable in their phenotypes (Geddes et al., 2011). 
The IL-17-family of cytokines is composed of six members (IL-17A, IL-17B, IL-17C, IL-17D, IL-
17E, and IL-17F), which are produced following the stimulation of Th17 responses.  Of those, the 
functions of IL-17A and IL-17F have been most thoroughly studied. This cytokine family has 
proinflammatory functions inducing the expression of chemokines by epithelial cells resulting in the 
downstream recruitment of neutrophils (Geddes et al., 2011; Jin and Dong, 2013). Produced mainly 
by Th17 T cells and ILCs such as the iTh17, IL-17 is typically produced at early and late stages of 
infection and is critical for the clearance of C. rodentium from the host (Kim et al., 2011). The early 
production of IL-17 and its downstream function serve to control the growing population of 
invading C. rodentium (Geddes et al., 2011; Kim et al., 2011). 
1.2.4 IL-22  
IL-22 is a member of the IL-10 family of cytokines that has demonstrated protective, 
reparative effects on tissue as well as pathogenic and inflammatory effects, depending on the context. 
IL-22 also serves as a bridge between the immune response and the epithelial cells, as it is expressed 
by T cells and innate lymphocytes (Ouyang et al., 2011; Rutz et al., 2013), yet mainly epithelial cells 
express the cognate receptor (Wolk et al., 2004). The dimeric receptor is composed of the IL-10R2 β 
chain (shared by many members of the IL-10 family) and the IL-22R1 as the α chain (Kotenko et al., 
2001). T cells and ILCs produce IL-22 following IL-6 and IL-23 stimulation (Trifari et al., 2009; 
Zheng et al., 2008). In the colon, ILCs are the major source of IL-22, particularly under infection 
conditions (Cella et al., 2009; Satoh-Takayama et al., 2009; Sonnenberg et al., 2011).   
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IL-22 acts to reinforce epithelial cells by stimulating the production of mucin proteins and 
other host defense mechanisms (Sugimoto et al., 2008; Zenewicz et al., 2013). The mucin layer in the 
gut physically separates the microbiota from the epithelial cells to prevent the over stimulation and 
activation of the epithelial innate responses within the gut. Consequently, Il-22-/- mice have an altered 
microbiota that is transferable to co-housed wild-type mice, leaving them more susceptible to colitis 
models (Zenewicz et al., 2013). IL-22 also stimulates the production of anti-microbial peptides such 
as alarmins, defensins, and the Reg proteins to directly kill or prevent the further growth of 
pathogenic bacteria (Liang et al., 2006; Zheng et al., 2008). These antimicrobial peptides target 
broadly conserved bacterial structures causing pore formation in the bacterial cell walls, killing the 
bacteria (Peterson and Artis, 2014).  
In this way, IL-22 induces protective responses following injury or inflammation, and given 
the lethality following C. rodentium infection in IL-22-/- (Sugimoto et al., 2008; Zheng et al., 2008), the 
protective stimuli IL-22 provides are of great importance.  IL-22-/- mice experience profound damage 
to the intestinal epithelial following infection, resulting in the systemic spread of C. rodentium to other 
organs (Zheng et al., 2008). The mechanism behind this lethality and the mechanisms by which 
pathogens may regulate the expression of IL-22 during infection remain to be elucidated.  
Despite the protective roles of IL-22, high levels of IL-22 have also been linked to Crohn’s 
disease and ulcerative colitis (Andoh et al., 2005; Brand et al., 2007; Wolk et al., 2007). Since, IL-22 
also induces the production of proinflammatory cytokines it has been hypothesized that this 
response can lead to immunopathology. Moreover, a pathogenic role of IL-22 has been best 
described in inflammatory skin models of disease such as psoriasis, and linked to the increased 
expression of other inflammatory cytokines (Lowes et al., 2007). The stimulatory and 
proinflammatory effects of IL-22 have also linked the expression or dysregulation of this cytokine 
with cancer, with increasing reports associating higher expression of IL-22 in various cancer settings 
(Jiang et al., 2013; Kim et al., 2014; Petanidis et al., 2013; Peterson and Artis, 2014; Xu et al., 2014). 
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Indeed, IL-22 overexpression in gastric cancer promoted proliferation signals and the migration of 
cancer cells (Ji et al., 2014). Thus, like most immune compartments, the careful regulation of this 
immune axis is imperative to prevent inducing immunopathology or oncogenic outcomes. 
1.3 Adaptive immune responses to C. rodentium  
The adaptive immune response is greatly shaped by the preceding innate immune response 
and is subject to the signals already established during the early part of the infection. The great power 
of the adaptive immune response is the ability to generate highly specific responses to invading 
pathogens through the use of genetic recombination events for the genes encoding their receptors. 
These responses allow for more than the detection of self vs. non-self, but in fact allow for the 
generation of memory to specific pathogens, preventing re-infection. These responses are also 
amplified by the innate immune response and are crucial for providing sterilizing immunity to many 
invading pathogens. In terms of C. rodentium, CD4 T cells and B cells are critical to control and clear 
the infection from the gut. Studies using RAG1-/- mice, which have no B and T cells, maintained high 
bacterial burden for weeks post infection and were ultimately unable to control or clear the infection 
(Simmons et al., 2003; Vallance et al., 2002). While these studies did not observe mortality following 
infection, the extensive pathology and huge bacterial burden demonstrate the importance of the 
adaptive immune response following infection. 
1.3.1 T cells 
It is well established that the type of CD4 T cell response to infection will shape the 
outcome of the infection and the B cell response. As naïve T cells are stimulated and activated the 
cytokine milieu plays an important role in guiding the phenotypic profile the CD4 T cell response will 
take. Typically, Th1 cells develop following exposure to IFNγ through the stimulation of T-bet and 
STAT1 to further drive the production of IL-12 and perpetuate the Th1 response (Mullen et al., 
2001). Th2 cells on the other hand develop in IL-4 rich environments activating the transcription 
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factors STAT6 and GATA-3, inducing the expression of more IL-4 (Zheng and Flavell, 1997).  Th17 
cells develop in the context of IL-6 and TGF-β secretion with the involvement of STAT3 and RORγ
t transcription factors (Ivanov et al., 2006; Jin and Dong, 2013). Each of these profiles has been 
characterized to guide the immune response to specific inflammatory insults such as the 
inflammatory Th1 response to bacteria, parasitic infection, and viruses, or the anti-inflammatory Th2 
response needed for helminth infection clearance.  
The T cell response to C. rodentium infection is vital to the control and clearance of the 
pathogen as mice deficient in CD4 T cells, are extremely susceptible to infection and experience high 
mortality (Simmons et al., 2003; Vallance et al., 2002). While these mice experienced less 
inflammation at the site of infection, they were unable to clear the infection and maintain their 
barrier integrity resulting in the systemic spread of infection. These studies demonstrated that the 
CD4 T cell response to infection aided the production of a humoral response that is critical for the 
control and clearance of C. rodentium (Simmons et al., 2003). Initially following C. rodentium infection, 
there is a robust Th1 response characterized by the production of IL-12 and IFNγ, that later is 
surpassed by a Th17 response following the production of IL-23 from antigen-presenting cells 
(Higgins et al., 1999; Khan et al., 2006; Shiomi et al., 2010). The Th1 response has been 
demonstrated to stimulate macrophage phagocytosis at the site of infection as well as promote the B 
cell antibody response in an IFNγ-dependent manner (Shiomi et al., 2010).   
Importantly, the C. rodentium infection model has been used to dissect out the function and 
significance of the Th17 and Th22 immune responses. The Th17-mediated IL-17 secretion at early 
and late stages of the C. rodentium response are critical for controlling the bacterial burden (Ishigame 
et al., 2009; Jin and Dong, 2013). Th17 cells are CD4 T helper cells that differentiate following TGF-
β and IL-6 signaling and secrete IL-17 and IL-22 and can exert both protective and pathogenic 
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effects depending on the context of stimulation. The combinatory effect of IL-17 recruiting 
neutrophils for clearing bacteria and the IL-22 effect on epithelial cell to induce the production of 
anti-microbial peptides demonstrate how these responses work in synergy to achieve clearance. In 
2012, it was determined that Th22 cells that developed in presence of IL-6 but not TGFβ are 
important and potent producers of IL-22, but not IL-17, in the context of infection with C. rodentium 
at later stages of infection (Basu et al., 2012), taking over for role of the iTh17 and ILCs (Geddes et 
al., 2011; Sawa et al., 2011; Sonnenberg et al., 2012).  
1.3.2 B cell 
The B cell branch of the adaptive immune response functions to limit the spread of the 
invading pathogen by secreting antibodies that physically attach to protein epitopes on the pathogen 
that match the antibody variable regions. Along the gut, IgA secreting plasma cells are constantly 
releasing IgA into the lumen to keep control over the microbiota (Peterson and Artis, 2014; Wu and 
Wu, 2012). In the context of C. rodentium infection, it is well known that IgG and IgA responses are 
induced against bacterial proteins (Frankel et al., 1996; Ghaem-Maghami et al., 2001). Studies that 
examined the role of CD4 T cells in response to C. rodentium infection also observed that when CD4 
T cells were depleted, reduced antibody responses also occurred (Simmons et al., 2003). These 
studies were followed up using B cell deficient mice (μMT mice that lack IgG and IgM responses), 
which demonstrated that similar to CD4 T cell deficiency, these mice were unable to control 
infection with C. rodentium (Simmons et al., 2003). However, the systemic transfer of immune serum 
was able to restore control of infection, despite not altering the mucosal response. Subsequently, it 
was determined that secretory antibodies, IgA and IgM, were dispensable for controlling the 
infection (Maaser et al., 2004). This is particularly intriguing since the mucosal response to infection 
involves the secretion of a great deal of IgA and the bacteria are residing right at the epithelial-
luminal surface (Frankel et al., 1996). More recently, it was determined that mice generated antibodies 
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that specifically recognized LEE-encoded virulence factors which labeled virulent bacteria in the 
lumen of infected mice (Kamada et al., 2015). During the highly colonized, early infection phase 
there is a high expression of the LEE encoded virulence genes. This expression is down-regulated as 
the infection peaks and begins to clear, leading to the rise of avirulent C. rodentium in the lumen 
(Kamada et al., 2012). While it remains unclear what leads to the down-regulation of LEE, it is 
hypothesized that these antibody-bound bacteria are then selectively engulfed by neutrophils, as they 
are required for mediating clearance of infection (Kamada et al., 2015).  
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Attaching/Effacing (A/E) pathogens including enteropathogenic Escherichia coli (EPEC), 
enterohemorrhagic E. coli (EHEC) and the rodent equivalent Citrobacter rodentium are important 
causative agents of foodborne diseases. Upon infection, a myriad of virulence proteins (effectors) 
encoded by A/E pathogens are injected through their conserved type III secretion systems (T3SS) 
into host cells where they interfere with cell signaling cascades, in particular the nuclear factor 
kappaB (NF-κB) signaling pathway that orchestrates both innate and adaptive immune responses for 
host defense. Among the T3SS-secreted non-LEE-encoded (Nle) effectors, NleC, a metalloprotease, 
has been recently elucidated to modulate host NF-κB signaling by cleaving NF-κB Rel subunits. 
However, it remains elusive how NleC recognizes NF-κB Rel subunits and how the NleC-mediated 
cleavage impacts on host immune responses in infected cells and animals. In this study, we show that 
NleC specifically targets p65/RelA through an interaction with a unique N-terminal sequence in p65. 
NleC cleaves p65 in intestinal epithelial cells, albeit a small percentage of the molecule, to generate 
the p651-38 fragment during C. rodentium infection in cultured cells. Moreover, the NleC-mediated p65 
cleavage substantially affects the expression of a subset of NF-κB target genes encoding 
proinflammatory cytokines/chemokines, immune cell infiltration in the colon, and tissue injury in C. 
rodentium-infected mice. Mechanistically, the NleC cleavage-generated p651-38 fragment interferes with 
the interaction between p65 and ribosomal protein S3 (RPS3), a ‘specifier’ subunit of NF-κB that 
confers a subset of proinflammatory gene transcription, which amplifies the effect of cleaving only a 
small percentage of p65 to modulate NF-κB-mediated gene expression. Thus, our results reveal a 
novel mechanism for A/E pathogens to specifically block NF-κB signaling and inflammatory 
responses by cleaving a small percentage of p65 and targeting the p65/RPS3 interaction in host cells, 
thus providing novel insights into the pathogenic mechanisms of foodborne diseases. 
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2.2 Author Summary 
The nuclear factor kappaB (NF-κB) signaling pathway is crucial for host defense, as it 
orchestrates both innate and adaptive immune responses. Beyond the best-studied Rel proteins (p65, 
RelB, c-Rel, p50 and p52), RPS3 has been recently identified as a “specifier” component of NF-κB, 
modulating the promoter selectivity and transcriptional specificity of NF-κB. In particular, the 
RPS3/p65-conferred signaling pathway was recently shown to play a critical role in host 
proinflammatory transcription and immune responses. Attaching and effacing (A/E) pathogens and 
others have acquired sophisticated mechanisms to modulate host NF-κB signaling pathways. We 
have found that NleC, a metalloprotease effector secreted by A/E pathogens, modulates host NF-κB 
signaling and inflammatory responses through a novel mechanism. NleC specifically recognizes and 
cleaves a small percentage of p65 and the generated N-terminal fragment of p65 interferes with the 
p65/RPS3 interaction, thereby amplifying the effect of cleaving only a small percentage of p65 
molecules to selectively inhibit NF-κB gene expression. Our findings highlight a previously 
unappreciated mechanism through which pathogen-encoded proteases interfere with signaling 
cascades and inflammatory responses in host cells. 
 
2.3 Introduction 
Foodborne diseases caused by enteric pathogens remain a significant and common health 
threat and an immense economic burden worldwide (Clarke, 2001). Among the causative agents of 
foodborne illness, diarrheagenic strains of Escherichia coli including enteropathogenic E. coli (EPEC) 
and enterohemorrhagic E. coli (EHEC), typically cause diarrhea, hemorrhagic colitis, and pediatric 
renal failure (Kaper et al., 2004). EPEC, EHEC, and the rodent-specific pathogen Citrobacter rodentium 
produce characteristic attaching/effacing (A/E) lesions on the host intestinal epithelium after they 
adhere to these cells (Donnenberg et al., 1997). These pathogens translocate a variety of virulence 
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proteins (effectors), through a conserved type III secretion system (T3SS), into intestinal epithelial 
cells (IECs) to modulate host cell functions to the pathogen’s advantage (Coburn et al., 2007; Hueck, 
1998). An ever-expanding repertoire of T3SS secreted effectors, termed non-LEE-encoded (Nle) 
effectors, was recently identified in A/E pathogens (Deng et al., 2010; Deng et al., 2004; Deng et al., 
2012; Garcia-Angulo et al., 2008; Tobe et al., 2006). The target proteins of Nle effectors in host cells 
have started to be identified (Baruch et al., 2011a; Gao et al., 2009; Nadler et al., 2010; Newton et al., 
2010; Pham et al., 2012; Royan et al., 2010; Sham et al., 2011; Vossenkamper et al., 2010; Wan et al., 
2011; Yen et al., 2010); however, it remains largely unknown how Nle effectors interfere with cell 
signaling cascades and dampen the immune responses in host cells. The recognition of pathogens by 
host sensors activates multiple signaling pathways to induce inflammatory responses and eradicate 
the pathogens (Le Negrate, 2012). Among those, the NF-κB signaling pathway is crucial for host 
defense, as it orchestrates both innate and adaptive immune responses (Le Negrate, 2012). On the 
other hand, A/E bacteria, like other successful pathogens, have acquired sophisticated mechanisms 
to modulate host NF-κB signaling pathways (Clements et al., 2012; Lilic et al., 2003; Mulhern et al., 
2009; O'Callaghan and Stebbins, 2010; Rahman and McFadden, 2006, 2011; Santoro et al., 2003). 
Not surprisingly, a handful of the Nle effector target proteins within host cells have been revealed to 
be NF-κB signaling molecules (Baruch et al., 2011a; Gao et al., 2009; Muhlen et al., 2011; Nadler et 
al., 2010; Newton et al., 2010; Pearson et al., 2011; Royan et al., 2010; Vossenkamper et al., 2010; 
Wan et al., 2011; Yen et al., 2010). Notably, however the molecular mechanisms through which each 
of these Nle effectors modulate NF-κB signaling have not been fully elucidated (Rahman and 
McFadden, 2011; Ruchaud-Sparagano et al., 2007). 
Besides the well-defined Rel family proteins (RelA/p65, RelB, c-Rel, p50 and p52) (Hayden 
and Ghosh, 2004), RPS3 and Src-associated substrate during mitosis of 68kDa (Sam68) were recently 
identified as “specifier” components of NF-κB (Wan and Lenardo, 2009), where they modulate the 
promoter selectivity and transcriptional specificity of NF-κB (Fu et al., 2013; Wan et al., 2007). The 
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nuclear translocation and “specifier” function of RPS3 have been revealed to be tightly regulated by 
NF-κB signaling cascades (Wan et al., 2011). Specifically, RPS3 is found in the cytoplasmic p65-p50-
IκBα inhibitory complex in resting cells (Wan et al., 2007). External stimuli activate the IκB kinase 
(IKK) complex, of which IKKβ phosphorylates IκBα resulting in its subsequent ubiquitination and 
degradation. IκBα removal unmasks a nuclear localization sequence (NLS), which allows nuclear 
import of p65 and p50 (Alkalay et al., 1995). Likewise, IKKβ phosphorylates RPS3 at serine 209 
(Ser209), independently enhancing the RPS3-importin-α interaction for nuclear translocation. Once 
in the nucleus, RPS3 cooperates with p65 to target NF-κB to select promoters and to trans-activate 
those genes (Wan et al., 2011). Of note, the significance of RPS3/NF-κB signaling pathway has been 
highlighted in an increasing number of pathophysiological conditions (Cadera et al., 2009; Gao et al., 
2009; Mokhtari et al., 2009; Sen et al., 2012; Wan et al., 2007; Wan et al., 2011), particularly in host 
proinflammatory transcription and immune responses against enteric pathogen infections (Gao et al., 
2009; Wan et al., 2011). More specifically, the EHEC NleH1 effector inhibits the nuclear 
translocation of RPS3, but not p65, during NF-κB activation by tempering RPS3 Ser209 
phosphorylation (Gao et al., 2009; Wan et al., 2011). As a consequence, NleH1 reduces the 
transcription of select, but not all, NF-κB target genes; most of the NleH1-attenuated RPS3/NF-κB-
dependent genes encode proinflammatory cytokines/chemokines (Gao et al., 2009; Wan et al., 2011). 
In support of the critical role of RPS3 in the transcriptional selectivity of NF-κB genes, we recently 
demonstrated that modulating the RPS3/p65 interaction by ectopic expression of an N-terminal 
fragment (amino acids 21-186) of p65 attenuates RPS3 nuclear translocation, without affecting p65, 
thus selectively blocking a subset of specific NF-κB gene transcription (Wier et al., 2012).  
NleC, a zinc-dependent protease effector conserved among A/E pathogens, was recently 
identified as one of the key effectors that dampen the innate immune response in host cells, 
particularly the production of inflammatory cytokines including interleukin-8 (IL-8) as well as others 
(Pearson et al., 2011; Sham et al., 2011; Yen et al., 2010). Mutagenesis of the consensus zinc 
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metalloprotease motif 183HEIIH187 abrogates the proteolytic activity of NleC and cleavage of host 
target proteins (Baruch et al., 2011b; Muhlen et al., 2011; Pearson et al., 2011; Yen et al., 2010). 
Although p300 (Shames et al., 2011), IκB (Muhlen et al., 2011), and the NF-κB Rel proteins p65 and 
p50 (Baruch et al., 2011b; Muhlen et al., 2011; Pearson et al., 2011; Shames et al., 2011; Yen et al., 
2010) have been reported as targets of NleC, it is largely understood that NleC cleaves and 
inactivates the NF-κB signaling pathway by primarily targeting the Rel proteins (Baruch et al., 2011b; 
Muhlen et al., 2011; Pearson et al., 2011; Yen et al., 2010), in line with the known critical role of NF-
κB in the transcription of inflammatory cytokine genes (Vallabhapurapu and Karin, 2009). Previous 
studies have shown that ectopically expressed or T3SS-translocated NleC degrades p65, p50 and c-
Rel, but not signal transducer and activator of transcription 1 (STAT1) or extracellular-signal-
regulated kinases (ERKs), which indicates there may be cleavage specificity of NleC for the Rel 
subunits of NF-κB signaling pathway (Baruch et al., 2011b; Pearson et al., 2011). However, work by 
Yen et al. suggests that NleC could be specific for p65, as recombinant NleC could not digest p50 in 
cell lysates (Yen et al., 2010). Moreover, two cleavage site(s) on p65 by NleC have been identified as 
between proline 10 and alanine 11 (P10/A11) (Yen et al., 2010) or cysteine 38 and glutamic acid 39 
(C38/E39) (Baruch et al., 2011b; Li et al., 2014; Turco and Sousa, 2014), although none of these 
studies ruled out the other cleavage site experimentally. The detailed mechanisms on how NleC 
specifically recognizes and cleaves p65 remain poorly understood. Moreover, even though 
recombinant proteins and ectopic expression of NleC in cell lines were employed in previous studies, 
only a very small percentage of p65 was shown to be cleaved by NleC with a large portion of full-
length p65 still present within the cells (Baruch et al., 2011b; Yen et al., 2010). In contrast, it is 
puzzling that previous studies reported that NF-κB activity by luciferase assays and IL-8 production 
were markedly increased in HeLa cells infected with EPEC ΔnleC mutant, compared to wild-type 
EPEC (Baruch et al., 2011b; Muhlen et al., 2011; Pearson et al., 2011; Sham et al., 2011; Shames et 
al., 2011; Yen et al., 2010). 
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Here we reveal that the N-terminus of p65 is specifically recognized by NleC, which is 
required for the subsequent NleC-mediated cleavage. Infection of mice with a C. rodentium mutant 
strain lacking NleC (ΔnleC) augmented the transcription of several proinflammatory cytokine genes 
including Cxcl1, Cxcl2, Il1b, Ifng, and Il22, and triggered more immune cell infiltration in the colon, 
compared to wild-type C. rodentium inoculation. Moreover, NleC primarily cleaves p65 at C38/E39 
during C. rodentium infection, and we show that the generated p651-38 fragment binds to RPS3 in NF-
κB complexes and selectively retards the nuclear translocation of RPS3, but not p65. While only a 
small percentage of molecules are cleaved, the association between the p651-38 fragment and RPS3 
that interferes with RPS3/p65 interaction-mediated transcription amplifies the impact of NleC 
cleaving p65. Therefore our results reveal a novel mechanism by which A/E pathogens selectively 
dampen RPS3 signaling and ensure inhibition of the RPS3/NF-κB-dependent inflammatory 
responses in host cells. 
2.4 Results 
2.4.1 NleC specifically cleaves p65, but not other NF-κB subunits 
The T3SS effector NleC from various A/E pathogens has been proposed to dampen the 
NF-κB-mediated proinflammatory responses in host cells by functioning as a metalloprotease that 
cleaves NF-κB, albeit through poorly-defined mechanism(s) (Baruch et al., 2011b; Muhlen et al., 
2011; Pearson et al., 2011; Sham et al., 2011; Shames et al., 2011; Yen et al., 2010). Moreover, Rel 
subunits p65 (Baruch et al., 2011b; Muhlen et al., 2011; Pearson et al., 2011; Sham et al., 2011; 
Shames et al., 2011; Yen et al., 2010), p50 (Muhlen et al., 2011), and c-Rel (Baruch et al., 2011b; 
Muhlen et al., 2011; Pearson et al., 2011; Sham et al., 2011; Shames et al., 2011; Yen et al., 2010) were 
proposed to be NleC target proteins. Alignment of the N-terminal sequences of both human and 
mouse Rel family proteins reveals that the best-characterized cleavage site, C38/E39 within the Rel 
homology domain, in p65 is also conserved among all human and mouse Rel proteins (Figure 2.1A 
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and Figure 2.2), indicating that NleC could potentially cleave all Rel proteins. To clarify which Rel 
protein(s) are NleC targets, we incubated whole cell lysates derived from HEK293T cells with 
recombinant NleC protein and examined the cleavage of endogenous Rel proteins using antibodies 
that specifically recognize the C-terminus of each Rel subunit. Consistent with previous studies 
(Baruch et al., 2011b; Muhlen et al., 2011; Pearson et al., 2011; Sham et al., 2011; Shames et al., 2011; 
Yen et al., 2010), a percentage of endogenous p65 was cleaved by NleC at the N-terminus thus 
generating a large C-terminal fragment (Figure 2.1B), whereas a catalytically inactive mutant of NleC, 
i.e. NleC (H117Y) with histidine 117 in the HExxH motif replaced by tyrosine (Yen et al., 2010), 
failed to do so (Figure 2.3). Moreover, NleC cleaved p65 to a similar extent in the presence and 
absence of tumor necrosis factor (TNF), a strong NF-κB stimulus (Figure 2.4), indicating that the 
NleC-mediated partial cleavage of p65 is not due to protection by other p65-binding proteins in the 
cytoplasm. In contrast to p65, the cleavage of other endogenous Rel proteins was not detectable, 
even when incubated with overwhelming amount (10 μg) of NleC recombinant protein (Figure 2.1B). 
Moreover, recombinant NleC cleaved the N-terminally FLAG-tagged p65 protein, with the tag 
allowing for better resolution of the small N-terminal fragment (Figure 2.1C). Of note, although 
recombinant NleC was able to cleave the ectopically expressed FLAG-tagged p50 protein, the 
product size marked by the N- and C-terminal FLAG tag indicates that cleavage occurs at the C-
terminus of p50 rather than the conserved cysteine 62/glutamic acid 63 in the N-terminus (Figure 
2.5), which corresponds to C38/E39 in p65. In addition, recombinant NleC failed to cleave 
ectopically expressed RPS3, which is a non-Rel subunit of NF-κB that confers the promoter 
selectivity and transcriptional specificity (Wan et al., 2007), in the recombinant protease cleavage 
assay (Figure 2.6). Therefore, NleC appears to selectively cleave p65, but not other NF-κB subunits. 
2.4.2 The N-terminal 20 amino acids of p65 are essential for NleC-mediated cleavage 
Notably the first 20 amino acids of p65 are unique to this protein and not conserved among 
the Rel proteins (Figure 2.1A and Figure 2.2), providing a clue to why NleC cleaves p65 specifically, 
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despite the fact that the C38/E39 cleavage site is shared by all other Rel subunits. Protease-substrate 
interaction-induced conformational changes are known to play an important role in the optimal 
cleavage of substrates by proteases (Sorimachi et al., 2012). We therefore hypothesized that the 
unique N-terminal sequence (a.a. 1-20) could be critical for the interaction between p65 and NleC, 
and be a prerequisite for NleC-mediated p65 cleavage. Using a library of C-terminal GFP-tagged p65 
truncation constructs (Wan et al., 2007), we mapped the necessary region(s) of p65 for the NleC-
conferred cleavage. Interestingly, recombinant NleC cleaved the p651-186 truncation as expected, 
whereas the p6521-186 truncation harboring the C38/E39 cleavage site but missing the first 20 amino 
acids was not cleaved by NleC, even in the presence of an overwhelming amount (10 μg) of the 
recombinant protease (Figure 2.7A). To confirm this, we moved the GFP tag to the N-terminus of 
p6521-186 truncation to increase resolution of the cleavage product and we were still unable to detect 
cleavage (Figure 2.8). These data suggest that the N-terminal 20 residues and C38/E39 cleavage site 
are both required for NleC-mediated p65 cleavage. In support of this notion, the full-length p65 
containing both elements was cleaved by NleC, whereas no cleavage was detected in the p65186-311 
and p65311-551 truncations as well as GFP vehicle control that do not contain either element (Figure 
2.7A, 3A-3B and S6). Together these results demonstrate that the first 20 amino acids are essential 
for NleC-mediated cleavage to occur, thus providing a rational for the specificity of NleC for p65 
rather than other Rel homology proteins, despite a shared Rel homology domain sequence. 
2.4.3 The N-terminal 20 amino acids of p65 are required for NleC recognition 
It has been widely acknowledged that the recognition of a substrate by a protease is critical 
for subsequent conformational changes to form a stabilized tetrahedral intermediate and to initiate 
optimal cleavage (Sorimachi et al., 2012). To examine whether the N-terminal 1-20 residues of p65 
are required for NleC to recognize and bind p65, we incubated the whole cell lysates from HEK293T 
cells expressing full-length or truncated p65, with catalytically inactive NleC (H117Y) mutant or wild-
type NleC at 4°C and conducted pull-down assays using nickel beads. NleC associated with full-
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length p65, but did not interact with p65311-551 (Figure 2.9), in line with the evidence that NleC 
cleaves full-length p65 rather than the truncated p65311-551 (Figure 2.7A). Moreover, a significant 
interaction between NleC (H117Y) and p651-186 was detected, whereas there was little, if any, 
interaction between NleC (H117Y) and p6521-186 (Figure 2.7B and Figure 2.9), suggesting that the N-
terminal 20 amino acids could be the key targeting sequence for NleC to specifically recognize and 
bind to p65. 
2.4.4 The major NleC cleavage site on p65 is between cysteine 38 and glutamic acid 39 
Previous studies showed that C38/E39 is the NleC cleavage site in p65 (Baruch et al., 2011b; 
Li et al., 2014; Turco and Sousa, 2014), whereas P10/A11 was also reported as an NleC cleavage site 
(Yen et al., 2010). We therefore conducted recombinant NleC cleavage assays using lysates 
containing p65 N-terminally tagged with GFP, which allowed us to further examine the cleavage 
location(s) on the N-terminus of p65. In agreement with our previous results (Figure 2.7A), 
recombinant NleC cleaved p65 at the N-terminus generating two fragments that were N-terminally 
tagged with GFP; the cleaved products, which migrate at 37 kDa and 30 kDa, respectively, were 
verified using an antibody that specifically recognizes the N-terminus of p65 (Figure 2.10A-B). Of 
note, substantially more GFP-tagged p651-38 fragment was detected, indicating that NleC chiefly 
cleaves p65 at C38/E39. Therefore our results, in line with previous reports (Baruch et al., 2011b; Li 
et al., 2014; Turco and Sousa, 2014; Yen et al., 2010), demonstrate that the N-terminus of p65 
harbors two NleC cleavage sites, P10/A11 and C38/E39, of which C38/E39 is the primary cleavage 
site whereas P10/A11 appears to be the secondary one (Figure 2.10C). In support of this notion, the 
resolved p65 crystal structure (Chen et al., 1998) reveals that the C38/E39 residues are located in a 
surface loop of the protein, which facilitates protease access (Figure 2.10D). Moreover, the NleC-
generated p651-38 fragment is substantially reduced by an alanine substitution to C38/E39 (Figure 
2.10E). However, the NleC-cleaved p651-10 fragment was also abolished by the C38A/E39A 
mutation. In contrast, the NleC-generated p651-38 fragment is less profoundly impacted by the alanine 
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substitution to P10, despite a complete inhibition of the NleC mediated cleavage of p65 at P10/A11 
(Figure 2.10E). These results therefore strengthen our conclusion that C38/E39 is the major NleC 
cleavage site within p65. Moreover, lysates from normal HEK293T cells were subjected to the NleC 
cleavage assays to examine how recombinant NleC cleaves endogenous p65. As detected by an 
antibody specific for the p65 N-terminus, a p65 fragment migrating as approximately 10 kDa on 
SDS/PAGE gels was generated by NleC in a dose dependent fashion (Figure 2.10F). Because 
cleavage of p65 at P10/A11 would result in a fragment approximately 1 kDa in size that would likely 
be degraded, we therefore determined the cleaved p65 fragment is most likely the product of 
cleavage at C38/E39. Likewise, we observed a larger C-terminal fragment, migrating around 60 kDa 
on SDS/PAGE, using an antibody specific for the C-terminus of p65 (Figure 2.10G). Together, our 
results suggest that C38/E39 is the major NleC cleavage site on p65, which generates a detectable 
p651-38 fragment. 
2.4.5 NleC cleaves p65 and generates the p651-38 fragment during C. rodentium and EPEC infections 
To further examine the pathophysiological relevance of NleC-mediated p65 cleavage, we 
employed the EPEC and C. rodentium infection models. After 3-hour infection of wild-type C. 
rodentium, we detected the p651-10 and p651-38 fragments in HEK293T cells expressing GFP-tagged 
p65 (Figure 2.11A). The p651-10 and p651-38 cleavage was abolished in the cells infected with a C. 
rodentium mutant strain lacking NleC (ΔnleC) (Sham et al., 2011), compared to wild-type C. rodentium 
(Figure 2.11A). Moreover, the attenuated p65 cleavage was robustly restored in the cells infected with 
a C. rodentium mutant strain that lacks NleC but was complemented with a HA-NleC plasmid 
(ΔnleC/pHA-NleC) (Sham et al., 2011) (Figure 2.11A). Notably, we also observed the NleC-cleaved 
endogenous p651-38 fragment in Caco-2 cells, a human colon cancer cell line, and isolated mouse 
primary colon epithelial cells (CECs) infected by wild-type EPEC and C. rodentium, respectively 
(Figure 2.11B and 4C). Strikingly, the p651-38 fragments were greatly diminished in cells infected with 
ΔnleC mutant bacteria; whereas the p65 cleavage was rescued in cells infected with complemented 
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ΔnleC/pHA-NleC strains (Figure 2.11B and C), suggesting that NleC cleaves p65 thus generating the 
p651-38 fragment during EPEC and C. rodentium infections in cell culture. In contrast to p65, the 
cleavage of p50 in Caco-2 cells and mouse CECs infected by EPEC and C. rodentium, respectively, 
was not detectable (Figure 2.12), further supporting that NleC specifically cleaves p65 among NF-κB 
subunits. To examine the possibility that the abolished p65 cleavage in CECs infected with ΔnleC C. 
rodentium could be due to defective attachment to host cells, in comparison to wild-type and 
complemented strains, we measured the attachment of variant C. rodentium strains to CECs during 
infection. As shown in Figure 2.11E, wild-type, ΔnleC, and ΔnleC/pHA-NleC C. rodentium attached to 
CECs in a similar pattern. Moreover, as assayed by enumeration of CEC-attached bacteria and 
immunoblot for marker proteins in mouse CECs (heat shock protein, Hsp90) and C. rodentium 
(lipopolysaccharides, LPS), the amount of ΔnleC and ΔnleC/pHA-NleC C. rodentium that attaches to 
CECs during infection was equal if not higher than the wild-type bacteria (Figure 2.11D and F). 
These results rule out the possibility that NleC deletion affects the interaction between C. rodentium 
and CECs, and suggest that NleC executes the p65 cleavage during EPEC and C. rodentium infections, 
generating a small amount of p651-38 fragment and leaving most p65 intact. 
2.4.6 NleC affects host immune responses in mice infected by C. rodentium  
Infection of C. rodentium in mice is known to cause colonic epithelial damage by acute 
inflammatory responses (Mundy et al., 2005), therefore we examined the impact of NleC on colonic 
inflammatory response in mice inoculated with variant strains of C. rodentium. As we reported 
previously (Sham et al., 2011), the colonization of wild-type and ΔnleC mutant C. rodentium in the 
colon of infected mice was comparable at day 8 and day 10 (Figure 2.13A and Figure 2.14, 
respectively). In line with previous reports that NleC-mediated p65 cleavage plays a critical role in 
dampening the NF-κB signaling pathway and suppressing proinflammatory gene expression in 
EPEC-infected cells (Pearson et al., 2011; Yen et al., 2010), we observed robust transcription of 
known NF-κB target genes Cxcl1 and Cxcl2 in the colon tissues removed from mice infected with 
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ΔnleC C. rodentium, compared to wild-type bacterium at day 14 (Figure 2.13B). We also detected 
significantly elevated levels of additional NF-κB target genes Ifng, Il1b, and Il22, thus highlighting the 
key function of NleC-mediated p65 cleavage in interfering with host NF-κB gene transcription 
(Figure 2.13B). Consistent with the colonic expression of proinflammatory cytokine/chemokine 
genes, the amount of infiltrated CD11b+ myeloid cells in the colon was increased by two fold in mice 
orally inoculated with ΔnleC C. rodentium, compared to that from mice infected with wild-type 
bacterium (Figure 2.13C-D). As expected, wild-type C. rodentium-infected mice developed severe 
clinical symptoms characterized by crypt elongation, thickening of the mucosal surface, and goblet 
cell depletion in histological staining, in comparison to phosphate-buffered saline (PBS) inoculated 
animals (Figure 2.13E-F). By contrast, infection with ΔnleC C. rodentium induced more severe damage 
to colon epithelia and general enlargement of the colonic tissue (Figure 2.13E-F). Our results 
therefore demonstrate that the p65 cleavage by NleC during C. rodentium infection has a dramatic 
effect on NF-κB gene transcription and inflammatory response in the infected animals.  
2.4.7 The NleC-cleaved p651-38 interacts with RPS3 
It is noteworthy that NleC cleaved only a small percentage of p65 during C. rodentium 
infection (Figure 2.11A-C) and even in the presence of an overwhelming amount (10 μg) of 
recombinant protease (Figure 2.1B, Figure 2.7A, Figure 2.10A-B, F-G). In particular, the dramatic 
effect of NleC on the proinflammatory cytokine production and NF-κB activity was proposed to be 
mediated by the cleavage of p65 by NleC (Baruch et al., 2011b; Muhlen et al., 2011; Pearson et al., 
2011; Sham et al., 2011; Shames et al., 2011; Yen et al., 2010); however, the large amount of full-
length p65 resistant to NleC cleavage makes it difficult to explain the remarkable impact of NleC on 
dampening host NF-κB signaling and inflammatory response. Of note, RPS3, a non-Rel subunit of 
NF-κB, was revealed to confer the promoter selectivity and transcriptional specificity of NF-κB 
(Wan et al., 2007; Wan and Lenardo, 2010), in particular the RPS3/NF-κB-mediated transcription of 
a subset of proinflammatory genes is critical for host defense against A/E pathogens (Gao et al., 
 70 
2009; Pham et al., 2012; Wan et al., 2011). Moreover, our previous studies showed that interrupting 
the subcellular localization and function of RPS3 by small interfering RNA (siRNA) (Wan et al., 
2007), bacterial effectors (Gao et al., 2009; Pham et al., 2012; Wan et al., 2011), and ectopic 
expression of an N-terminal truncated p6521-186 fragment (Wier et al., 2012), are able to selectively 
block NF-κB target gene transcription, without affecting the nuclear translocation of p65. We 
therefore hypothesized that the NleC-cleaved p651-38 product would execute a similar function as the 
p6521-186 fragment (Wier et al., 2012), which interferes with RPS3 signaling. To test this hypothesis, 
we examined the ability of GFP-tagged p651-38 and p6539-551 truncated proteins to alter NF-κB 
signaling in cultured cells. As demonstrated by subcellular fractionation, both p651-38 and p6539-551 
truncated proteins were primarily located in the cytoplasm of transfected HEK293T cells, even 
following 30-min TNF treatment (Figure 2.15A). This result is in agreement with previous reports 
that NleC inactivates p65 in the cytoplasm (Baruch et al., 2011b; Yen et al., 2010), and suggests that 
the NleC-cleaved products would mainly interfere with cytoplasmic NF-κB signaling in host cells. 
We further examined the interaction between RPS3 and the GFP-tagged p651-38 and p6539-551 
fragments by immunoprecipitation. The RPS3-p651-38 interaction was comparable to, if not even 
stronger than, that of RPS3 and full-length p65, whereas the association between RPS3 and the p6539-
551 fragment was barely detectable (Figure 2.15B). Moreover, the p651-38 truncated protein was 
substantially enriched in the GST-RPS3 pulldown sample, compared to the GST vehicle control 
(Figure 2.16), which independently verifies the interaction between p651-38 and RPS3. Our results 
therefore suggest that the NleC-cleaved p651-38 product, rather than the p6539-551 fragment, of p65 is 
able to interact with the NF-κB non-Rel subunit RPS3.   
2.4.8 The p651-38 product selectively attenuates the nuclear translocation of RPS3 
Stimuli-triggered translocation from the cytoplasm to the nucleus is a prerequisite for RPS3 to 
facilitate NF-κB binding and transactivation of specific target genes (Wan and Lenardo, 2009, 2010). 
We recently showed that ectopic expression of p6521-186 truncated protein competed RPS3 off 
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endogenous full-length p65, thereby interfering with the nuclear translocation of RPS3 during the 
NF-κB response (Wier et al., 2012). Ectopic expression of the p651-38 fragment, compared to the 
GFP control, did not alter TNF-stimulated IκBα degradation (Figure 2.15C) and p65 nuclear 
translocation (Figure 2.15D). By contrast, overexpression of p651-38 fragment remarkably attenuated 
TNF-triggered nuclear translocation of RPS3, which was induced normally in the GFP-expressing 
cells (Figure 2.15D). To further assess the impact of p651-38 fragment on NF-κB activation, we 
examined the expression of an Ig-κB site-driven luciferase reporter gene, which was previously 
shown to be RPS3-dependent (Wan et al., 2007; Wan et al., 2011; Wier et al., 2012), in HEK293T 
cells expressing the p651-38 fragment. Indeed, in comparison to the GFP vehicle control, ectopic 
expression of the p651-38 fragment attenuated NF-κB reporter luciferase expression in a dose 
dependent manner (Figure 2.15E). These results suggest that the p651-38 fragment is capable of 
interfering with the endogenous p65/RPS3 interaction and selectively attenuating the nuclear 
translocation of RPS3 rather than affecting other branches of NF-κB signaling (Figure 2.17), which 
provides a novel mechanism for A/E pathogens to specifically modulate host NF-κB-mediated gene 
transcription and inflammatory responses. 
2.5 Discussion 
The NF-κB signaling pathway orchestrates both innate and adaptive immune responses in 
host cells, thereby executing an important function in host defense to a variety of pathogens (Le 
Negrate, 2012). That said, the mechanisms controlling promoter selectivity and transcriptional 
specificity of NF-κB genes in acute pathogen-host interactions remain obscure. Beyond the well-
characterized NF-κB Rel subunits, we recently identified two non-Rel subunits, i.e. RPS3 and Sam68, 
in the NF-κB DNA binding complexes that confer distinct transcriptional specificity of NF-κB (Wan 
and Lenardo, 2009, 2010). The RPS3- and Sam68-conferred NF-κB activation model suggests that 
the Rel subunits are required, but not the sole determinants, for the activation of NF-κB target genes. 
In contrast, the synergistic interactions between Rel and non-Rel subunits at the promoters are 
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critical for the transactivation of certain NF-κB target genes (Wan and Lenardo, 2009, 2010). An 
increasing number of studies (Cadera et al., 2009; Gao et al., 2009; Mokhtari et al., 2009; Sen et al., 
2012; Wan et al., 2007; Wan et al., 2011) suggest that the RPS3/NF-κB signaling pathway is vital in 
the host proinflammatory transcription and immune responses against infection by A/E pathogens 
(Gao et al., 2009; Wan et al., 2011). Specifically, the T3SS effector NleH1 from EPEC, EHEC, and 
C. rodentium attenuates the nuclear translocation of RPS3, but not p65, during NF-κB activation by 
inhibiting the IKKβ-mediated Ser209 phosphorylation of RPS3 (Gao et al., 2009; Wan et al., 2011). 
This leads to reduced transcription of select, but not all, NF-κB target genes, most of which are 
RPS3/NF-κB-dependent proinflammatory cytokine genes (Gao et al., 2009; Wan et al., 2011). In this 
work, we show that the T3SS effector protease NleC predominantly cleaves p65 at C38/E39. The 
NleC cleavage-generated p651-38 fragment interferes with the RPS3/p65 interaction in the cytoplasm, 
resulting in the attenuated nuclear translocation of RPS3, without affecting p65 nuclear translocation. 
Similar to what we have shown previously (Gao et al., 2009; Wan et al., 2007; Wan et al., 2011; Wier 
et al., 2012), cytoplasmic sequestering of RPS3 prevents the transactivation of the RPS3/p65-
dependent proinflammatory cytokine genes and the infiltration of inflammatory immune cells to 
infected tissue. Of note, NleC cleaves a small percentage of p65 in C. rodentium-infected mouse 
CECs. In contrast, NleC cleavage has a substantial effect on proinflammatory cytokine gene 
transcription, as evidenced by infections using the EPEC and C. rodentium genetic mutants with 
disruptions in the NleC gene, compared to wild-type strains. We are aware that NleC, as a 
metalloprotease, cleaves other host proteins beyond p65, such as p300 (Shames et al., 2011), p38 
(Sham et al., 2011), and others, which could also result in the observed striking effects of NleC on 
colonic cytokine gene expression and inflammatory responses in infected mice. However, our 
proposed “amplifying” mechanism through the RPS3-conferred NF-κB specific transcription 
provides a novel explanation for the disconnect regarding the extent of NleC-mediated NF-κB 
cleavage and the impact of NF-κB transactivation by such cleavage. In conjunction with our previous 
studies showing that NleH1 attenuates RPS3 Ser209 phosphorylation (Gao et al., 2009; Wan et al., 
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2011), our results highlight the critical role of the RPS3/NF-κB signaling pathway in the host 
immune response to A/E pathogen infections. Although NleC and NleH1 are both secreted by the 
A/E pathogen T3SS, the kinetics and amount of NleC and NleH1 within host cells during infection 
remains largely unknown. It has been well documented that certain successful pathogens have 
acquired sophisticated mechanisms to directly interfere with host NF-κB signaling through regulating 
or mimicking host proteins to their own advantage, and these co-opted strategies can operate at 
multiple levels of the sequential process of NF-κB signaling (Baruch et al., 2011a; Gao et al., 2009; 
Muhlen et al., 2011; Nadler et al., 2010; Newton et al., 2010; Pearson et al., 2011; Royan et al., 2010; 
Vossenkamper et al., 2010; Wan et al., 2011; Yen et al., 2010). We therefore speculate that A/E 
pathogens utilize NleC and NleH1 to simultaneously (or sequentially) interfere with the RPS3/NF-
κB signaling pathway through distinct strategies, therefore ensuring with this redundancy that the 
NF-κB signaling and inflammatory responses are dampened in host cells. Notably, the RPS3-p65 
branch of NF-κB signaling has been associated with transcription of anti-apoptotic genes (Sen et al., 
2012) and inflammatory genes (Gao et al., 2009; Wan et al., 2011) therefore selectively targeting this 
arm could prove advantageous to the pathogen. Given that the spatial and temporal coordination of 
effectors injected into host cells remains unclear (Shames and Finlay, 2012; Wong et al., 2011), it is 
intriguing to consider that manipulating inflammatory gene transcription would be valuable early 
during infection and ensuring apoptosis would be an escape strategy allowing the pathogen to spread 
to the next host. While it has been documented that a relatively low amount of NleC is delivered into 
host cells during infection in cultured cells (Deng et al., 2012), the timing, longevity, and activity of 
the effectors within the host cell during an in vivo animal infection remains elusive. Greater resolution 
of the timing and amount of NleC’s introduction into the host cell and interaction with p65 is still 
needed. 
 The most abundant species among the NF-κB complexes in cells consists of p65, p50, and 
other proteins (Wan et al., 2007). Moreover, p65 possesses a transactivation domain (TAD) that is 
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essential to recruit general transcriptional machinery to transcribe target genes, whereas p50 lacks the 
TAD domain thereby normally suppressing gene expression (Wan and Lenardo, 2009). These 
features make p65 unique within the NF-κB Rel subunits and a likely target for pathogen effectors. 
Our results show that NleC cleaves p65 more efficiently than other Rel family proteins and non-Rel 
subunits, RPS3 and Sam68. In further support of this notion, the N-terminal 20 residues of p65, 
which are not conserved among other Rel family proteins, play a critical role in the recognition and 
cleavage of p65 by NleC during A/E pathogen infection. Therefore it is not surprising that p65, the 
most important NF-κB Rel subunit, is a major target for a wealth of pathogens, allowing them to 
interfere with the NF-κB signaling pathway in host cells (Baruch et al., 2011b; Muhlen et al., 2011; 
Pearson et al., 2011; Sham et al., 2011; Yen et al., 2010). Indeed, previous studies showed that p65 
was cleaved by a myriad of pathogen encoded proteases (Cameron et al., 2004; Christian et al., 2010; 
Coiras et al., 2008; Doyle et al., 2011; Neznanov et al., 2005; Silva et al., 2013), although the direct 
consequence of cleaving p65 on NF-κB signaling has not been extensively studied. For instance, 
Chlamydia trachomatis, a gram-negative bacterium that causes urethritis, cervicitis, and other diseases, 
encodes a PDZ containing tail-specific protease (Lad et al., 2007b). The enzyme was proposed to 
suppress host NF-κB activity by cleaving p65 and generating two p65 fragments (approximately 40 
kDa and 25 KDa, respectively) (Lad et al., 2007a). Moreover, the A-B toxin metalloprotease encoded 
by the fish pathogen Photobacterium damselae piscicida was recently shown to cleave p65 at C38/E39, 
similar to NleC (Silva et al., 2013). It would be interesting to examine if p65 fragment interference is 
a previously unrecognized but possibly widespread mechanism of virulence for abrogating host NF-
κB signaling, especially when pathogen encoded proteases are unable to cleave the majority or entire 
cellular source of p65. By selectively blocking NF-κB “specifiers”, as we demonstrated here for 
RPS3, pathogens could more acutely manipulate the host environment by regulating the timing and 
abundance of injected effectors, allowing collections of genes to be turned on and off to their 
advantage. 
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2.6 Material and Methods 
Ethics statement. All animal experiments were performed according to protocol number MO13-
H349, approved by the Johns Hopkins University’s Animal Care and Use Committee and in direct 
accordance with the NIH guidelines for housing and care of laboratory animals. 
Cell line, antibodies, and plasmids. HEK293T and Caco-2 cells (ATCC, Manassas, VA) were 
cultured in DMEM medium containing 10% fetal calf serum, 2 M glutamine, 100 U ml-1 penicillin, 
and 100 U ml-1 streptomycin. Antibodies used were: p65 (C-terminus, C-20, sc-372), p65 (N-
terminus, F-6, sc-8008x), p50 (NLS, sc-114), c-Rel (C, sc-71) from Santa Cruz Biotechnology (Dallas, 
TX); β-actin (AC-15, A5441) and FLAG (M2, F1804) from Sigma-Aldrich (St. Louis, MO); PARP-1 
(46D11, 9532) from Cell Signaling Technology (Danvers, MA); GFP (7.1 and 13.1, 11814460001) 
from Roche Applied Science (Indianapolis, IN); CD11b (M1/70, 101202) from BioLegend (San 
Diego, CA); Hsp90 (610418) from BD Biosciences (San Jose, CA); E. coli O152 LPS (81449) from 
Statens Serum Institut (Copenhagen, Denmark); RPS3 as previously described (Wan et al., 2007). 
Tumor necrosis factor (TNF) was purchased from R&D System (Minneapolis, MN). The plasmids 
His-NleC (Pearson et al., 2011), FLAG-p50, p50-FLAG (Dooher et al., 2011), GFP-tagged full-
length p65, p651-186, p6521-186, p651-311, p65186-311, and p65311-551 (Wan et al., 2007) were previously 
described. The GFP-p651-38 and GFP-p6539-551 were generated by inserting the appropriate fragments 
into the pEGFP-N1 vector (Clontech Laboratories, Mountain View, CA) using the InFusion Cloning 
System (Clontech Laboratories). The His-NleC (H117Y) and GFP-tagged p65 (C38A/E39A) and 
p65 (P10A) mutants were generated by site-directed mutagenesis using the Quick Change Kit 
(Stratagene, La Jolla, CA) with appropriate primers. All the plasmids were verified by DNA 
sequencing. 
Transient transfection. DNA constructs were transfected into HEK293T cells using the TurboFect 
in vitro transfection reagent (Thermo Scientific, Waltham, MA) according to the manufacturer’s 
instructions, as described previously (Wier et al., 2012). 
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NleC protease digestion assays. Overnight cultures of BL21 (pET-NleC) were induced with1 mM 
IPTG and His-NleC proteins were purified by nickel affinity chromatography. The NleC protease 
digestion was conducted as previously described (Pearson et al., 2011). Briefly, cells were collected 
and lysed on ice with 0.4 ml of lysis buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1% NP-40 and 
0.5% sodium deoxycholate, 1  complete protease inhibitor cocktail [Roche Applied Science]) for 30 
min. After centrifuge at 10,000  g at 4°C for 10 min, 200 µl of supernatant was removed to a 
separate tube and incubated with indicated amount of His-NleC protein at 37°C for 3 h.  
Nickel bead and GST pull-down assays. For the interactions between NleC and indicated 
proteins, the 200 µl of supernatant mixed with 1 µg of His-NleC protein were subjected to pull-down 
assays by adding 30 μl of Nickel beads (Qiagen, Germantown, MD), and rotating for 30 min at 4°C. 
The GST pulldown assays were conducted as previously described (Fu et al., 2013). The pull-down 
proteins were washed at least four times with cold lysis buffer followed by separation with SDS-
PAGE. 
Isolation of primary colon epithelial cells. Colon epithelial cells (CECs) were isolated from 
C57BL/6J mice as previously described (Flint et al., 1991). Briefly, after euthanizing mice, the entire 
colon was removed under aseptic conditions and washed twice with ice-cold PBS. After dividing the 
colon into 2–3 mm long fragments and transferring them into chelating buffer (27 mM trisodium 
cirtcrate, 5 mM Na2HPO4, 96 mM NaCl, 8 mM KH2PO4, 1.5 mM KCl, 0.5 mM DTT, 55 mM D-
sorbitol, 44 mM sucrose, 6 mM EDTA, 5 mM EGTA [pH 7.3]) for 45 min at 4oC, CECs were then 
dislodged by repeated vigorous shaking. Tissue debris was removed by a 70-μm cell strainer (Fisher 
Scientific, Suwanee, GA) and CECs were harvested by centrifugation at 4oC. The viability of CECs 
was confirmed by trypan blue staining and isolated CECs were cultured at 37oC for 1 h for recovery, 
followed by infection. 
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Citrobacter rodentium and EPEC growth conditions and infection in cultured cells. Wild-type 
C. rodentium (DBS 100) and EPEC (E2348/69), as well as the NleC deletion mutant (ΔnleC) and the 
HA-NleC complemented (ΔnleC/pHA-NleC) strains (Sham et al., 2011) were grown from single 
colonies on Luria-Bertani (LB) plates in LB broth at 37°C overnight with shaking. Infection of 
EPEC in Caco-2 cells was performed as previously described (Sham et al., 2011). Prior to infection 
experiments, C. rodentium was washed with ice-cold PBS and resuspended in pre-warmed 
corresponding media. Bacteria concentration was measured by absorbance at optical density 600, 
followed by a serial dilution and seeding on a MacConkey agar plate (VWR, Radnor, PA) to confirm 
the administered colony-forming units (CFU). The HEK293T cells and isolated CECs were infected 
with the indicated strains of C. rodentium at a multiplicity of infection (MOI) of 100 for 3 h, as 
described previously (Sham et al., 2011). Cells were counted using a hemacytometer prior to each 
experiment and equal numbers of cells (1-2 × 106) were aliquoted into each infection condition. To 
determine bacterial attachment to CECs infected in suspension, cells and bacteria were passed 
through a Percoll gradient (40% and 60%) and CECs were collected from the top of half of the 40% 
gradients and overlay (Childs and Gibbons, 1988; Colombo et al., 2006; Izhar et al., 1982). Cells were 
washed with PBS and placed on cover slips or lysed for immunofluorescence staining or 
immunoblot. 
Immunofluorescence staining in colon epithelial cells. Post C. rodentium infection, mouse CECs 
were spun down to Poly-L-Lysine-coated coverslips, fixed with 4% PFA, and stained with 
appropriate primary antibodies and fluorescence dye-conjugated second antibodies. Following 
staining of nuclei with 1 µg ml-1 of DAPI (Sigma-Aldrich), coverslips were mounted onto slides using 
Fluoro-gel with Tris Buffer (Electron Microscopy Sciences, Hatfield, PA) and examined using an 
Axio Observer fluorescence microscope (Zeiss, Oberkochen, Germany). The numbers of C. rodentium 
that attached to mouse CECs were quantified using ImageJ software (NIH, Bethesda, MD) and 
normalized to cell perimeter. 
 78 
Citrobacter rodentium infection in mice. Male C57BL/6 mice (6 to 8 weeks) purchased from the 
Jackson Laboratory (Bar Harbor, ME) were maintained in a specific pathogen-free facility and fed 
autoclaved food and water ad libitum. Food was withheld from the mice for 6-8 hours before they 
were orally inoculated with 200 μl of PBS containing 2 × 109 CFU of wild-type or ΔnleC mutant C. 
rodentium or PBS alone, and euthanized at the indicated time points post infection.  
Colon tissue collection, histology, and immunofluorescence staining. After euthanizing mice, 
their colons were removed under aseptic conditions, washed once with ice-cold PBS, and the 
terminal 0.5-cm piece of the colon was frozen in optimal cutting temperature (O.C.T.) media (Tissue-
Tek, Elkhart, IN) or incubated overnight in 4% PFA. 5-micron frozen sections were cut using a 
Microm HM 550 Cryostat (Thermo Scientific), collected on coated slides and processed for 
immunofluorescence staining. Frozen sections were fixed in paraformaldehyde, washed with PBS, 
and blocked with appropriate sera in PBS. After incubating with appropriate antibodies, sections 
were washed and incubated with fluorescence dye-conjugated second antibodies and 1 µg ml-1 of 
DAPI (Sigma-Aldrich). Stained sections were washed and mounted under a coverslip using Fluoro-
gel with Tris Buffer (Electron Microscopy Sciences). For histological analysis, the colon tissue was 
embedded in paraffin and 5-micron sections were cut, collected on coated slides and processed for 
Hematoxylin and Eosin (H&E) staining. Stained sections were examined using an Axio Observer 
fluorescence microscope (Zeiss). Histopathology scores were determined in a blinded fashion using 
the following criteria as previously described by Qualls et al. (Qualls et al., 2006): 0, Normal tissue; 
Grade 1, mild inflammation was present containing mostly mononuclear cell infiltrate and little 
damage to the epithelia; Grade 2, inflammation greater than Grade 1 with mononuclear and 
polymorphonuclear infiltrate, mucin and Goblet cell depletion, and epithelium beginning to detach 
from basement membrane; Grade 3, inflammation and cellular infiltrate is greater than Grade 2 with 
cellular infiltrates reaching the submucosa, greater Goblet cell depletion, and greater epithelial 
disruption; Grade 4, severe inflammation containing mostly neutrophils, completely detached 
epithelium, and crypt destruction. 
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Quantitative real-time PCR. Total RNA was isolated from colon tissues using Trizol reagent (Life 
Technologies) and treated with the TURBO DNA-free Kit (Life Technologies) to remove residual 
genomic DNA. cDNA was synthesized using qScript cDNA SuperMix Kit (Quanta Biosciences, 
Gaithersburg, MD) according to the manufacturer's instructions. Gene specific products were 
amplified using SsoAdvanced SYBR Green Supermix (Bio-Rad Laboratories, Hercules, CA) with the 
following primers:  
Cxcl1-f,  5’-TGCACCCAAACCGAAGTCAT-3’;  
Cxcl1-r,  5’-TTGTCAGAAGCCAGCGTTCAC-3’;  
Cxcl2-f, 5’-CCTGCCAAGGGTTGACTTCA-3’;  
Cxcl2-r, 5’-TTCTGTCTGGGCGCAGTG-3’;  
Ifng-f, 5’-ATGAACGCTACACACTGCATC-3’;  
Ifng-r, 5’-CCATCCTTTTGCCAGTTCCTC-3’;  
Il1b-f, 5’-GAAATGCCACCTTTTGACAGTG-3’;  
Il1b-r, 5’-CTGGATGCTCTCATCAGGACA-3’; 
Il22-f, 5’-CAGAGGTAGACTTGATAACCAC-3’;  
Il22-r, 5’-GGTTATGGAAATGAAGTTACATAAGC-3’. 
Subcellular fractionation. Subcellular fractionation was performed by differential centrifugation as 
previously described (Fu et al., 2013). Briefly, cells were resuspended in Buffer A (10 mM HEPES 
[pH 7.9], 10 mM KCl, 1.5 mM MgCl2, 0.1 mM EDTA, 0.5 mM DTT, 0.4 % NP-40, 0.5 mM PMSF, 
1  complete protease inhibitor cocktail [Roche Applied Science]) at 4°C for 5 min. Lysates were 
centrifuged at 4°C, 500  g for 3 min, and supernatants were collected as cytosolic fractions. Pellets 
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were incubated in Buffer C (20 mM HEPES [pH 7.9], 420 mM NaCl, 1.5 mM MgCl2, 25% glycerol, 
0.5 mM PMSF, 0.2 mM EDTA, 0.5 mM DTT, 1  complete protease inhibitor cocktail) at 4°C for 
10 min, followed by a centrifuge at 4°C, 13,000  g for 10 min. Supernatants were collected as 
nuclear fractions. 
Immunoprecipitation and immunoblot. The cells were harvested and lysed on ice with 0.4 ml of 
lysis buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1% NP-40 and 0.5% sodium deoxycholate, 1 
 complete protease inhibitor cocktail) for 10 min. The lysates were centrifuged at 10,000  g at 4°C 
for 10 min. The protein-normalized lysates were subjected to immunoprecipitation by adding 10 mg 
ml-1 of the appropriate antibody, 30 μl of protein G-agarose (Roche Applied Science), and rotating 
for more than 2 h in the cold room. The precipitates were washed at least four times with cold lysis 
buffer followed by a separation by SDS-PAGE under reduced and denaturing conditions. The 
resolved protein bands were transferred onto nitrocellulose membranes (Bio-Rad Laboratories, 
Hercules, CA), probed as described previously (Fu et al., 2013), developed by the Super Signaling 
system (Thermo Scientific) according to the manufacturer's instructions, and imaged using a 
FluorChem E System (Protein Simple, Santa Clara, CA). 
Luciferase reporter gene assays. Luciferase reporter gene assays were performed as previously 
described (Wan et al., 2007; Wan et al., 2011; Wier et al., 2012). Briefly, cells were cotransfected with 
5 × Ig κB site-driven firefly luciferase constructs and the Renilla luciferase pTKRL plasmid (ratio 
10:1), together with appropriate plasmids. Cells were cultured for 18 hours, stimulated in triplicate, 
and analyzed using the Dual-Luciferase Kit (Promega, Madison, WI). 
Statistical analysis. All statistical analysis was performed using GraphPad Prism version 6.0 
(GraphPad Software, San Diego, CA). The difference between treated and control groups were 
examined by unpaired Student’s t tests. Standard errors of means (s.e.m.) were plotted in graphs. n.s. 
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means non-significant difference and significant differences were considered * at p < 0.05; ** at p < 
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Figure 2.1 NleC specifically cleaves p65/RelA among the NF-κB Rel family proteins.  
A. Sequence alignment of the human Rel family proteins. The conserved Cys/Glu residues in their respective 
Rel domains and the unique N-terminal 20 residues in p65/RelA are highlighted. The numbers at right show 
the position in the amino-acid sequence of the last residues depicted. B. Whole cell lysates derived from 
HEK293T cells were incubated with indicated amount of His-NleC recombinant protein, followed by 
SDS/PAGE separation and immunoblotted for indicated proteins with antibodies specifically recognizing the 
C-termini of p65, p50 and c-Rel, respectively. The full-length p65 and cleaved p65 C-terminal fragment are 
indicated by filled and open triangles, respectively. C. Whole cell lysates derived from HEK293T cells 
expressing N-terminally FLAG-tagged p65 were incubated with indicated amount of His-NleC recombinant 
protein. The cleavage of FLAG-tagged p65 was immunoblotted with anti-FLAG antibody, following 







Figure 2.2 The first 20 amino acids of the mouse RelA are unique 
The conserved Cys/Glu residues in their respective Rel domains in the mouse and the unique N-terminal 20 
residues in p65/RelA are highlighted. The numbers at right show the position in the amino-acid sequence of 





Figure 2.3 The protease-dead NleC mutant is unable to cleave p65 
Whole cell lysates derived from HEK293T cells were incubated with the indicated amount of wild-type (WT) 
or catalytically inactive H117Y mutant His-NleC recombinant protein, followed by SDS/PAGE separation and 
immunoblotted for indicated proteins. The full-length p65 and cleaved p65 C-terminal fragment are indicated 





Figure 2.4 TNF stimulation does not alter NleC-mediated p65 cleavage 
A-B. HEK293T cells (A) and HEK293T cells expressing N-terminally GFP-tagged p65 (B) were treated with 
50 ng ml-1 of TNF for 30 min or the PBS vehicle control. Whole cell lysates were derived and incubated with 
the indicated amount of His-NleC recombinant protein, followed by SDS/PAGE separation and 
immunoblotted for indicated proteins. The full-length p65 and cleaved p65 C-terminal fragment are indicated 





Figure 2.5 NleC-mediated cleavage of p50 occurs at the C-terminal in overexpression 
conditions 
Whole cell lysates derived from HEK293T cells expressing N- and C-terminally FLAG-tagged p50 were 
incubated with the indicated amount of His-NleC recombinant protein. The cleavage of FLAG-tagged p50 was 
immunoblotted with anti-FLAG antibody, following SDS/PAGE separation. The NleC cleavage sites in p50 





Figure 2.6 RPS3 is not a substrate of NleC 
Whole cell lysates derived from HEK293T cells expressing FLAG-tagged RPS3 were incubated with indicated 
amount of His-NleC recombinant protein. The cleavage of FLAG-tagged RPS3 was immunoblotted with anti-





Figure 2.7 The N-terminal 20 amino acids of p65 are required for NleC to bind and cleave 
p65.  
A. Various truncations of C-terminal GFP-tagged p65, as illustrated at the bottom, were transfected into 
HEK293T cells. Whole cell lysates were subjected to the His-NleC cleavage assay, and immunoblotted with 
anti-GFP antibody for NleC-cleaved fragments. The GFP-tagged p651-186 protein and cleaved fragment were 
labeled by filled and open triangles, respectively, and the NleC cleavage sites in p65 were indicated below. B. 
Whole cell lysates derived from HEK293T cells expressing GFP or the indicated GFP-tagged p65 proteins 
were incubated with the catalytic mutant His-NleC (H117Y) at 4°C. Nickel beads were added to pull-down 









Figure 2.8 The location of the GFP tag does not alter NleC-mediated cleavage of p651-186 
Various truncations of N- or C-terminally GFP-tagged p65, as indicated, were transfected into HEK293T cells. 
Whole cell lysates were subjected to the His-NleC cleavage assays, and immunoblotted with anti-GFP antibody 
for NleC-cleaved fragments. The cleaved fragments from GFP-p65 and p651-186-GFP proteins were labeled by 





Figure 2.9 The N-terminal 20 amino acids are required for NleC to bind to p65 
Whole cell lysates derived from HEK293T cells expressing the indicated GFP-tagged p65 proteins were 
incubated with His-NleC at 4°C. Nickel beads were added to pull-down His-NleC and associated proteins. 




Figure 2.10 The dominant NleC cleave site on p65 is Cys38/Glu39. 
A-B. Whole cell lysates derived from HEK293T cells expressing N-terminal GFP-tagged p65 were subjected to 
the cleavage assay using wild-type His-NleC or the catalytic mutant His-NleC (H117Y), and immunoblotted 
with p65 N-terminus specific antibody for NleC-cleaved p65 fragments. C. Schematic of proposed NleC 
cleavage sites on p65. D. The structure of N-terminus of p65, with dimerization domain (DimD), N-terminal 
domain (NTD), Cys38, and Glu39 highlighted in yellow, orange, red, and blue, respectively. Image was created 
from PDB file 1VKX (Chen et al., 1998) using the Pymol software. E. Whole cell lysates derived from 
HEK293T cells expressing wild-type or mutant GFP-tagged p65 as indicated were subjected to the NleC 
cleavage assay and immunoblotted with p65 N-terminus specific antibody for NleC-cleaved p65 fragments. 
The percentage of GFP-tagged full-length p65, p651-38 fragment, and p651-10 fragment among the total GFP-
tagged p65 proteins under each condition was quantified by densitometry. F-G. Whole cell lysates derived from 
HEK293T cells were subjected to the His-NleC cleavage assays, and immunoblotted with p65 N-terminus (F) 





Figure 2.11 NleC cleaves p65 during C. rodentium and EPEC infections. 
A. HEK293T cells expressing N-terminal GFP-tagged p65 were mock infected or infected with indicated C. 
rodentium strains at 100 MOI for 3 h. Whole cell lysates were derived, separated by SDS/PAGE, and 
immunoblotted for indicated proteins. The GFP-tagged p651-10 cleavage products are indicated by an arrow, 
and an asterisk labels nonspecific bands. B. Caco-2 cells were mock infected or infected with indicated EPEC 
strains at 100 MOI for 1 h. Whole cell lysates were derived, separated by SDS/PAGE, and immunoblotted for 
indicated proteins. C. Mouse colon epithelial cells (CECs) were mock infected or infected in suspension with 
indicated C. rodentium strains at 100 MOI for 3 h. Whole cell lysates were derived, separated by SDS/PAGE, 
and immunoblotted for indicated proteins. The full-length p65 and cleaved p65 C-terminal fragment are 
indicated by filled and open triangles, respectively. D. Mouse CECs infected as in C were separated from free 
C. rodentium by Percoll gradient centrifugation. Whole cell lysates from CECs and attached C. rodentium were 
derived, separated by SDS/PAGE, and immunoblotted for indicated proteins. E. Representative 
immunofluorescence micrographs of mouse CECs infected as in C that were centrifuged onto cover slips and 
stained for C. rodentium LPS, with nuclei counterstained by DAPI. Scale bars, 10 μm. F. The numbers of C. 
rodentium attached to mouse CECs as in E (from 6 random fields) were quantified and normalized to the 






Figure 2.12 p50 is not cleaved during infection with EPEC or C. rodentium 
A. Caco-2 cells were mock infected or infected with the indicated EPEC strains at 100 MOI for 1 h. Whole cell 
lysates were derived, separated by SDS/PAGE, and immunoblotted for indicated proteins. B. Mouse colon 
epithelial cells (CECs) were mock infected or infected in suspension with the indicated C. rodentium strains at 






Figure 2.13 NleC suppresses inflammatory responses in C. rodentium-infected mice. 
A. Representative immunofluorescence micrographs of C. rodentium LPS, with nuclei counterstained by DAPI, 
in colon sections derived from C57BL/6 mice 8 days post inoculation with the indicated strains of C. rodentium. 
Scale bars, 10 μm. Lu indicates the colon luminal space. B. Quantitative PCR (qPCR) was used to determine 
mRNA levels of indicated cytokine/chemokine genes relative to Actb (β-actin) in the colons collected from 
C57BL/6 mice 14 days post inoculation with wild-type or ΔnleC mutant strain of C. rodentium. C-D. 
Immunofluorescence micrographs of CD11b+ inflammatory immune cells in the colons collected from 
C57BL/6 mice as in B, with nuclei counterstained by DAPI. Scale bars, 10 μm. The colon-infiltrated 
inflammatory immune cells (from 5 random fields) with CD11b staining were quantified (D). E. Hematoxylin 
and eosin (H&E) staining of colons collected from C57BL/6 mice as in D. Scale bars, 200 μm. F. The 
histopathology scores of colon sections derived from mice infected as indicated as in D. Shown are mean ± 






Figure 2.14 Wild-type and ΔnleC C. rodentium colonize mice equivalently 
Colons were harvested from C57BL/6 mice at day 10-post inoculation with the indicated C. rodentium strains 
and cleaned of their contents, and homogenized in PBS. Serial dilutions were performed and plated on 




Figure 2.15 The p651-38 fragment interferes with the RPS3-p65 interaction in the cytoplasm 
and selectively attenuates the nuclear translocation of RPS3. 
A. HEK293T cells were transfected with C-terminal GFP-tagged p651-38, p6539-551, or GFP control plasmids. 28 
h later, the cytosolic and nuclear fractions were derived and immunoblotted (IB) for indicated proteins. Hsp90 
and PARP1 served as loading controls and cytosolic and nuclear markers, respectively. B. HEK293T cells were 
transfected with indicated GFP-tagged p65 or GFP control plasmids. 28 h later, whole cell lysates (Input) were 
derived and directly IB, or after immunoprecipitation (IP) with RPS3 antibody, for indicated proteins. Non-
specific bands and immunoprecipitated GFP-p65 proteins are indicated by asterisks and arrows, respectively. 
HC, heavy chain; LC, light chain. C. HEK293T cells expressing GFP-tagged p651-38 or GFP alone were 
stimulated with 50 ng ml-1 of TNF for indicated periods. Whole cell lysates were derived and IB for IκBα, with 
β-actin as a loading control. D. HEK293T cells were transfected and stimulated as in C, and nuclear fractions 
were derived and IB for indicated proteins. Hsp90 and PARP1 served as loading controls and cytosolic and 
nuclear markers, respectively. E. HEK293T cells were transfected with increasing amounts of GFP-p651-38, 
compensated with GFP control, together with 5 × κB-Luc reporter and pTKRL plasmids. After 28 h, the cells 







Figure 2.16 The p651-38 binds to RPS3 
Pull-down with recombinant GST or GST-RPS3 proteins with whole cell lysates derived from HEK293T cells 







Figure 2.17 Schematic model of selective inhibition of NF-κB gene expression by the NleC-
cleaved p651-38 fragment.  
Under normal conditions (A), NF-κB stimuli activate both RPS3-dependent and -independent NF-κB signaling 
pathways. When injected into host cells via the T3SS during A/E pathogen infections (B), NleC cleaves a small 
percentage of p65, generating the p651-38 fragment that interferes with the RPS3-p65 interaction and 
sequestrates RPS3 in the cytoplasm. This leads to selective inhibition of the RPS3-dependent NF-κB gene 
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Pathogens have evolved a myriad of ways to abrogate and manipulate the host response to 
infections. Of the various mechanisms involved, pathogen-encoded and sometimes host-encoded 
proteases are an important category of virulence factors that cause robust changes on the host 
response by targeting key proteins along signaling cascades. The nuclear factor kappaB (NF-κB) 
signaling pathway is a crucial regulatory mechanism for the cell, controlling the expression of 
survival, immune, and proliferation genes. Proteases from pathogens of almost all types have been 
demonstrated to target and cleave members of the NF-κB signaling pathway at nearly every level. 
This review provides discussion of proteases targeting the most abundant NF-κB subunit, p65, and 
the impact of protease-mediated p65 cleavage on the immune responses and survival of the infected 
host cell. After examining various examples of protease interference, it becomes evident that the 
cleavage fragments produced by pathogen-driven proteolytic processing should be further 
characterized to determine whether they have novel and unique functions within the cell. The 
selective targeting of p65 and its effect on gene transcription reveals unique mechanisms by which 
pathogens acutely alter their microenvironment and further research may open new opportunities for 
novel therapeutics to combat pathogens. 
3.2 Introduction 
Epithelial cells and innate immune cells stand as the first line of defense against tissue 
damage and invading pathogens at mucosal surfaces. Encoding a variety of pattern recognition 
receptors (PRRs) that are capable of responding to an even greater variety of pathogen-associated 
molecular patterns (PAMPs), mucosal epithelial cells initiate immune responses. Stimulation of PRRs 
results in the activation of signaling cascades, through adaptor proteins, that transduce the signal to 
the transcription factor level.  Most commonly, key transcription factors, including nuclear factor 
kappaB (NF-κB), activator protein 1 (AP-1), cAMP response element-binding protein (CREB), and 
interferon-regulatory factor (IRF), are the targets of these signaling pathways, resulting in the 
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transactivation of an array of target genes. The activation of inflammatory and anti-apoptotic 
proteins ultimately alerts the immune system of invasion and induces the recruitment of leukocytes 
to the site of infection. Cell surface receptors, such as toll-like receptors (TLRs), stimulate the cellular 
signaling and activation of NF-κB when the corresponding ligand binds its receptor. The NF-κB 
signaling pathways are crucial for the host response, as they serve as a master regulator and 
orchestrator of both the innate and adaptive immune responses (Finlay & McFadden, 2006, Le 
Negrate, 2012), making it a key target for pathogen interference (Thaker, 2014, Vallabhapurapu & 
Karin, 2009). A great number of previous studies have elucidated the mechanism by which the NF-
κB pathways are regulated in normal and disease conditions (Hayden & Ghosh, 2012, Lenardo & 
Baltimore, 1989). Typically, NF-κB activation is initiated by ligand binding to a membrane bound 
cytokine or PRR receptor whose signal is transduced by the adaptor protein myeloid differentiation 
primary response gene 88 (MyD88) and others until the IκB kinase (IKK) complex is activated. The 
IKK beta subunit (IKK) phosphorylates and marks IκB for proteasomal degradation, which in turn 
unmasks the nuclear localization signal (NLS) of NF-κB thus liberating the NF-κB complex for 
translocation into the nucleus. Once in the nucleus, the NF-κB complex binds to a variety of specific 
double-stranded DNA sequences, termed κB sites, in the genome and recruits the general 
transcriptional machinery to induce the transcription of target genes (Lenardo & Baltimore, 1989), 
including those controlling immune responses and survival of host cells. 
Besides the best-characterized Rel family proteins, i.e. p65 (also named RelA), RelB, c-Rel, 
p50, and p52, other non-Rel protein subunits in NF-κB complexes play an important role in 
optimizing the binding of target DNA and transcription of target genes. Ribosomal protein S3 
(RPS3) was identified as the first ‘specifier’ subunit of NF-κB that confers the promoter selectivity 
and transcriptional specificity of NF-κB. RPS3 occurs along with p65 and IκB in a portion, but not 
all, of the inhibitory NF-κB complexes in the cytoplasm (Wan et al. unpublished results). Once 
activated, RPS3 translocates, independent of p65, into the nucleus where it increases the affinity of 
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p65/p50 to particular κB sites (Wan et al., 2007, Wan et al., 2011). RPS3 functions as a ‘specifier’ of 
NF-κB gene transcription, shedding light on a major lingering question within the field regarding 
promoter selectivity and transcriptional specificity, especially considering how diverse stimuli 
generate specific responses amongst the large number of κB binding sites scattered throughout the 
genome. Moreover, this additional binding partner strengthens the association of the p65/p50 dimer 
at the particular κB sites of a growing list of genes that are now considered RPS3-dependent genes, 
allowing the activation of only a subset of the vast potential p65-dependent genes (Wan et al., 2007, 
Wan et al., 2011, Sen et al., 2012). Since then, other specifiers have been attributed to helping hone 
the activation of NF-κB-dependent genes. Src-associated substrate during mitosis of 68 kDa (Sam68) 
has been discovered as another non-Rel subunit of p65, functioning in the nucleus to mediate the 
binding of NF-κB to the CD25 promoter in activated T cells (Fu et al., 2013), and Kruppel-like 
factor 6 (KLF6) has been identified as another nuclear co-activator of NF-κB for a subset of genes 
(Zhang et al., 2014). The discovery of these specifier proteins not only serves to answer the question 
of promoter selectivity but also emphasize that while NF-κB dimer binding is required at the 
promoter, it is not sufficient to induce the transcription of particular genes. The specifier proteins 
function to promote the binding and enhance the efficiency of transcriptional activation of particular 
genes over others. The function of the currently known specifier proteins in particular inflammatory 
settings or specific tissue/cell types remains unknown. The existence of cell type specific responses 
to similar stimuli is well recognized and exemplified by the discussion of how gut epithelial cells tend 
to response to infection with a mainly anti-apoptotic profile (and some inflammatory responses), 
whereas the infiltrating immune cells build the majority of the inflammatory response (Spehlmann & 
Eckmann, 2009, Eckmann & Neish, 2011). Understanding the cell type specific responses to stimuli 
is particularly important when many pathogens have evolved preferences for infecting particular cell 
types which presumably aides their survival within the host. 
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As a result of the many host protective mechanisms, pathogens have co-evolved many 
strategies to overcome these host defense mechanisms. Encoding virulence factors, such as toxins, 
adhesins, secretion systems, decoy receptors, kinases, proteases, and compounds, that modulate host 
immune responses have resulted in the ability to greatly manipulate the host response (Casadevall & 
Pirofski, 2009). Pathogens express an array of virulence factors that change as the pathogen 
progresses through its life cycle/infection cycle. These factors target all aspects of the cellular 
immune responses to infection, however those that target proteins where intracellular signaling 
cascades converge are arguably the most challenging for host cells to overcome. This is likely because 
many surface receptors rely on a smaller pool of adaptor proteins, that if disrupted, prevent the relay 
of signals from the outside of the cell to the nucleus (Silke & Hartland, 2013), therefore the pathogen 
does not need to encode a virulence factor to target all cellular receptors, when it can target a 
common adaptor protein to turn off the cellular signaling cascades. Whether the pathogen is 
intracellular or extracellular and/or encodes a secretion system capable of translocating proteins into 
a host cell, it can gain access to the major signaling junctions employed by the mammalian host to 
orchestrate immune responses (Brodsky & Medzhitov, 2009). Due to the convergence of many PRR 
signaling cascades on proteins such as IKK and mitogen activated protein kinase (MAPK), it is more 
effective for pathogens to target the intracellular activator than attempt to block all the extracellular 
receptors (Silke & Hartland, 2013). With this strategy, pathogens can exact robust effects on cell 
signaling while encoding fewer effectors. Along with targeting a myriad of signaling pathways, 
pathogens also encode virulence factors with redundant functions in an effort to abrogate the host-
signaling cascade. Many pathogens have acquired sophisticated mechanisms to directly interfere with 
the host NF-κB signaling pathways through regulating or mimicking host proteins to their own 
advantage, highlighting the importance of NF-κB signaling. Bacteria, viruses, and parasites encode 
virulence factors that operate at multiple levels of the sequential process of NF-κB signaling using 
redundancy to ensure blockade of the pathway, demonstrating how crucial inhibiting this particular 
pathway is for pathogen survival. Of note, deubiquitinating enzymes (Ndubaku & Tsui, 2015), 
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kinases (Krachler et al., 2011), proteases, and other encoded proteins are key virulence factors 
employed by pathogens to modulate NF-κB signaling in host cells. Of these, proteases are of 
particular interest because they alter the inherent structure of host proteins, thus preventing their 
native functions, although the cleaved fragments may play additional roles within the cell. This review 
will focus on the targeting of the NF-κB signaling pathway by intracellular proteases encoded by 
various pathogens. The regulation of NF-κB and the activation of downstream gene targets remain 
of great interest in host-pathogen interactions, but understanding how pathogens are manipulating 
these interactions to abrogate intracellular NF-κB signaling and dampen immune responses is 
paramount.  
3.3 Targeting the upstream signaling molecules in the NF-κB pathway 
Upon receptor engagement, the activation of adaptor proteins occurs to start the NF-κB 
signal transduction cascade in the cytoplasm that leads to changes at the transcriptional level of 
specific NF-κB target genes in the nucleus. The NF-κB signaling cascade contains many intermediate 
molecules (as well as important post-translational modifications) that are subject to pathogen 
intervention, in particular pathogen-encoded protease virulence factors. The Toll–interleukin 1 
receptor (TIR) domain-containing proteins TRIF and MyD88, both of which are important adaptor 
proteins residing just inside the cellular membrane, were reported to be targeted by the NS3/4A 
protease encoded by Hepatitis C virus (HCV) (Li et al., 2005a) and the 3C protease encoded by 
enterovirus 68 (Xiang et al., 2014), whereas infection by the bacterium Yersinia enterocolitica activates 
human Caspase 3 to cleave these host proteins (Novikova et al., 2014) . Targeting TRIF prevents 
signal transduction from TLR3 and TLR4, whereas abrogating MyD88 blocks signal transduction 
from most surface stimulation, as it is employed by all TLRs (except TLR3) and some cytokine and 
chemokine receptors (Kawai & Akira, 2010, Piras & Selvarajoo, 2014). Thus the protease-mediated 
cleavage of TRIF and MyD88 has an extensive effect on downstream pathways, as evidenced by the 
lack of NF-κB activation during HCV (Li et al., 2005a), enterovirus 68 (Xiang et al., 2014), and Y. 
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enterocolitica (Novikova et al., 2014) infections. Of note, besides the NF-κB signaling pathway, the 
NS3/4A and 3C proteases also block the activation of the interferon response by targeting TRIF 
(Kawai & Akira, 2010, Piras & Selvarajoo, 2014). As a result, these pathogens have robust effects on 
host defense with minimal energy input, by encoding a single protease that can target the nexus of 
multiple signaling pathways. Moreover, HCV is especially adept in this respect, as the same protease 
also targets the intracellular adaptor mitochondrial antiviral-signaling protein (MAVS) (Li et al., 
2005b, Meylan et al., 2005) that is crucial for RIG-I helicase-initiated activation of NF-κB and 
interferon responses (Yoneyama & Fujita, 2007). Moreover, the porcine reproductive and respiratory 
syndrome virus (PRRSV) encoded protease NSP4 has been shown to cleave NEMO/IKKγ (Huang 
et al., 2014), a regulatory subunit of the IKK complex that serves as the master NF-κB regulator that 
is activated by the stimulation of various cell surface molecules. Furthermore, the 3C protease 
encoded by Coxsackievirus has been demonstrated to cleave IκBα (Saura et al., 2007, Zaragoza et al., 
2006), which sequesters NF-κB in the cytoplasm. Interestingly, the cleavage of IκBα by 
Coxsackievirus 3C protease does not completely degrade IκBα, something that would lead to the full 
liberation and constitutive activation of NF-κB. Instead, the proteolytic fragment, remains bound to 
and translocates into the nucleus with NF-κB complexes, dominantly interfering with NF-κB DNA 
binding capability, thus dampening the NF-κB activation in host cells during Coxsackievirus 
infection (Saura et al., 2007, Zaragoza et al., 2006). These pathogen-encoded proteases and their 
proposed target proteins in host cells are summarized in Table 1. By targeting the upstream nodes of 
this signaling cascade, these proteases are capable of causing a global suppression of the NF-κB 
signaling pathway specifically, as well as other signaling cascades that crosstalk via some of these 
adaptor molecules.  
3.4 p65, a major target of pathogen proteases 
In addition to targeting various key molecules upstream of the NF-κB signaling pathway, 
pathogens have acquired strategies to interfere with NF-κB, in particular the Rel subunits that are 
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directly involved in binding to DNA promoters of various target genes. Although there is some cell 
type variability, the most abundant NF-κB species in a cell consists of p65, p50, and other proteins 
(Wan et al., 2007). The p65 protein also possesses a transactivation domain (TAD) that is crucial for 
recruiting the general transcriptional machinery for the transactivation of target genes (Wan & 
Lenardo, 2010). These features make p65 unique among Rel family proteins and most frequently 
modulated by many pathogens including bacteria, parasites, and viruses.. 
3.4.1 Bacteria encoded proteases 
Pathogenic bacteria encoding a membrane-bound protein complex, termed the type III 
secretion system (T3SS), such as the attaching/effacing (A/E) pathogens including enteropathogenic 
Escherichia coli (EPEC), enterohemorrhagic E. coli (EHEC), and the mouse pathogen Citrobacter 
rodentium, are prime examples of pathogens that interact with host intracellular signaling cascades to 
alter their microenvironment (Hartland & Leong, 2013, Shames & Finlay, 2012, Silke & Hartland, 
2013, Wong et al., 2011). EHEC, EPEC, and C. rodentium encode a long list of virulence proteins 
(effectors) that are delivered into host cells during infection via the T3SS. These effectors target 
multiple cellular pathways present within the cell and function to manipulate the host cellular 
signaling, often with multiple effectors targeting the same pathway (reviewed in (Wong et al., 2011)). 
As such, the non-LEE-encoded (Nle) effectors NleB, NleE, NleH1, and NleC all target the NF-κB 
signaling pathway, of which NleB blocks the signal transduction between the TNF receptor-
associated factor 2 (TRAF2) and NF-κB upstream proteins by preventing the ubiquitination of 
TRAF2 (Pham et al., 2013); NleE modifies TGF-β Activated Kinase 1 Binding Protein 2/3 (TAB2/3) 
that transduces the activating signal from a cytokine receptor to TGF-β Activated Kinase 1 (TAK1) 
or IKK kinases (Yao et al., 2014); NleH1 inhibits the phosphorylation of RPS3 thereby preventing its 
nuclear translocation and ‘specifier’ activity (Gao et al., 2009). Using multiple effectors to block NF-
κB signaling allows the pathogen to regulate its microenvironment and ensure particular host signal 
transduction pathways are blocked. Another effector targeting NF-κB is the metalloprotease NleC, 
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which was shown to cleave mainly p65 (Baruch et al., 2011, Hodgson et al., 2015, Li et al., 2014, 
Muhlen et al., 2011, Pearson et al., 2011, Turco & Sousa, 2014, Yen et al., 2010), although p300 was 
also proposed (Shames et al., 2011), in host cells. As a canonical zinc metalloprotease with the 
conserved HEXXH motif, NleC is well conserved among EHEC, EPEC, and C. rodentium (Turco & 
Sousa, 2014). NleC was first described as an important effector for the infection-mediated 
suppression of interleukin-8 (IL-8) in host cells (Yen et al., 2010, Sham et al., 2011) and subsequently 
revealed by multiple groups to cleave p65 in order to suppress host inflammatory responses (Baruch 
et al., 2011, Hodgson et al., 2015, Li et al., 2014, Muhlen et al., 2011, Pearson et al., 2011, Turco & 
Sousa, 2014, Yen et al., 2010). Moreover, the molecular details about the interaction between p65 and 
NleC have also been illustrated by recent crystal structural analyses showing that the complimentary 
electrostatic interactions surrounding the catalytic zinc binding site of NleC and the DNA binding 
loop of p65 (Li et al., 2014) and that NleC structurally and chemically mimics DNA to exploit the 
DNA binding motifs of p65 (Turco & Sousa, 2014). Although different cell lines and pathogens were 
utilized, the cleavage sites of p65 by NleC from previous studies appear to occur between proline 10 
and alanine 11 (P10/A11) (Yen et al., 2010), cysteine 38 and glutamic acid 39 (C38/E39) (Baruch et 
al., 2011, Li et al., 2014, Turco & Sousa, 2014), or both with C38/E39 being the primary site 
(Hodgson et al., 2015). More importantly, the C38/E39 cleavage site on p65 is of particular interest 
as C38 sulfahydration was recently proposed to be a crucial post-translational modification to 
stabilize the p65-RPS3 interaction, thus facilitating RPS3/p65-dependent NF-κB target gene 
transcription (Sen et al., 2012).  
  The gram-negative bacterium Photobacterium damselae piscicida (Phdp) that causes fish 
pasteurellosis, a disease characterized by septicemia and high mortality is a considerable threat for 
mariculture (Barnes et al., 2005, Romalde, 2002). Phdp encodes an A-B toxin termed AIP56, whose 
N-terminus is homologous to NleC, maintaining the conserved HEIVH zinc binding domain, 
whereas the C-terminus serves as an internalization mechanism for the secreted AIP56 to enter target 
cells (Silva et al., 2013), macrophages and neutrophils (do Vale et al., 2007, do Vale et al., 2003). 
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During Phdp infection, macrophages and neutrophils, the primary cell type employed by the immune 
system to clear apoptotic cells before secondary necrosis, undergo AIP56-dependent apoptosis (do 
Vale et al., 2007, Silva et al., 2013), causing the release of their cytotoxic components thus resulting in 
an inflammatory response (do Vale et al., 2007, do Vale et al., 2003). Given the homology between 
NleC and AIP56, it is not surprising that AIP56 also targets the same Cys/Glu residues, i.e. C39/E40 
in fish, within the Rel homology domain (RHD) of p65 for cleavage. The apoptotic effect executed 
by AIP56 is thought to result from the abrogated gene transcription of anti-apoptotic genes normally 
conferred by NF-κB/p65 (Silva et al., 2013). In this setting, blocking the NF-κB-mediated anti-
apoptotic gene transcription induces an overwhelming immune response and severe 
immunopathology in fish hosts subsequent to Phdp infection.  
 The well known intracellular bacteria, Chlamydia trachomatis, is the primary cause of 
preventable blindness worldwide as well as the most commonly found sexually-transmitted disease in 
the United States (Brunham & Rey-Ladino, 2005), which makes it a pathogen of intense clinical 
interest. Although the murine infection model nicely recapitulates the acute genital tract infection 
observed in women, spontaneous clearance and life long immunity make the mouse disease differ 
from the human disease in which infections can last several months and re-infection is common 
(Morrison & Caldwell, 2002). As an intracellular pathogen, C. trachomatis employs several proteases at 
various life stages to regulate host-cellular signaling. CT441 is a tail-specific protease (Tsp) containing 
a PDZ (postsynaptic density protein [PSD95], Drosophila disc large tumor suppressor [Dlg1], and 
zonula occludens-1 protein [zo-1]) domain and conserved serine and lysine residues that serve as the 
catalytic unit. CT441 shares approximately 70% sequence identity around the catalytic unit with other 
PDZ domain-containing Tsp proteases (Lad et al., 2007b). Lad and colleagues reported that CT441 
cleaves human p65, however the murine protein is resistant to cleavage, due to several differences in 
their amino acid sequences between residues 331-359 (Lad et al., 2007b). Moreover, swapping the 
residues 331-359 between human and murine p65 proteins renders the human p65 resistant to 
CT441 cleavage. Of note, selectively cleaving only the human protein versus the mouse protein could 
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serve as a key-determining factor explaining the disease difference between the two species. It has 
been speculated that without cleaving p65, the mouse immune response may be induced early 
enough to prevent widespread dissemination of the Chlamydia bacteria, leading to an accelerated 
clearance. Lad and colleagues also demonstrated that expression of CT441 not only induced cleavage 
of human p65 but also prevented NF-κB activation, as illustrated by a lack of IκB degradation and 
p65 nuclear translocation (Lad et al., 2007a). Cleavage of p65 could result in the lack of p65 nuclear 
translocation; moreover, the cleaved N-terminus of p65, defined as p40, was proposed to directly 
interact with IκB, adding additional dominant negative regulation to NF-κB activation. The p40-
IκB interaction was hypothesized to protect IκB from degradation, although the protective 
mechanism is unclear and there exists the possibility that another effector encoded by C. trachomatis 
has a role in protecting IκB from degradation (Lad et al., 2007a). Indeed, targeting the same 
signaling pathway via multiple strategies is not uncommon for many pathogens, as such redundancy 
ensures full manipulation of the host microenvironment to the pathogens’ advantage. It remains to 
be determined whether the lack of IκB degradation and subsequent NF-κB activation are also 
restricted to human infection, but not in the murine infection. Further inquiry would further clarify 
the cause of the IκB protection being dependent on the presence of the p40 cleavage product, since 
only the human p65 can be cleaved to generate the p40 product.  
3.4.2 Parasite encoded proteases 
The Leishmania parasite is responsible for the infection of more than 2 million people around 
the world every year (de Vries et al., 2015). Spread by the Phlebotomus sandfly, this vector borne 
parasite has many life stages which vary in their expression and activation of various proteins, 
constantly providing a moving target for treatment and vaccine development (Jain & Jain, 2015). It 
was reported that the Leishmania metalloprotease gp63 cleaves p65 and produces a stable truncated 
form of p65, termed p35RelA, which executes a functional role within the cell (Gregory et al., 2008a). 
The p35 fragment retains the nuclear translocation ability of the full-length protein where it 
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heterodimerizes with p50 and binds DNA. Surprisingly, despite both proteins lacking a TAD 
domain, the p35 truncation and p50 heterodimer are still capable of turning on the expression of a 
particular set of chemokines (Gregory et al., 2008a). This indicates that beyond NF-κB, additional 
transcriptional factor(s) that possess a TAD may be involved in the transcription of these chemokine 
genes, considering that it is known that NF-κB couples with other transcription factors such as AP-1 
and STATs to form a higher-order enhanceosome for optimizing the gene expression in immune 
responses (Fan et al., 2010, Fujioka et al., 2004, Neff et al., 2001). Previous studies showed that 
infection with Leishmania parasites resulted in the failed activation of macrophages and 
proinflammatory signaling. Moreover, infected macrophages have also been revealed to be defective 
in reactive oxygen species (ROS) production and chemotaxis (Gregory et al., 2008b, Olivier et al., 
2005). However, it remains unknown how the expression of certain chemokines, such as macrophage 
inflammatory protein 1α (MIP-1α), MIP-1β, and Regulated on Activation, Normal T Cell Expressed 
and Secreted (RANTES) are induced during Leishmania infection (Dasgupta et al., 2003, Olivier et al., 
2005). In particular the transactivation of these chemokines is a survival strategy for the parasite, as 
the recruitment of more macrophages to the infection site allows the parasite to move into a new 
host cell and continue the infection cycle (Dasgupta et al., 2003). Gregory and colleagues 
demonstrated that the cleaved p35 fragment induced chemokine gene transcription, however, little 
more mechanistic detail beyond DNA binding was offered. The authors speculated that the 
remaining molecules of the p35 fragment present within the nucleus could be acting in a dominant 
negative capacity to block the transactivation of other NF-κB target genes, such as Nos2, encoding 
inducible nitric oxide synthase that would be detrimental to the parasite (Gregory et al., 2008a). In 
this way, the p35 fragment may be acting in a repressive manner, similar to how p50 homodimers are 
thought to act, as they also lack the TAD domain. Hence, gp63 induced cleavage of p65 provides the 
parasite with the ability to acutely modify its microenvironment by regulating NF-κB target gene 
transcription.  
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3.4.3 Viral encoded proteases 
Viruses also encode various virulence factors that allow them to manipulate the crucial 
signaling pathways in host cells, which is more critical for viruses than other pathogens as viruses 
solely rely on host cells for replication. For instance, all members of the picornavirus family encode a 
3C cysteine protease that processes the viral RNA encoded polyprotein (reviewed in (Palmenberg, 
1990)). Among them, it has been demonstrated that poliovirus, as well as a few others, targets NF-κB 
p65 in order to shut down aspects of the innate immune response in host cells (Neznanov et al., 
2005). Poliovirus infects humans via the gastrointestinal tract and enters the bloodstream via the local 
lymphoid tissue. Most infections are asymptomatic or mild; however in a subset of individuals the 
virus eventually infects cells within the central nervous systems (CNS) where it causes the 
characteristic paralysis known as poliomyelitis. In vitro, poliovirus infection of host cells causes a 
short-lived activation of NF-κB, as demonstrated by nuclear translocation of p65/p50 and IκB 
degradation peaking at about 4 hours post infection (Neznanov et al., 2005). Interestingly, around 3 
hours post infection, the appearance of an N-terminal truncation of p65, termed p65ΔC, occurs 
simultaneously with the translation and detection of the poliovirus-encoded 3C protease (Neznanov 
et al., 2005). It was further demonstrated that the cleavage product is a result of the 3C protease and 
not the induction of apoptosis, which is also supported by the careful control over the timing and 
induction of apoptosis that poliovirus infection is able to exert on the cell (Agol et al., 2000, Levkau et 
al., 1999). Indeed, the control of apoptosis and the initial activation of the NF-κB signaling pathway, 
which causes the expression of some anti-apoptotic genes, allow the host cell to survive long enough 
for the virus to replicate its genome. While poliovirus is a well-studied example of the picornavirus 
family, Neznanov and colleagues also showed that other representatives of the family encode 3C, 
such as ECHO-1 and rhino-14, and can also cleave p65 (Neznanov et al., 2005). Elucidating the 
spatial-temporal regulation of these virulence factors is needed in future studies to allow for a deeper 
understanding of how these many strategies and regulatory pathways interact within host cells. 
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3.4.4 Host-encoded proteases benefiting pathogens 
Besides interfering with host signaling pathways directly with pathogen-encoded proteases, 
pathogens take advantage of host protein functions (NF-κB being one of them) to serve their own 
needs. This is best exemplified by the human immunodeficiency virus (HIV). Indeed, the HIV 
genome encodes and requires NF-κB binding sites to boost the transcription of certain viral proteins 
(Alcami et al., 1995, Bachu et al., 2012, Coiras et al., 2008, Perkins et al., 1993, Zhang et al., 2012). Since 
HIV primarily infects and replicates in activated T cells, Coiras and colleagues characterized the 
effects of T cell activation on the NF-κB signaling pathway (Coiras et al., 2008). Interestingly, they 
uncovered that immediately after the phorbol myristate acetate (PMA) or phytohemagglutinin (HA) 
stimulation of T cells, an apoptosis-unrelated, low-level activation of Caspase-3 leads to proteolytic 
processing of p65. The group further characterized the fate of the cleaved C-terminal product of p65, 
containing amino acids 97-551 and termed ΔNH2p65. They demonstrated that ΔNH2p65 bound to 
IκB and caused constitutive activation of p65 by protecting the full-length p65 from IκB 
inhibition, ultimately leading to an increase in HIV viral replication (Coiras et al., 2008). While the 
HIV-encoded proteins themselves are not causing the cleavage of p65, the virus’s preference for a 
cell type that innately cleaves a low level of p65 upon activation, is indicative of the advantage HIV 
gains by replicating in such a host cell. The careful balance between activating Caspase-3 at low levels 
to cleave some of the p65 molecules within T cells and inducing extensive apoptosis should be 
highlighted here as too much Caspase-3 activity could certainly backfire on the virus. Anti-apoptotic 
genes would still be transactivated in such an infected cell, as most of the p65 molecules in the cell 
are left intact and constitutive NF-κB activation would induce their expression, which therefore 
results in the maintenance of an infected cell with enough host signaling left intact to produce more 
viral copies and propagate the infection. 
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3.5 NF-κB/p65 cleavage: linear or selective inhibition? 
As supported by the previous cited studies, it is apparent that pathogen-encoded protease mediated 
cleavage of a variety of signaling molecules in host cells, especially the NF-κB signaling pathway (as 
summarized in Table 2), executes a dramatic and robust impact on the host immune responses. In 
most cases, it is proposed that the cleavage of a single key molecule in the NF-κB signaling pathway, 
along with other encoded virulence factors, is sufficient to block the signal transduction necessary to 
activate NF-κB target genes, especially proinflammatory cytokine/chemokine genes, thus modulating 
the global host immune responses to the pathogen’s advantage and allowing the persistence of the 
infection (Figure 1). This explanation, at first glance, appears to be a reasonable incorporation of 
observations made during pathogen infection; however, it falls short in clarifying the dramatic impact 
on host inflammatory cytokine/chemokine gene expression when p65 is cleaved during the bona fide 
pathogen infections. A great number of studies have established that NF-κB is acutely and robustly 
activated during pathogen infections, as illustrated by a rapid nuclear translocation of the majority of 
p65, as well as the other Rel proteins, in host cells (Hayden & Ghosh, 2012, Li & Verma, 2002, Pott 
& Hornef, 2012, Sun & Andersson, 2002, Thaker, 2014). This is further emphasized by the need to 
encode a series of virulence factors that target multiple levels of the same signaling pathway as has 
been demonstrated by the A/E pathogens (Wong et al., 2011). If each p65 molecule in the host cell 
makes an equal contribution to the transactivation of NF-κB-targeted genes, pathogen-encoded 
proteases would have to cleave the majority, or even the entirety of the p65 pool in the cell to reach a 
substantial suppression of cytokine/chemokine gene transcription. However, most of the reported 
protease-mediated cleavage events in infected host cells have been characterized qualitatively, 
focusing on the identification of target host protein(s), but lacking further definition quantitatively. 
Even under conditions such as ectopic expression in host cells and in vitro protease assays with 
recombinant proteins, only a percentage of the entire p65 molecule pool in host cells is cleaved by 
the pathogen-encoded protease in question, leaving a substantial amount of intact full-length p65 
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(Baruch et al., 2011, Coiras et al., 2008, Hodgson et al., 2015, Li et al., 2014, Muhlen et al., 2011, Silva 
et al., 2013, Turco & Sousa, 2014, Yen et al., 2010). Unsurprisingly, the amount of p65 cleavage is 
even lower under the pathophysiological conditions of pathogen infection in vivo where the 
expression level of the protease is likely lower (Deng et al., 2010). Hence, it remains puzzling how 
incomplete cleavage of p65 by many pathogen-encoded proteases has a disproportionally dramatic 
impact on NF-κB-mediated gene transcription and the global inflammatory response. Even in 
scenarios where pathogens encode multiple effectors to target one pathway, knockout of just the 
protease, as in the case of NleC, is capable of dramatically changing the NF-κB activation status. 
Therefore, redundancy in effectors is unable to fully explain the effects observed when incomplete 
cleavage occurs. 
Of note, recent progress in elucidating the mechanisms that control the promoter selectivity 
and transcriptional specificity of NF-κB provides new insights into this apparent inconsistency 
between the protease-mediated p65 cleavage and the impact on NF-κB-conferred inflammatory gene 
expression and inflammatory response in host cells. This is best exemplified by our recent study on 
how the afore-mentioned protease effector NleC interferes with the NF-κB ‘specifier’ component 
RPS3 and the selective activation of RPS3-dependent, NF-κB target gene transcription during EPEC 
and C. rodentium infections by cleaving p65 (Hodgson et al., 2015). NleC was recently revealed as an 
important effector functioning to dampen the secretion of inflammatory cytokines in A/E pathogen-
infected cells by cleaving p65 (Baruch et al., 2011, Li et al., 2014, Muhlen et al., 2011, Pearson et al., 
2011, Shames & Finlay, 2011, Turco & Sousa, 2014, Yen et al., 2010). Injected via the T3SS into host 
cells at low abundance, relative to other effector molecules (Deng et al., 2010), NleC cleaves only a 
small percentage of the p65 molecules in infected host cells, even when ectopically expressed (Baruch 
et al., 2011, Muhlen et al., 2011, Yen et al., 2010). For many pathogen-encoded proteases it remains 
uncommon to further characterize the fate and possible function of the cleaved fragments, however, 
our group uncovered that the newly produced fragments had a further functional role within the cell. 
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The N-terminal fragment of p65, termed as p651-38 (Hodgson et al., 2015), generated by NleC 
cleavage, executes a unique function by interfering with the cytoplasmic RPS3/p65 interaction and 
inhibiting the nuclear translocation of RPS3, but not the remaining uncleaved p65. It is noteworthy 
that RPS3 occurs along with p65 and IκBα in a portion, but not all, of inhibitory NF-κB complexes 
in the cytoplasm (unpublished observation) and that the nuclear translocation of RPS3 is crucial for 
the transactivation of the RPS3/p65-dependent NF-κB target genes (Gao & Hardwidge, 2011, Gao 
et al., 2009, Sen et al., 2012, Wan et al., 2007, Wan et al., 2011, Wier et al., 2012). By interfering with 
and preventing RPS3 from nuclear translocation with the cleaved p651-38 fragment, the NleC protease 
is not required to cleave all or even most of the p65 molecules present within the cell, since 
disrupting the limited NF-κB complexes containing both RPS3 and p65 is sufficient to alter the 
RPS3-dependent NF-κB gene transcription (Hodgson et al., 2015, Sen et al., 2012, Wan et al., 2007, 
Wier et al., 2012). It should be noted that aside from the NleC cleaved p651-38, other effectors 
introduced into the host cell during infections will limit the amount of active p65 and NleH will also 
specifically target p65/RPS3, creating redundancy. The RPS3-conferred NF-κB promoter selectivity 
provides a novel avenue for pathogen interference, effectively “amplifying” the effect of cleaving a 
small percentage of p65 in A/E pathogen-infected host cells in order to sequester RPS3 in the 
cytoplasm (Figure 1). In support of the interrupted RPS3/p65 model, our previous proof-of-concept 
study demonstrated that an ectopically expressed N-terminal truncation of p65 is capable of blocking 
the RPS3/p65 interaction and altering NF-κB activity (Wier et al., 2012). Moreover, this work 
demonstrated that a host Caspase-3 cleaved p651-97 fragment also functions to block the RPS3/p65 
interaction. The power of amplifying the effects of NleC lies in the documented importance of the 
RPS3/p65-mediated NF-κB signaling for host defense against A/E pathogen infections (Gao et al., 
2009, Hodgson et al., 2015, Holmes et al., 2012, Perkins, 2012, Pham et al., 2013, Pham et al., 2012, 
Wan et al., 2007, Wan et al., 2011). In comparison to the global model, this selective inhibition 
strategy proposes a more targeted strategy for a pathogen to exert a robust impact on host signaling 
pathways and inflammatory response with one virulence factor, and the NleC-mediated p65 cleavage 
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serves as a biologically relevant example of this amplification mechanism, though it is likely not the 
only scenario where this amplification strategy occurs. 
Although not extensively examined in the context of other protease-mediated p65 cleavage, 
the RPS3-dependent selective inhibition mechanism could also be implicated during other 
pathogenic infections, particularly when proteases create N-terminal fragments that maintain the 
p65/RPS3 binding interaction. The sulfahydration modification on the C38 of p65 mediates and 
stabilizes the interaction with RPS3 (Perkins, 2012, Sen et al., 2012); in this way, p65 fragments could 
maintain their affinity for RPS3 as long as that modification is preserved. The homology between 
AIP56 and NleC and the similar cleavage site at the N-terminus of p65 indicate that Phdp could 
employ a similar strategy to suppress host inflammatory response (Silva et al., 2013). Moreover, 
AIP56 also inhibited the gene expression of certain anti-apoptotic genes, which have been revealed 
to rely on RPS3/p65 for their transcriptional activation, such as Birc3 (encoding cellular inhibitor of 
apoptosis protein-2, cIAP2) and Bcl2l1 (encoding B-cell lymphoma-extra large, Bcl-XL) (Sen et al., 
2012). Hence, it would be logical to hypothesize that the p65 cleavage product produced by AIP56 is 
also able to maintain its interaction with RPS3, sequestering RPS3 away from full-length p65 in 
immune cells, as demonstrated in C. rodentium-infected colon epithelial cells (Hodgson et al., 2015). 
As demonstrated in the in vitro experiments (Hodgson et al., 2015), the interaction between the 
AIP56-cleaved p65 fragment and RPS3 would prevent the nuclear accumulation of RPS3. Such an 
interaction in Phdp-infected neutrophils and macrophages would still need to be confirmed with 
further experiments, as there may be cell type specific effects and the importance of RPS3/p65 
signaling has yet to be confirmed in these cells. Moreover, the p65ΔC fragment generated by 3C 
protease cleavage during poliovirus, ECHO-1, and rhino-14 infections (Neznanov et al., 2005) and 
the p65 N-terminal fragment generated by the activated host Caspase-3 during HIV infection (Coiras 
et al., 2008), the Chlamydia CT441 protease (Lad et al., 2007a), and the Leishmania GP63 protease 
(Dasgupta et al., 2003, Gregory et al., 2008a) could be capable of blocking the RPS3-p65 interaction, 
although the fate or function of these N-terminal fragments of p65 have not been well defined yet 
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with regards to RPS3. In particular, we demonstrated previously that truncated p65 fragments as 
large as 21-186 (Wier et al., 2012) and 1-311 (Wan et al., 2007) are capable of maintaining their 
binding to RPS3. Though the most profound RPS3 interference was observed with the p6521-186 
fragment, the ability of additional larger N-terminal p65 fragments to interfere with the RPS3/p65 
interaction and function remains to be elucidated (Wier et al., 2012). Moreover, Johannes et al. 
speculated at the possibility of p65 cleavage occurring to block the anti-apoptotic response during 
picornavirus infection, noting that some NF-κB target genes, e.g. IL-6 and IL-8 (Johannes et al., 
1999), appeared unaffected while others, including IκBα, were never reset to the steady state levels 
(Neznanov et al., 2005). Overall this suggests that p65 cleavage modulates the transcriptional 
specificity of NF-κB to some degree during these infections. While the entire repertoire of RPS3/p65 
dependent genes in distinct cell type(s) has not yet been defined, exploiting systems that show 
divergent activation and expression of NF-κB target genes will further define this cohort of genes or 
identify other specifier proteins. The evidence that not only NleC but also other pathogen-encoded 
proteases generate N-terminal p65 fragments with potential interactions with RPS3 indicates that p65 
fragment interference could be a widespread virulence strategy for pathogens in order to abrogate 
RPS3-dependent NF-κB activation in host cells. It is therefore worthy to further examine whether 
the cleaved p65 fragments manipulate RPS3, or other specifier proteins, for inhibition or activation 
of a subset of NF-κB target genes in future studies, in particular when the pathogen-encoded 
proteases are unable to cleave the majority of the cellular pool of p65. Moreover, when cleavage of a 
target protein is recognized within host cells, deeper consideration of how the pathogen amplifies its 
efforts may uncover previously underappreciated protein interactions and gene regulation strategies. 
3.6 Conclusion 
Emerging evidence highlights pathogen-encoded proteases as critical virulence factors that can have 
dramatic effects on the course of the infection and the ability of the host to detect and respond to 
infection. In this review, we have discussed how targeting the NF-κB signaling pathway, specifically 
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protease-mediated cleavage of p65, has allowed various pathogens to achieve control over their 
microenvironment. Future studies to characterize proteases would benefit from overcoming some 
major obstacles, such as 1) confirming their interactions with target proteins in vivo as opposed to 
exclusively relying on ectopic or recombinant expression systems; 2) the development of a unified 
system to measure protease activity would allow for greater control, consistency, and comparison 
between different research groups; and 3) the development of more sensitive detection methods to 
study the spatial-temporal activity, localization, and induction of pathogen-encoded proteases (and 
other virulence factors) during infections. It is likely that recombinant and overexpression systems 
may lead to the over-identification of target substrates as they rely on purified proteins mixed at 
concentrations that may not be biologically relevant. Moreover, interactions detected in vitro may not 
be relevant in the context of in vivo infection as these proteins may not function in proximity of each 
other for the cleavage to be pathophysiologically relevant. The zinc metalloprotease NleC is an 
example of such a situation, where multiple groups, including our own, have reported differences in 
the target substrates. While most of the groups employed an NleC ectopic expression system (Baruch 
et al., 2011, Muhlen et al., 2011, Yen et al., 2010) or purified NleC recombinant proteins (Li et al., 
2014, Turco & Sousa, 2014), our group was unable to detect cleavage of targets outside of p65 when 
examining endogenous protein levels (Hodgson et al., 2015). A similar discussion has occurred in 
reference to the Chlamydial proteases CT441 (Lad et al., 2007a, Lad et al., 2007b) and CPAF 
(Christian et al., 2010, Zhong, 2011), further demonstrating the need to resolve the difference in 
proposed target substrates. To further help clarify the results between research groups, a standard 
unit of protease activity would work in much the same way to unify the results from multiple studies. 
Variations in the methods and buffers employed for protein purification may account for the 
discrepancy in substrate specificity and cleavage efficiency reported by different groups. The field 
would arguably benefit the most by the improvement of the tools used to study the spatial-temporal 
regulation of virulence factors and their functions in vivo. Novel methods for more sensitive detection 
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of low abundant proteins and their interacting partners within host cells would allow for a deeper 
understanding of how pathogens manipulate host cell signaling pathways. 
Determining the fate of cleaved fragments generated by pathogen-encoded proteases or host 
proteases to elucidate any further activity would also significantly benefit the field, as exampled by 
the NleC and Chlamydia CT441 studies (Hodgson et al., 2015, Lad et al., 2007a, Lad et al., 2007b). 
The targeting and cleavage of host proteins is an advantage that pathogens have acquired, enhancing 
their odds of survival. We have highlighted events in which this advantage has resulted in the 
regulation of a cellular pathway in a very precise and particular manner, which would have gone 
unnoticed without the full characterization of the cleaved fragments role in the host cell. RPS3 
selective targeting serves as a mechanism by which aspects of a signaling hub, where multiple 
pathways converge, are targeted without disrupting the entirety of hub activity (Brodsky & 
Medzhitov, 2009). By targeting the RPS3 branch, pathogens are specifically blocking inflammatory 
and anti-apoptotic signaling within host cells. Other NF-κB specifiers have already been identified, 
such as Sam68 (Fu et al., 2013) and KLF6 (Zhang et al., 2014), and their functions could also serve as 
targets for selective inhibition by pathogens in a cell type specific manner. Our model demonstrates 
that as the promoter selectivity and specificity of NF-κB regulation is further elucidated, there are 
opportunities to uncover further virulence strategies by pathogens that have been until now 
underappreciated. Advancements in the tools available and a deeper understanding of the cell types 
and tissues where specifier proteins are playing a role in regulating NF-κB target genes would also 
add significantly to the study of host-pathogen interactions. The development of conventional 
and/or conditional knockout mice lacking these specifier proteins would provide further insight as to 
the importance of infection site (target cell type), pathogen-mediated blockade of a signaling 
pathway, and the effect this has on the subsequent host responses to infections. As discussed briefly 
above, the hypothesis that anti-apoptotic responses dominate the tissue response, whereas survival 
and inflammatory responses dominate the infiltrating immune cell response can be teased apart 
through the creation and use of lineage specific knockout mice (i.e. conditional RPS3 ablation driven 
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by the Villin-Cre transgene to knockout RPS3 in intestinal epithelial cells). Such innovations would 
clarify the crosstalk and redundancy among virulence factors, opening the field for the development 
of more targeted and specific therapeutics to combat pathogens. 
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Figure 3.1 Comparison of linear and selective inhibition interpretation models of pathogen-
protease mediated NF-κB interference. 
Figure 1. Comparison of global and selective inhibition interpretation models of pathogen-encoded 
protease mediated NF-κB interference. Under infection conditions, NF-κB activation results in p65 
nuclear translocation and the transactivation of a wide array of target genes, a subset of which require 
the aid of known specifier proteins, such as RPS3 and Sam68. This leads to a coordinated cellular 
responses and clearance of infection (A). Pathogen-encoded proteases can have devastating, 
widespread effects (global, B) or they can inhibit specific aspects of a pathway. Complete cleavage of 
p65 interrupts the signal transduction cascade, preventing all downstream outcomes in a global 
fashion. However, partial proteolytic processing of p65 can result in selective inhibition (C), as there 
are still some full length and functioning p65 molecules within the cell. In the experimentally verified 
(checked) examples of NleC-mediated cleavage of p65, during A/E pathogen infections, an N-
terminal fragment is produced that sequesters RPS3, preventing the activation of that arm of the NF-
κB signaling pathway. This inhibition thus results in the amplification of the effect of cleaving only a 
percentage of the p65 cellular pool. It is likely, yet remains to be verified experimentally (question 
marked), that a similar mechanism is employed by other pathogens. EPEC/EHEC/C. rodentium- 






Table 3.1 Pathogen-encoded and co-opted proteases targeting other NF-κB signaling molecules 
Pathogen Protease Protease category Host target Cleavage site(s) Cleavage verification Reference 
EPEC NleC Zinc Metalloprotease p50 Not characterized in vitro Pearson et al. 2011 
EPEC NleC Zinc Metalloprotease p50 Not characterized in vitro Muhlen et al. 2011 
EHEC NleC Zinc Metalloprotease RelB C144/E145 recombinant Turco & Sousa 2014 
EHEC NleC Zinc Metalloprotease p50 C61/E62 recombinant Turco & Sousa 2014 
CVB3 3Cpro Serine Protease Iκ  Q249/G250 recombinant, in vitro Zaragoza et al. 2006 
HCV NS3/4A Serine Protease CARDIF/
MAVS 
C508/H509 in vitro Meylan et al. 2005; 
Li et al. 2005b 
HCV NS3/4A Serine Protease TRIF C372/S373 recombinant, in vitro Li et al. 2005a 
EV68 3C Serine Protease TRIF Q312/S313, 
Q653/S654 
in vitro Xiang et al. 2014 
PRRSV NSP4 Serine Protease NEMO E349/S350 in vitro Huang et al. 2014 
Y. enterocolitica Caspase-3 
(host) 
Cysteine Protease MyD88 D135/S136 recombinant, in vitro Novikova et al. 2014 
EPEC, Enteropathogenic E. coli; EHEC, Enterohemorrhagic E. coli; CVB3, Coxsackievirus B3; HCV, Hepatitis C virus; EV68, Enterovirus 68; PRRSV, 
Porcine reproductive and respiratory syndrome virus; Y. enterocolitica, Yersini enterocolitica; recombinant, purified protein assays; in vitro, cell culture/ transfection 
assays; in vivo, animal studies. 
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Table 3.2 Pathogen-encoded and co-opted proteases targeting p65 












EPEC, EHEC NleC Zinc Metalloprotease P10/A11 in vitro Undetermined Linear Yen et al. 2011 
EPEC NleC Zinc Metalloprotease Not 
characterized 
in vitro Undetermined Linear Muhlen et al. 2011 
EPEC NleC Zinc Metalloprotease C38/E39 in vitro Undetermined Linear Pearson et al. 2011 
EPEC NleC Zinc Metalloprotease C38/E39 recombinant 
 in vitro 
Undetermined Linear Baruch et al. 2011 
EPEC,  
C. rodentium 
NleC Zinc Metalloprotease Not 
characterized 
in vitro,  
in vivo 
Undetermined Linear Sham et al. 2011 
EHEC NleC Zinc Metalloprotease C38/E39 recombinant Undetermined Undetermined Li et al. 2011 
EHEC NleC Zinc Metalloprotease C38/E39 recombinant Undetermined Undetermined Turco & Sousa 2014 
EPEC,  
C. rodentium 
NleC Zinc Metalloprotease P10/A11, 
C38/E39 





Amplification Hodgson et al. 2015 




Undetermined Linear Silva et al. 2015 
C. trachomatis CT441 TSP Protease F351/T352 in vitro p40 product 
binds to IκBα 
Amplification Lad et al. 2007a; Lad 
et al. 2007b 
Leishmania  Gp63 Metalloprotease C-terminus in vitro p35 fragment 
binds DNA with 
p50 
Amplification Gregory et al. 2008a 
Poliovirus 3C Cysteine Protease Q480/G481 in vitro Undetermined Linear Neznanov et al. 2005 
HIV-1 Caspase-3 
(host) 
Cysteine Protease D97/G98 recombinant  
in vitro 
binds p50/IκBα Amplification Coiras et al. 2008 
EPEC, Enteropathogenic E. coli; EHEC, Enterohemorrhagic E. coli; Phdp, Photobacterium damselae piscicida; C. trachomatis, Chlamydia trachomatis; HIV, human 
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4 Identification and characterization of a C. rodentium mutant strain with 
attenuated virulence in IL-22-/- mice 
4.1 Introduction 
Gastrointestinal infections remain a leading cause of morbidity and mortality worldwide that 
causes a serious economic and public health burden (Clements et al., 2012; Donnenberg and Whittam, 
2001; Hartland and Leong, 2013). Attaching and effacing (A/E) pathogen infections, such as 
Enteropathogenic and Enterohemorrhagic E. coli, contribute significantly to this burden (Ochoa and 
Contreras, 2011). The mouse specific pathogen, Citrobacter rodentium, has served as a model for the study 
of A/E pathogens and has been instrumental in the discovery and characterization of novel aspects of 
gut immunology (Borenshtein et al., 2008; Collins et al., 2014; Koroleva et al., 2015; Mundy et al., 2005). 
Upon infection with C. rodentium, mice experience acute self-limiting colitis that clears approximately 4 
weeks post infection. During this phase, there is a considerable proinflammatory cytokine response 
elicited by immune cells responding to infection. Interferon- (IFN-), tumor necrosis factor  (TNF-α), 
interleukin 6 (IL-6), and IL-22 are all induced during infection and act on the epithelial and immune cells 
to clear the infection (Collins et al., 2014; Dann et al., 2014; Li et al., 2014; Symonds et al., 2009; Zheng et 
al., 2008). The role of IL-22 during C. rodentium infection has recently garnered attention for bridging the 
gap between the epithelial innate immune response and the lymphocytic driven adaptive response to 
infection (Eidenschenk et al., 2014; Honda, 2012; Rutz et al., 2013; Rutz et al., 2014). 
Produced only by immune cells, both adaptive CD4 T cells and innate lymphocytes (ILCs), IL-22 
signals to cells expressing its cognate receptor, IL-22R1 and IL-10R2, which are primarily epithelial cells 
(Basu et al., 2012; Collins et al., 2014; Eidenschenk et al., 2014; Kumar et al., 2013; Sabat et al., 2014). In 
the gut, IL-22 acts on colon epithelial cells and goblet cells to induce the production of antimicrobial 
peptides such as RegIII, RegIII, S100A8, and mucin (Collins et al., 2014; Zenewicz et al., 2013; Zheng 




control of bacterial proliferation, functioning to limit the bacterial burden (Cella et al., 2009; Satoh-
Takayama et al., 2009; Zheng et al., 2008). The CD4 Th22 response takes over the production of IL-22 at 
later stages of infection to amplify the anti-microbial peptide expression (Basu 2012). In the IL-22-/- 
setting, C. rodentium infection leads to severe morbidity and mortality within the first two weeks of 
infection. This is accompanied by a break in the barrier integrity, leading to the dissemination of bacteria 
systemically, presumably contributing to mortality (Aychek et al., 2015; Zheng et al., 2008).  
  To further understand the key host-pathogen interactions during C. rodentium infection in the 
presence and absence of IL-22, we sought to identify an attenuated strain of C. rodentium that would allow 
deeper characterization of the effects of IL-22. The use of an attenuated strain of C. rodentium would 
prevent the rapid decline toward death, providing more opportunity to study the effects of IL-22 at all 
stages of the immune response. From our stock of C. rodentium strains, we endeavored to screen them 
using IL-22-/- mice. Upon considering strains for screening, we opted not to use strains that were known 
not to cause infection in wild type mice. We also did not use strains that harbor mutations that induce a 
more robust inflammatory response than wild-type C. rodentium for fear that this would exacerbate 
mortality witnessed in IL-22-/- mice. We determined that the Mut1 strain would be a worthy candidate for 
characterization in IL-22-/- mice as we were unaware of the mutation it harbored but also saw no robust 
changes in infection in wild-type mice previously. Here we present the initial characterization of the Mut1 
strain in infection of IL-22-/- as well as the identification of the gene disrupted in the Mut1 strain of C. 
rodentium.  
4.2 Results 
4.2.1 Infection with Mut1 causes less severe morbidity and mortality in IL-22-/- mice 
C. rodentium infection in IL-22-/- mice results in a severe phenotype in which only 20% of mice 
survive by day 14, compared to a 100% survival rate in wild-type mice (Zheng et al., 2008). Therefore, IL-




phenotypes that may not be as competitive in wild-type hosts. Using these mice, we screened and 
characterized a mutant C. rodentium strain entitled Mut1 for its ability to cause infection and inflammation 
in IL-22-/- mice. At early time-points Mut1-infected animals have similar weight loss (Figure 4.1A) and 
clinical scores (Figure 4.1B) as wild-type C. rodentium infected mice. However, after day 8-post infection 
the weight loss between the two groups consistently differed by approximately 10% (Figure 4.1A). Also 
at this time point, the Mut1-infected animals clinical symptoms begin to improve, as determined by a 
reduction in the clinical score (Figure 4.1B), whereas the wild-type C. rodentium infected animals continue 
to deteriorate. Consistently, Mut1 infected animals experience 80% survival following infection; 
compared to the observed 20% survival in wild-type C. rodentium infected animals (Figure 4.1C). 
Therefore, the Mut1 strain causes an attenuated infection compared to the effects of wild-type C. 
rodentium infection in IL-22-/- mice.  
 
4.2.2 Mut1 C. rodentium displays no defects in growth or attachment to CEC 
We examined the growth kinetics of the Mut1 strain to determine the cause of the attenuation. 
First, we established that there was no difference in the replication in vitro when Mut1 and wild-type C. 
rodentium were grown in LB broth (Figure 4.2A). Second, we assessed the ability of the Mut1 strain to 
attach to colon epithelial cells (CEC) isolated from IL-22-/- mice in vitro. There was no difference in 
bacterial attachment between the Mut1 and wild-type C. rodentium strains (Figure 4.2B) suggesting that 
Mut1 has no defect in forming attachments to CEC and therefore establishing infections. This suggests 
that the bacterial machinery used for attachment is unaffected by the Mut1 mutation. 
  To determine the Mut1 growth and attachment in vivo, we examined the fecal clearance from IL-
22-/- animals following infection with either strain. There was no difference in the bacterial load between 
the Mut1 and wild-type C. rodentium infected animals (Figure 4.2C), indicating that the Mut1 strain is 




of the Mut1 strain, we harvested the colons of mice at 8 days post infection, and stained for LPS in 
paraffin embedded sections. Day 8 was chosen as the time-point just before the wild-type C. rodentium 
infected mice began to experience significant morbidity and mortality. Almost no LPS staining was 
observed in the colons from Mut1 infected animals except for in small areas along the top of the crypts 
(Figure 4.2D second panel), however positive LPS staining was readily detected along almost the entire 
length of the colons sections of wild-type C. rodentium infected mice (Figure 4.2D third panel). In some 
areas dramatic infiltration of the bacteria into the colonic crypts is visible (Figure 4.2D last panel), as 
reported previously (Zheng et al., 2008). Taken together, these results indicate that Mut1 and wild-type C. 
rodentium strains are replicating at the same rate in vivo albeit in different locations.   
 
4.2.3 Animals infected with Mut1 infection display limited intestinal inflammation 
Next, we wanted to characterize the inflammatory response to Mut1 infection at the same day 8-
time point. Histological analyses of Mut1-infected IL22-/- mice demonstrated minimal signs of 
inflammation; in striking contrast, the wild-type C. rodentium group displayed immune cell infiltration, 
thickening of the colonic crypts, goblet cell loss, and hyperplasia (Figure 4.3A). The lack of bacterial 
colonization of epithelial cell layer is visible here. Similar to Figure 4.2D, wild-type C. rodentium is clearly 
visible in focal aggregates and microcolonies (Bergstrom et al., 2010) over the epithelial cells and into the 
colonic crypts at this time-point.  
We then examined a panel of genes to characterize the inflammatory response. Target genes 
were chosen for the known or suggested roles during wild-type C. rodentium infection in wild-type mice. 
Infection with Mut1 did not induce the expression of Cxcl1, Cxcl2, Cxcl5, Nos2, Il6, Ifng, Il17a, and Il2 
(Figure 4.3B) and in some cases suppressed their expression when compared to wild-type C. rodentium. 
There was also no up-regulation of matrix metalloprotease 9 (Mmp9) and Mmp10 in Mut1-infected 




environment (Koller et al., 2012; Liu et al., 2013) caused by Mut1 infection (Figure 4.3B and Figure 4.4). 
The induced expression of Cxcl1, Cxcl2, and Cxcl5 typically leads to the recruitment of neutrophils, which 
are a major source of IL-22 during infection (Brown et al., 2011; Crepin et al., 2015; Lee et al., 2015; 
Shea-Donohue et al., 2008; Spehlmann et al., 2009). Along with these chemokines, the induction of 
Mmp9, Mmp10, and Icam1 also allow infiltration of immune cells into the colon tissue following wild-type 
C. rodentium infection. At this time point we did not observe the robust induction of Il4, Il10, Il12, Il21, or 
Il23 by either strains, as they are likely induced at a later time-point. 
4.2.4 Mut1 infection does not induce barrier disruption or systemic bacterial dissemination 
Taking together the induction of matrix metalloproteases, the robust proinflammatory response, 
and previous work demonstrating systemic spread of wild-type C. rodentium in IL-22-/- mice (Zheng et al., 
2008), we examined the effect of infection on tight junctions in the epithelial cell layer as an indicator of 
barrier function. The regulation of barrier permeability relies upon the maintenance of tight junctions 
between the epithelial cells along the gastrointestinal tract, as they regulate the passage of ions and 
metabolites (Conlin et al., 2009). Colon sections from day 8-post infection were examined for 
immunofluorescence staining of claudin-3, a tight junction protein that has previously shown to be 
altered by wild-type C. rodentium infection (Conlin et al., 2009). Mut1-infected animals did not appear to 
have significant changes in the claudin3 staining, where there was intense and distinct cell surface staining 
(Figure 4.5A). Conversely, wild-type C. rodentium infected animals appeared to have diffuse and low-
intensity staining, indicative of tight junction disruption (Figure 4.5A). Consistent with the maintenance 
of claudin-3 (Figure 4.5A), Mut1 infected animals did not have recoverable, live bacteria in their spleens 
or livers (Figure 4.5B). However, the spleens and livers of wild-type C. rodentium infected animals had a 
robust amount of bacteria present (Figure 4.5B). The overall lack of a response to infection with Mut1 C. 
rodentium suggests that the genetic deletion has abrogated a key virulence factor that has altered many 




to colonize and maintain itself within the host, it is also not causing any immune activation or even 
serious clinical symptoms possibly due to its lack of interaction with the epithelial cell layer. 
4.2.5 Mut1 carries a disruption of a putative DNA recombinase 
Random transposon mutagenesis is a powerful genetic tool used for the screening of bacterial 
genes by randomly interrupting a coding region via the insertion of a transposable element and, typically, 
a resistance marker (Serina et al., 2004; Xu et al., 2011). Using the sequence of the transposable element 
and taking advantage of two particular 5 nucleotide sequences (termed anchor sequences) that repeat 
approximately every 245 or 252 basepairs of the genome, we devised a PCR strategy to selectively amplify 
the genomic sequence upstream of the transposable element (Figure 4.6A-B). After we amplified the 
target region, sequencing and BLAST searches of the wild-type C. rodentium genome were conducted to 
determine the site of insertion by sequence alignment. The Mut1 strain contained an interruption in a 
site-specific DNA recombinase that has yet to be characterized (Figure 4.6C). The presence of the 
transposable element at this location was confirmed by PCR using primers specific to the wild type 
genomic sequence at the 5’ and 3’ ends of the recombinase gene (set 1), as well as by primers specific to 
the 5’ end of the gene and the transposon (set 2) (Figure 4.6C). Using set 1 primers for the recombinase 
gene, the wild-type C. rodentium and ΔEscN strain (Wan et al., 2011) (used as an additional negative 
control), show bands corresponding to the size of the recombinase gene, approximately 600 kb (Figure 
4.6D). There is no detectable band for the Mut1 gene as expected, given the extension times used for the 
reaction and the expected size of the gene and the transposable element that interrupts the gene. To 
further confirm the location of the transposable element, we used primers for set 2 that cover the 5’ part 
of the gene and the 5’ end of the transposon. In these reactions, only the Mut1 strain has a detectable 
band, as the wild-type C. rodentium and ΔEscN strain have no transposable element. Further 
characterization of this recombinase gene is required to determine if this is responsible for the 




4.3 Discussion and Future Directions 
The importance of IL-22 for maintaining and reinforcing the epithelial barrier in the gut is 
underscored by the severe morbidity and mortality experienced by IL-22-/- mice following C. rodentium 
infection (Basu et al., 2012; Honda, 2012; Pickert et al., 2009; Zheng et al., 2008). Herein, we 
demonstrated the use of IL-22-/- mice as a tool to screen mutant strains of C. rodentium for altered 
phenotypes, which may lead to the identification and characterization of novel virulence factors that will 
likely go undetected using wild-type mice. Currently, there have been many reports describing the 
importance of a particular gene important for infection (by the pathogen) or for protection from 
infection (by the host). We consider the combination of these strategies to provide a larger window for 
the detection of valuable host-pathogen interactions. Hence, we employed the use of IL-22-/- mice, as 
their increased susceptibility to infection should render them an ideal setting to rapidly screen many 
strains and observe attenuated C. rodentium strains. However, many further experiments are needed to 
fully elucidate the importance of the DNA recombinase for C. rodentium infection and the exact role that 
IL-22 is playing in protecting against fatal outcomes of infection.  
4.3.1 Mut1 replicates within the lumen and not at the epithelial cell layer 
The modest morbidity caused by Mut1 infection in IL-22-/- mice suggests that the strain is 
deficient in its ability to colonize the epithelial cell layer directly in vivo albeit maintaining the ability to 
replicate and attach to individual epithelial cells in vitro. The physical separation of the Mut1 bacteria from 
the epithelial cells is consistent with the lack of response to infection, as the degree of bacterial 
penetration into the tissue has been previously linked to the degree of inflammatory response (Assi et al., 
2013; Johansson et al., 2014; Reid-Yu et al., 2015; Yoshida et al., 2006). Mutant strains of C. rodentium 
harboring severe defects in the major virulence genes, such as those without a functional type three 
secretion system (T3SS) or missing the regulator Ler, are completely unable to maintain themselves in the 




strains are never detectable in the fecal pellets from infected mice, unlike the Mut1 strain that is readily 
detectable in the feces up to at least 19 days post infection. 
 As the fecal clearance data do not show differences between the Mut1 and wild-type C. rodentium 
strains, this may not be the best measure to determine infection rates. Indeed, the number of bacteria 
present in the fecal samples and the lumen is not always reflective of the number of bacteria that actually 
infect epithelial cells (Bergstrom et al., 2010; Bhullar et al., 2015; Hansson, 2012; Johansson et al., 
2011).Therefore further experiments are need to determine the quantity of bacteria attached to the tissue 
compared to that found within the lumen to provide a more accurate picture of the infection rates by 
Mut1 and wild-type C. rodentium. Colon tissues collected from infected mice at various time points should 
be separated into the luminal contents and the tissue. After extensively washing the tissue, both the 
luminal contents and the tissue should be serially diluted and plated to determine the CFU present in 
each compartment of the colon. Both Mut1 and wild-type C. rodentium infected animals will likely 
demonstrate a bacterial burden within the luminal contents that increases until peak of infection and then 
wanes. It has been previously established that as C. rodentium infection reaches peak bacterial loads in the 
fecal pellets, the bacteria transition from presiding primarily in the lumen to increasing their presence 
within the inner mucus layer, gaining closer contact with the epithelial cells (Gustafsson et al., 2013). 
Hence, there should be an expected increase in the number of tissue-associated bacteria as the time 
points approach peak infection roughly 10-14 days post infection. The lumen to tissue transition is likely 
not occurring, or occurring in a very limited capacity, in Mut1 infected animals, given the previously 
demonstrated lack of LPS staining at the tissue and the limited inflammatory profile. However, wild-type 
C. rodentium infected animals will likely demonstrate tissue-associated bacterial burdens that increase over 
time as the animals approach peak infection or a moribund state. This increase in bacterial attachment to 
the epithelial cells will correspond to the inflammatory profile previously discussed. If the Mut1 strain is 
primarily residing within the lumen and not reaching the epithelial cells, it suggests that the genetic defect 
of Mut1 does not completely prevent infection, yet alters the colonization location away from the 




4.3.2 IL-22-/- mice have an altered mucus composition 
Further examination of the entire luminal structure of the colon of IL-22-/- mice is essential for 
our understanding of role IL-22-/- is playing in protecting the colon. The entire tract of the colon is lined 
with a mucus layer that serves as both a mechanical and chemical means to shield the epithelial cells from 
the microbiota and luminal contents. The outer mucus layer is heavily colonized with commensal bacteria 
(Johansson et al., 2011) where the mucin glycoproteins serve as both scaffold and an energy source for 
bacteria (Bergstrom et al., 2010; Johansson et al., 2011; Lievin-Le Moal and Servin, 2006; Mizoguchi, 
2012). However, the inner layer is more complex and primarily sterile, unless virulence factors allow 
invading bacteria to penetrate the inner mucus layer (Bergstrom et al., 2010; Hansson, 2012; Johansson et 
al., 2014; Lievin-Le Moal and Servin, 2006). IL-22 has been demonstrated to enhance the production of 
mucus and induces goblet cell restitution following inflammation (Sugimoto et al., 2008). The IL-22-
STAT3 signaling pathway activates mucin expression in goblet cells as well as induces the expression anti-
microbial peptides (Lievin-Le Moal and Servin, 2006; Mizoguchi, 2012; Sugimoto et al., 2008). Moreover, 
anti-IL-22 treatment in mice abolishes the mucus layer (Sugimoto et al., 2008), yet the effect of genetic 
ablation of IL-22 on the mucus layer has yet to be directly examined. This point is especially important 
when considering that IL-22-/- mice have normal colonic architecture, displaying no overt spontaneous 
colitis (Zenewicz and Flavell, 2011; Zenewicz et al., 2013). This may be in part because until now IL-22 
has been implicated in inducing the expression of some mucin proteins (Sugimoto et al., 2008), but not 
Muc2, which is the primary structural protein of the two mucus layers found in the colon (Johansson et 
al., 2011; Mack et al., 1999).  
Hence, future experiments should include the isolation of colons from IL-22-/- mice using 
Carnoy fixative to preserve the entire luminal structure (Cohen et al., 2012; Johansson et al., 2011). Tissue 
sections from these colons should be stained for the various mucin proteins in order to determine the 
mucus composition in uninfected IL-22-/- mice as a baseline. It is likely that IL-22-/- mice have some 




(Johansson et al., 2011; Van der Sluis et al., 2006), which is not seen in IL-22-/- mice as mentioned 
previously. These sections from uninfected animals can be compared with age matched Mut1 and wild-
type C. rodentium infected colons processed in the same manner. This will inform the effect of Mut1 and 
wild-type C. rodentium on mucin production during infection as well as confirm the compartment of the 
colon colonized by each strain of C. rodentium, with the addition of LPS staining. Typically during 
inflammation and infection, mucin production is induced to flush out the invading pathogen as an innate 
mechanism for protecting the host epithelial cell layer. To measure this, the thickness of the mucus can 
be measured in each of the conditions. Therefore, consistent with the inflammatory profiles already 
observed, it is likely that Mut1 infection will elicit little to no mucus production, while the wild-type C. 
rodentium strain will induce increased mucus secretion and production. In an effort to confirm these 
findings, mRNA transcripts for the various mucin proteins can also be analyzed by RT-PCR, where 
similar results would be expected. 
4.3.3 Mut1 is unable to penetrate the colonic mucus layer 
During normal infection, C. rodentium is able to transition from the lumen to the epithelial cells by 
penetrating through the mucus layer (Bergstrom et al., 2010; Hansson, 2012). The previous proposed 
experiments staining for LPS on Carnoy fixed tissue will likely confirm that the Mut1 C. rodentium is 
replicating in either the outer mucus layer or the lumen of the colon and unable to reach the epithelial 
cells. To directly examine whether the Mut1 strain would be capable of inducing a robust infection in the 
absence of the mucus layer, Muc2-/- mice should be infected with either Mut1 or wild-type C. rodentium 
and followed for signs of morbidity, such as fecal colonization, weight loss, and survival. If the Mut1 
strain is capable of causing infection to a similar degree as the wild-type C. rodentium strain in this 
scenario, then the major default of the Mut1 strain is its inability to bypass the mucus layer. There may a 
defect in the ability of Mut1 bacteria to survive in the mucus layer. To address this hypothesis, crude 
mucus from IL-22-/- mice can be extracted from mucosal scrapings of the colon tissue (Bergstrom et al., 




forming units (CFUs) counted from each strain can be compared after serial dilution to determine the 
differences in the survival of either strain. The Mut1 strain is likely to survive the mucus exposure in vitro 
similarly to wild-type C. rodentium because despite the inability to establish close colonization of the 
epithelial cell layer, the Mut1 strain is able to find a niche and maintain itself within the lumen of the 
colon as it is readily detected in the feces for many days post infection. 
Alternatively, binding to the mucus layer will also prevent its ability to penetrate through to the 
epithelial cells. Therefore an ELISA-like-assay (Linden et al., 2008) can be preformed using mucin bound 
to a microtiter plate and incubated with labeled Mut1 or wild-type C. rodentium. The labeled bacteria are 
produced using standard kits such as BacLight (Life Technologies), which label bacteria with either red or 
green fluorescent dyes that can be read using a plate reader measuring the appropriate channels. It may be 
that the Mut1 strain retains its ability to bind to mucin, establishing itself in the outer mucus layer, yet 
cannot further penetrate to the inner mucus layer since we cannot detect Mut1 bacteria in close 
association with the epithelial cells in vivo. 
Upon observing no differences in bacteria survival or mucin binding, it may be that the Mut1 
strain is unable to digest its way through the mucosal layer. The importance of the mucus layer described 
above suggests that invading bacteria need to encode mechanisms that allow penetration of the physical 
and biochemical barrier posed by the complex mucin proteins. It is currently hypothesized that all gut 
bacteria employ one of two ways to penetrate the mucus layer, via flagella-mediated motility or via 
degradation of mucin proteins by proteases (McGuckin et al., 2011). Since C. rodentium encodes no 
flagella, it is likely that it relies on mucinase like proteins for invasion of the mucus layer. As previously 
mentioned, enteric pathogens encode proteases that allow the digestion of the mucin layers in order to 
access the epithelial cells (Bhullar et al., 2015; Grys et al., 2005; Grys et al., 2006; Lidell et al., 2006; 
Moncada et al., 2006). Currently, there are few such proteases characterized in C. rodentium, such as the 
serine protease autotransporter, Pic (Bhullar et al., 2015). The Pic protease has multiple functions, among 




mutant strain (Bhullar et al., 2015). This suggests that there are other mucinases encoded by C. rodentium 
that could compensate for Pic that remain uncharacterized. Similarly, EHEC encodes a secreted zinc 
metalloprotease, StcE, targets mucin 7 (MUC7) that may aid in penetrating the mucus layers in the gut 
upon infection (Grys et al., 2005; Grys et al., 2006). These studies determined that EHEC expressing 
StcE exhibited increased intimate attachment to cells in culture and mucinase activity in vitro. While 
BLAST searches reveal no homologous protein in C. rodentium, further work is needed to identify the 
virulence genes required for penetrating the gut mucosa.  
Without a clear target protein to purify, the mucinase activity of Mut1 and wild-type C. rodentium 
can be measured using the following two assays. First, agar plates can be prepared utilizing mucin as the 
sole carbon source (Collier et al., 2003; Deplancke et al., 2002; Png et al., 2010) in this way, only bacteria 
expressing a mucolytic enzyme are capable of accessing the carbon source needed for growth and 
survival. If Mut1 C. rodentium are unable to form colonies on this media and wild-type C. rodentium do, it 
would suggest that Mut1’s inability to access the epithelial layer in vivo stems from its inability to digest 
through the mucus layer. Secondly, the supernatants from Mut1 and wild-type C. rodentium cultures 
should be collected and concentrated to collect secreted proteins. These supernatants can then be 
incubated with mucin, either crude or from a commercial source such the bovine submaxillary mucin 
from Sigma (Bhullar et al., 2015). After the appropriate incubations, the reactions can be separated on 
SDS-PAGE gels and analyzed with a glycoprotein staining kit. Digested mucin proteins will run at lower 
molecular weights, while undigested glycoproteins will remain mostly in the stacking gel, appearing as a 
smear, due to their high molecular weights.  
4.3.4 IL-22 is needed to protect against LPS-induced shock following infection 
In our studies, we also examined the barrier permeability of IL-22-/- mice during infection with 
either Mut1 or wild-type C. rodentium by examining the localization of claudin 3, a tight junction protein, 
and examining the spread of C. rodentium to the liver and spleen of infected animals. Given our current 




Guttman and Finlay, 2009) by inducing a redistribution of the tight junction proteins. This results in the 
dissemination of luminal contents into the bloodstream and conversely the leak of protein rich serum 
into the lumen. In an IL-6-/- setting, C. rodentium infected mice experienced ulcerations that allowed for an 
influx of nutrients from the bloodstream which gave rise to dense micro-colonies observed intimately 
associated with the epithelial layer (Dann et al., 2008). Similar ulcerative lesions are observed in Muc2-/- 
mice during infection (Bergstrom et al., 2010), in IL-22-/- mice during infection (Zheng et al., 2008) (and 
ourselves), and TCRα deficient mice given a mucolytic drug (Sugimoto et al., 2008). In contrast, SCID 
mice infected with C. rodentium are colonized across the epithelial cell surface without ulceration or micro-
colony formation (Dann et al., 2008). These studies support further examination of the effect that 
infection-induced ulcers and epithelial cell injury have on the severe morbidity and mortality experienced 
by these mice following infection.  
 Future studies should measure the degree of barrier permeability following infection with wild-
type C. rodentium and Mut1 using the FITC-dextran method (Bergstrom et al., 2010; Gibson et al., 2008a; 
Gibson et al., 2008b). Due to the lack of inflammatory response and cell association of the Mut1 strain, it 
is unlikely to cause any defect in the barrier integrity. However, given the large bacterial loads recovered 
from the spleens and livers of wild-type C. rodentium infected IL-22-/- mice, it is expected that the FITC-
dextran will be readily detected in the blood of these mice during the latter stages of the infection, 7 to 10 
days. The presence of bacteria in the blood and at these typically sterile sites is not enough to cause the 
significant mortality we observed, since there is also a degree of bacterial escape following infection in 
wild-type mice (Zheng et al., 2008). Moreover, intravenous challenge of wild type mice with C. rodentium 
does not cause mortality (McDaniel et al., 2015). This may be attributed to the protective effect of IL-22 
on the liver by inducing the production of LPS binding protein, which has been shown to temper 
systemic inflammation (Sabat et al., 2014). It would be intriguing to determine if localized delivery of IL-
22 to the liver (Sugimoto et al., 2008) or the systemic distribution of LPS binding protein would be 




4.3.5 Characterizing the function of the putative DNA recombinase disrupted in Mut1 
The attenuated phenotype of Mut1 C. rodentium suggests that the specific mutation alters its 
pathogenicity in IL-22-/- mice compared to wild-type C. rodentium. Ultimately, we determined that the 
Mut1 strain carries an interrupted, uncharacterized, site-specific DNA recombinase (Figure 4.6). 
Confirming the protein product as well as constructing a KO strain specifically for the recombinase gene 
would help clarify the effect of this gene on pathogenicity. This gene is located within a 5.3 kb long 
genomic island that has no known function currently (Petty et al., 2010) and shares homology upwards of 
50% with various other pathogenic and non-pathogenic enteric bacteria recombinases (BLAST, NCBI). 
Site-specific recombinases induce one of three changes to the genomic structure of the organism, i.e. 
integration (as in the classical phage infection), resolution of transposable elements, or inversion of a 
DNA sequence located between two consensus sequences. There are two major classes of recombinases, 
tyrosine recombinases and serine recombinases (reviewed in (Grindley et al., 2006)). Based on sequence 
homology, this recombinase is likely a serine recombinase and therefore may play a role in DNA 
inversions commonly seen in host adaptations by programmed DNA alterations (Johnson, 2015). Of 
note, DNA inversions and recombination events are employed by many bacterial pathogens and have 
been described to play important roles in antigenic rearrangements for host evasion and other virulence 
mechanisms (Johnson, 2015; Scott et al., 2007).  
The on-going reassortment of the genomic material available to pathogens allows for rapid 
responses from environmental threats as well as explains the diversity of bacterial effectors that even 
closely related pathogens exhibit (Agbor and McCormick, 2011; Dean, 2011). These reassortment events, 
either through phage infection or horizontal gene transfer, account for the diversity between EPEC, 
EHEC, and C. rodentium who share just under 3000 genes of the almost 5000 genes encoded by C. 
rodentium (Petty et al., 2010). The homology and shared genes account for the similarity in infection 
mechanisms and virulence strategies, justifying and supporting the use of C. rodentium as a model for 




observed in C. rodentium could be partially attributed to the spontaneous activation and expression of 
prophages found within the genome under normal growth conditions. Upon examining the activity of 
these rearrangement events in vivo, they determined that in response to host induced stress several 
prophages might be activated to induce a differential gene expression pattern (Petty et al., 2011). 
Campylobacter jejuni is a prime example of such stress responses. During host infection, there is evidence of 
frame shifting and inversion of the origin of replication of specific genomic regions to alter gene 
regulation (Scott et al., 2007). As such, the authors concluded that during infection there are 
subpopulations of Campylobacter expressing various versions of their genome that will allow survival of, at 
minimum, a subset of these bacteria (Scott et al., 2007). 
While it has been demonstrated fairly recently that the C. rodentium genome undergoes significant 
recombination events during infection and passage through the mouse and many of the genomic islands 
identified are flanked by potential insertion sequences (Petty et al., 2011), our future experiments need to 
determine whether these recombination events are still occurring in our Mut1 strain. To do this, samples 
of genomic DNA should be isolated from cultures of wild-type C. rodentium and Mut1 C. rodentium as well 
as from isolates of each strain extracted from fecal pellets from infected mice, as has been done by Petty 
and colleagues. Wild-type C. rodentium and Mut1 isolates from various time points should be examined by 
pulse-field gel electrophoresis (PFGE). Briefly, after serial dilution of fecal pellets and plating onto 
MacConkey agar plates, single colonies should be picked and grown overnight. Bacterial DNA plugs can 
be prepared using a CHEF Genomic DNA Plug Kit (Bio-Rad Laboratories) and incubated with a 
restriction enzyme. The plug is then electrophoresed through an agarose gel, following the 
manufacturer’s directions. This produces a banding pattern that can be compared between the wild-type 
C. rodentium and Mut1 C. rodentium from samples pre- and post- infection in mice. Differences in the 
banding pattern post infection between the wild-type C. rodentium and the Mut1 strain would indicate that 
the interrupted recombinase is functioning to cause changes in the genomic structure of the Mut1 strain.  




identify potential target genes being regulated by the recombinase and how these genes alter virulence. 
We can identify the potential genes by employing a recently described method based off of paired-end 
whole genome sequencing (WGS) (Goldberg et al., 2014). In short, genomic DNA extracted from a 
culture of bacteria should be sheared to generate inserts approximately 500 bp in size. A sequencing 
library can be generated using the Paired-end Sample Prep Kit (Illumina). This sequencing process 
provides a short read (90-100 bp) of both ends of an individual insert that can be aligned to the reference 
genome in order to determine a gap-size (the distance between the paired reads). The genomic location 
and gap-size for each insert should be plotted resulting in a graph where most of the reads will fall 
around a gap-size that corresponds to the size to which the genomic DNA was sheared (500 bp). In the 
event of a genomic inversion, the pair-end sequencing reads will be in the same orientation when aligned 
to the reference sequence. When reads along an inversion are plotted against the genomic location, their 
gap-size will be much larger than the rest of the genes and it will form a distinctive pattern on the graph. 
Using this technique, inversions can be identified along the entire genome. By comparing the paired-end 
data between the wild-type and Mut1 C. rodentium strains we can confirm the activity of the recombinase 
as well as trace the location of genomic inversions.   
The DNA recombinase we identified in this study likely functions in a similar manner as the 
Salmonella Hin system (Johnson, 2015) or the Bacteroides fragilis MPI recombinase (Coyne et al., 2003), 
which are also serine recombinases. Following the data from the paired-end WGS, we can confirm these 
inversions by analyzing those genomic locations for serine recombinase consensus motif sequences that 
should flank genes targeted for inversion by our site-specific recombinase. Inversions at these promoters 
act as a molecular switch to turn on or off transcription. To determine if these genes are directly 
regulated by this specific recombinase, the promoters of these genes need to be cloned onto plasmids and 
tested for inversion using a PCR strategy that produces products when the promoters have undergone 
inversion but not when they remain unchanged. This is done through the use of the directional primers 
matching the cloned promoter region and a primer for the plasmid. Upon inversion, the promoter 




inversion occurs, the primers will not be oriented in the appropriate manner for the polymerase to 
produce a product. For these experiments, it is imperative that the plasmid and our recombinase are 
transformed into a bacterial host that has no endogenous recombinase activity. This system has been 
used to study the genes regulated by the MPI serine recombinase in Bacteroides fragilis using the bacteria 
Bacteroides vulgatus, which has no endogenous recombinase activity (Coyne et al., 2003). In our case, 
whether the genes controlled by this site-specific recombinase function to alter the antigenic surface 
appearance of the bacteria to the immune system or to turn on specific virulence genes needed to invade 
the host, remains to be seen. Given the little information we have regarding the inflammatory response 
and the lack of penetration of the epithelial cell layer, it seems reasonable to suggest that this recombinase 
alters the function of genes involved in gaining access to the epithelial cell layer or regulating the 
expression of certain key virulence factors, yet further elucidation of the specific targets will required 
learning more about the limitations of the Mut1 strain, as proposed in the earlier sections. 
4.4 Conclusion 
While it remains unclear the exact mechanisms causing the lack of virulence associated with the 
Mut1 strain, there are many avenues of research open for assessment. This approach has provides us with 
a two pronged approach to gain a deeper understanding of the pathogenesis of C. rodentium, through 
highlighting areas of further research on both the host and the pathogen. Our current studies in the IL-
22-/- mice allowed us to interrogate the activity of this mutant C. rodentium strain in vivo. Through this, we 
observed that the Mut1 strain’s deficiency in directly attaching to the epithelial cells in vivo led to a lack of 
inflammatory response, as measured by real time PCR, and lack of barrier disruption. This attenuated 
phenotype of Mut1 C. rodentium may allow further study of the importance of the IL-22 cytokine during 
the later phase of the immune response, since the Mut1 strain doesn't induce the rapid mortality 
associated with wild-type C. rodentium infection. Using this host has also raised questions more specifically 
about the importance of IL-22 during infection with wild-type C. rodentium that have yet to be resolved in 




strategy that are not yet fully understood, such as the mechanism(s) employed to gain access to the 
epithelial cells. The resolution of the remaining questions may uncover new targets for therapeutics for 
the treatment and prevention of A/E infections as well as lead to a deeper understanding of the immune 
response following infection. This information may inform treatment options to boost the immune 
response and help heal the protect the gut, as this is one of the primary functions ascribed to IL-22 and 
fuel the further interest in this topic.  
4.5 Methods and materials 
Animal care and ethics 
All animal experiments were approved and performed according to protocol number MO13H349 under 
the Johns Hopkins University’s Animal Care and Use Committee and in direct accordance with the NIH 
guidelines for housing and care of laboratory animals. 
Infection 
Male IL-22-/- mice on the C57BL/6 background were kindly shared by Dr. Cynthia Sears (Johns Hopkins 
University). Mice were maintained in a specific pathogen-free facility and fed autoclaved food and water 
ad libitum. On infection days, food and water was withheld from the mice for 6–8 hours before they 
were orally inoculated with 200 μl of PBS containing 2x109 CFU of wild-type or Mut1 C. rodentium or 
PBS alone, and euthanized at the indicated time points post infection as described previously (Hodgson 
et al., 2015). 
Clinical score of colitis    
Animals were observed daily for weight and morbidity using the following scoring system (Qualls et al., 
2006). Weight loss scores were determined as 0 = no change; 1 = 1%-5% weight loss; 2 = 5%-10% 
weight loss; 3 = 10%-15% weight loss; 4 = 15% - 20% weight loss; 5 = more than 20% weight loss. Stool 




feces; 4 = watery diarrhea. Bleeding was determined as 0 = no bleeding; 2 = slight bleeding; 4 = gross 
bleeding. The clinical score is the sum of the three parameters, where 0 indicates no clinical symptoms 
and 13 indicates severe colitis. 
Fecal Clearance 
Fecal pellets were collected on the indicated days from each animal, weighed, and diluted 0.1 g in 1 ml in 
sterile PBS. Diluted pellets were vortexed at medium speed and placed on shaker in the cold room for 30 
to 60 min. Pellets were vortexed again until fully dissolved. Samples of individual mice were pooled by 
infection and serially diluted. MacConkey agar plates were used to plate dilutions in triplicate. Plates were 
incubated overnight at 37°C. Colonies were counted the following day to determine CFU per group.  
Systemic Bacterial Dissemination 
Spleens and livers were resected from euthanized mice at the indicated time points and were weighed and 
homogenized. Homogenates were serially diluted and plated in triplicate on MacConkey agar. C. rodentium 
CFUs were measured as described above. 
Histology (H/E and IFA) 
Following euthanasia, the colons of mice were harvested under aseptic conditions, washed once with ice-
cold PBS, and the terminal 0.5-cm section of the colon was either frozen in optimal cutting temperature 
(O.C.T.) media (Tissue-Tek, Elkhart, IN) or incubated overnight in 4% PFA. 5-micron frozen sections 
were cut using a Microm HM 550 Cryostat (Thermo Scientific), collected on coated slides and processed 
for immunofluorescence staining. Frozen sections were fixed in 4% PFA, washed with PBS, and blocked 
with appropriate sera in PBS. After incubating with appropriate antibodies, sections were washed and 
incubated with fluorescence dye-conjugated second antibodies and 1 μg/ml of DAPI (Sigma-Aldrich). 
Stained sections were washed and mounted under a coverslip using Fluoro-gel with Tris Buffer (Electron 




For histological analysis, the colon tissue was paraffin embedded and 5-micron sections were cut, 
collected on coated slides and processed for Hematoxylin and Eosin (H&E) staining. Stained sections 
were examined using an Axio Observer fluorescence microscope (Zeiss). Histopathology scores were 
determined in a blinded fashion using the following criteria as previously described (Qualls et al., 2006): 
0, Normal tissue; Grade 1, mild inflammation was present containing mostly mononuclear cell infiltrate 
and little damage to the epithelia; Grade 2, inflammation greater than Grade 1 with mononuclear and 
polymorphonuclear infiltrate, mucin and Goblet cell depletion, and epithelium beginning to detach from 
basement membrane; Grade 3, inflammation and cellular infiltrate is greater than Grade 2 with cellular 
infiltrates reaching the submucosa, greater Goblet cell depletion, and greater epithelial disruption; Grade 
4, severe inflammation containing mostly neutrophils, completely detached epithelium, and crypt 
destruction. 
In vitro attachment 
Colon epithelial cells (CECs) were isolated from C57BL/6J mice as previously described (Flint et al., 
1991). Briefly the colon was resected under aseptic conditions and washed twice with ice-cold PBS. After 
opening the colon longitudinally and then dividing the colon into 2–3 mm long fragments, the tissue 
pieces were transferred into chelating buffer (27 mM trisodium cirtcrate, 5 mM Na2HPO4, 96 mM NaCl, 
8 mM KH2PO4, 1.5 mM KCl, 0.5 mM DTT, 55 mM D-sorbitol, 44 mM sucrose, 6 mM EDTA, 5 mM 
EGTA [pH 7.3]) for 25 min at 4°C. CECs were then further dislodged by repeated vigorous shaking. 
Tissue debris was removed by a 70-μm cell strainer (Fisher Scientific, Suwanee, GA) and CECs were 
harvested by centrifugation at 4°C. CEC viability was confirmed by trypan blue staining and isolated 
CECs were cultured at 37°C for 1 h for recovery, followed by infection with C. rodentium at MOI 100 in 
antibiotic free media. Post C. rodentium infection, infected CECs were spun down to Poly-L-Lysine-coated 
coverslips, fixed with 4% PFA, and stained with appropriate primary antibodies and fluorescence dye-
conjugated second antibodies. Following staining of nuclei with 1 μg/ml of DAPI (Sigma-Aldrich), 




Hatfield, PA) and examined using an Axio Observer fluorescence microscope (Zeiss, Oberkochen, 
Germany). The numbers of C. rodentium that attached to mouse CECs were quantified using ImageJ 
software (NIH, Bethesda, MD) and normalized to cell perimeter. 
RT-PCR and primers 
Total RNA was isolated from colon tissues at the indicated time points using Trizol reagent (Life 
Technologies) and treated with the TURBO DNA-free Kit (Life Technologies) to remove residual 
genomic DNA. cDNA was synthesized using qScript cDNA SuperMix Kit (Quanta Biosciences, 
Gaithersburg, MD) according to the manufacturer’s instructions. Gene specific products were amplified 
using SsoAdvanced SYBR Green Supermix (Bio-Rad Laboratories, Hercules, CA) with the following 
primers:  
Cxcl1-f, 5’-TGCACCCAAACCGAAGTCAT-3’;  
Cxcl1-r, 5’-TTGTCAGAAGCCAGCGTTCAC-3’;  
 
Cxcl2-f, 5’-CCTGCCAAGGGTTGACTTCA-3’;  
Cxcl2-r, 5’- TTCTGTCTGGGCGCAGTG-3’;  
 
Ifng-f, 5’-ATGAACGCTACACACTGCATC-3’;  








Nos2-f, 5’-GCCACCAACAATGGCAACA -3’; 





Il17a-f, 5’- TTTAACTCCCTTGGCGCAAAA -3’; 
Il17a-r, 5’- CTTTCCCTCCGCATTGACAC-3’; 
 
Il22bp-f, 5’- TGTGACCTGACCAATGAAACC -3’; 
Il22bp-r, 5’- CGACCGGAGGATCTAGTTTTGT-3’; 
 
Mmp9-f, 5’- CTGGACAGCCAGACACTAAAG -3’; 
Mmp9-r, 5’- CTCGCGGCAAGTCTTCAGAG-3’; 
 




Mmp10-r, 5’- CTGAGCAAGATCCATGCTTGG-3’; 
 
Mmp13-f, 5’-TGTTTGCAGAGCACTACTTGAA -3’;  
Mmp13-r, 5’-CAGTCACCTCTAAGCCAAAGAAA -3’; 
 
Icam1-f, 5’- GTGATGCTCAGGTATCCATCCA-3’; 
Icam1-r, 5’- CACAGTTCTCAAAGCACAGCG-3’; 
 
Il2-f, 5’-CCTGAGCAGGATGGAGAATTACA -3’; 
Il2-r, 5’- TCCAGAACATGCCGCAGAG-3’; 
 
Il4-f, 5’- GGTCTCAACCCCCAGCTAGT -3’; 
Il4-r, 5’- GCCGATGATCTCTCTCAAGTGAT -3’; 
 
Il10-f, 5’- GCTCTTACTGACTGGCATGAG-3’; 
Il10-r, 5’- CGCAGCTCTAGGAGCATGTG-3’; 
 




Il12-r, 5’-TCTCTGGCCGTCTTCACCAT -3’; 
 
Il20-f, 5’- TCTTGCCTTTGGACTGTTCTCC-3’; 
Il20-r, 5’- GTTTGCAGTAATCACACAGCTTC-3’; 
 
Il21-f, 5’-GGACCCTTGTCTGTCTGGTAG -3’; 
Il21-r, 5’- TGTGGAGCTGATAGAAGTTCAGG-3’; 
 
Il23-f, 5’-TGTTGCCCTGGGTCACTCA -3’; 
Il23-r, 5’- CCAGGCTAGCATGCAGAGATT-3’; 
 
Vcam1-f, 5’-GTGACTCCATGGCCCTCACT -3’; 
Vcam1-r, 5’- CGTCCTCACCTTCGCCTTTA-3’; 
 
PCR for mutation identification 
Bacterial cultures were grown overnight, 1ml of fresh culture was pelleted, washed in dH2O twice, and 
resuspended in 1ml dH2O. 5μl of bacteria was used a template for round 1 of PCR. Forward PCR 
primers were designed containing an artificial tag, a random sequence spacer, and an anchor sequence 




known transposon sequence. These primers used for PCR with the MyTaq Red Mix (BIOLINE, 
Massachusetts). The PCR conditions were as follows: 95°C for 5 min; 95°C for 30 sec, 42°C for 30 sec, 
72°C for 3 minutes (cycle 6 times); 95°C for 30 sec, 52°C for 30 sec, 72°C for 3 minutes (cycle 25 times). 
Dilute final product in 80μl of H2O and use 5μl for round 2 of PCR. A forward primer for the artificial 
tag from round 1 and a reverse primer for another transposon sequence were used for round 2. PCR 
conditions were as follows: 95°C for 5 min; 95°C for 30 sec, 45°C for 30 sec, 72°C for 3 minutes (cycle 
40 times). PCR clean up (Macherey-Nagel, Duren, Germany) was preformed according to manufacturer’s 
directions and samples were sent for sequencing. Sequencing results were screened for gene matches 
using BLAST (NCBI). Primers were generated specific to the identified gene for confirmation.  
 
Forward round 1- 5’-GGCCACGCGTCGACTAGTACNNNNNNNNNNCGGCG-3’ 
Reverse round 1- 5’-CGTTAAAACTGCCTGGCACAGCA-3’ 
Forward round 2- 5’-GGCCACGCGTCGACTAGTAC-3’ 
Reverse round 2- 5’-CGTCGAGTTTTTTGATTTCACGGG-3’ 
 
Statistics 
All statistical analysis was performed using GraphPad Prism version 6.0 (GraphPad Software, San Diego, 
CA). The difference between treated and control groups were examined by unpaired Student’s t tests. 
Standard errors of means (s.e.m.) were plotted in graphs. n.s. means non-significant difference and 






Figure 4.1 Mut1 causes limited morbidity and mortality in IL-22-/- mice. 
Mice were infected with either wild-type C. rodentium or Mut1 C. rodentium and monitored for weight loss (A), clinical 
score (B), and survival (C). Clinical score was measured as the sum of colitis disease scores for weight loss (1-5 






Figure 4.2 Mut1 C. rodentium has no growth or attachment defects. 
(A) OD readings were taken every hour for Mut1 C. rodentium and wild-type C. rodentium strains that were equally 
diluted in LB broth. OD600 readings were plotted by time. (B) CECs were harvested from IL-22-/- mice and 
infected with either Mut1 C. rodentium or wild-type C. rodentium in vitro, fixed, and stained as indicated. The number 
of adherent bacteria were counted per cell in 20 random fields and normalized to cell size. Scale bar, 10 um. (C) The 
fecal load of Mut1 C. rodentium and wild-type C. rodentium was determined by serial dilution of fecal pellets collected 
from IL-22-/- mice at the indicated time points. (D) The colons of Mut1 C. rodentium and wild-type C. rodentium 
infected IL-22-/- mice were isolated, fixed, and paraffin embedded at day 8 post infection. Tissue sections were 










Figure 4.3 Mut1 infection induces limited intestinal inflammation. 
IL-22-/- mice were infected with PBS, Mut1 C. rodentium, or wild-type C. rodentium and colon tissue was harvested at 
day 8-post infection. (A) Colon tissue was paraffin embedded and H&E staining was performed to examine the 
tissue pathology. Scale bar, 100 um. (B) RNA was extracted from 1cm long colon tissue sections. RT-PCTR analysis 





Figure 4.4 Continued RT-PCR panel. 
IL-22-/- mice were infected with PBS, Mut1 C. rodentium, or wild-type C. rodentium and colon tissue was harvested at 






Figure 4.5 Mut1 infection does not alter barrier permeability. 
IL-22 KO mice infected with PBS, Mut1 C. rodentium, or wild-type C. rodentium were euthanized at day 8-post 
infection. (A) Colon tissue was paraffin embedded and stained with anti-claudin-3. Scale bar, 20 um. (B) The liver 
and spleen of each animal was resected, homogenized in PBS, and plated onto MacConkey agar plates to determine 





Figure 4.6 Mut1 C. rodentium carries a disruption in a site-specific recombinase gene. 
Schematic of the round 1 (A) and round 2 (B) PCR primers and procedure used to generate the DNA fragment sent 
to sequencing to identify the area of disruption. (C) DNA gel electrophoresis of the products obtained from a PCR 
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The constant battle between invading pathogens and the host immune system is a fascinating and 
ever evolving area of study. Gaining a deeper understanding of the mechanisms involved in  both sides of 
the equation, would allow us to take more informed approaches toward the development of therapeutics 
and preventative measures. However, there are many challenges in studying host pathogen interactions in 
vivo and we are therefore forced to rely on reductionist and in vitro approaches. These approaches are very 
powerful in elucidating the detailed interactions that occur between proteins, but they must be brought 
back to the in vivo level for confirmation and validation. More specifically, three major hurdles that would 
greatly advance the study of how pathogen-encoded proteases alter host signaling would be 1) in vivo or in 
infection verification of substrate specificity to avoid pseudo-positive targets identified by in vitro protease 
assays; 2) a unified system to measure protease activity that would allow for better control and 
comparison of studies from different research groups; and 3) more sensitive detection methods to study 
the spatial-temporal activity, localization, and induction of pathogen-encoded proteases (or other 
virulence factors) during pathogen infections.  
Arguably, the development of more sensitive strategies for the detection of low expression level 
virulence factors would provide the greatest advantage to the field. The timing of when effectors are 
active during infection may be key to understanding why some studies report gene expression activation 
and others can report repression for the same pathogen. During infection by Citrobacter, Leishmania, and 
poliovirus (as discussed in chapters 2 and 3) the exact timing of the protease expression and cleavage 
events would clarify the delicate balance between activating NF-κB signaling and selectively turning off 
part of the response. While strong antibodies exist for the poliovirus 3C protease and at later stages of 
infection it is expressed at high levels, it is likely that early events are going undetected before the 
expression of 3C is greatly amplified during the viral infection cycle. Similarly, NleC is introduced into 
cells at low levels and determining its function and localization is difficult to do using infection 




in vitro experiments to delineate a pathophysiological relevant response. Improvements in these areas 
would generally benefit the study of host-pathogen interactions and protease activity and regulation. 
Pathogens have evolved multiple effective strategies to counteract the host immune response to infection 
and understanding the intricacies of these interactions will reveal more about the host immune response 
that had previously gone unnoticed. Our model (chapter 2) demonstrates that as the mechanisms of NF-
κB promoter specificity are further elucidated, studies demonstrating cleavage events of NF-κB proteins 
need to further characterize the fate of the cleaved products to determine if they have a biological 
function in the context of infection or host-mediated cleavage.  
The effect that complex host-pathogen protein interactions have on the global response to infection 
requires further inquiry. Basic research has enabled us to gain in-depth knowledge about the regulation of 
very specific protein functions and their effect on transcription. However, as technology advances, it 
allows for the greater examination of the crosstalk between multiple signaling pathways; thus it is 
becoming more important to holistically incorporate these functions into disease models. For example, as 
more “specifier” type proteins are uncovered to dictate the promoter selectivity of NF-κB signaling it will 
become important to define the specific target genes that are regulated by each “specifier” protein. These 
cohorts of genes can be identified through the use of knockdowns and chromatin-immunoprecipitation 
combined with sequencing (ChIP-seq). Following these advancements, profiles of NF-κB activation can 
be constructed relating to the specific stimuli and “specifier” function. Such frameworks, akin to the CD4 
T cell development profiles, will enable processing of the implications when a particular “specifier” is 
compromised, either through genetic mutation or pathogen interference.  
In the context of our current work (chapter 2), the implication of selectively blocking RPS3-
dependent genes is that the tempered immune response provides an advantage to the pathogen. It is 
known that following C. rodentium infection, IL-22 is induced and we have demonstrated an increase in 
IL-22 expression when NleC is unable to block RPS3. IL-22 is critical for protecting the host from C. 




blockade, likely benefits the bacteria. In this way C. rodentium can allow for low level IL-22 production, 
without inducing robust expression of mucins and anti-microbial peptides. Moreover, by selectively 
blocking RPS3-dependent genes but not global NF-κB-mediated transcription C. rodentium is modulating 
its environment to better suit its needs. Follow up studies should serve to link the host-pathogen protein-
protein interactions we observed to the larger tissue protective effects the induced immune response 
attempts to produce.  
It remains to be seen whether the selective regulation of NF-κB has an impact on the fitness of C. 
rodentium, independent of the effect on the host. In this regard, understanding how the inflammatory 
environment of the infected host alters bacterial gene expression remains to be elucidated. It is currently 
understood that C. rodentium induces the expression of certain virulence operons following exposure to 
bicarbonate within the gut, demonstrating that virulence genes can be regulated by environmental 
exposures.  The use of immunocompromised hosts, such as the IL-22-/- mouse, may be key to further 
revealing the regulatory mechanisms of bacterial virulence gene transcription as host defects may reveal 
signals that induce bacterial gene expression. Alternatively, using mutant bacterial strains such as our 
attenuated Mut1 C. rodentium strain that seemingly lack a DNA recombinase can also serve to identify 
novel regulatory mechanisms of bacterial gene expression. Given the inability to induce robust 
inflammation even in a compromised host suggests that the genes controlled by the DNA recombinase 
play a vital function in pathogenesis. However, as discussed in chapter 4, a significant amount of work is 
still required to understand the attenuation of the Mut1 strain and characterize the DNA recombinase 
protein given that we do not yet know which genes are regulated by this recombinase. 
The complex environment of the gastro-intestinal tract poses serious challenges for studying the in 
vivo interactions involved. Yet through a combination of in vitro studies, the development and use of new 
infection model systems and permissive hosts, and a better understanding of pathogen gene regulation 
significant contributions can be made to the field. Our studies discussed here serve as an example of how 




context of infection. By examining the regulatory mechanisms of gene expression and how either side 
hijacks these mechanisms will undoubtedly serve to further our understanding of the complex host 
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